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The brain is a fascinating organ, made up of billions of neurons within complex 
structural and functional networks that contribute to human behavior, health and 
disease. Over time, advanced whole brain and cellular imaging techniques have been 
developed to study the human brain at different scales, from microscopes capable of 
visualizing individual neurons to magnetic resonance imaging (MRI) machines that are 
capable of imaging the whole brain in action. However, these microscopic to 
macroscopic techniques often remain the domain of distinct neuroscience disciplines, 
and communication between these fields can be limited. Bridging the gap between 
these different disciplines and promoting interdisciplinary neuroscience creates 
exciting opportunities to advance our understanding of human behavior and mental 
health.  
One particularly interesting aspect of our brain is its capacity to undergo constant 
structural and functional reorganization, generally termed neuroplasticity. Proposed 
by Donald Hebb in 1949, the hypothesis that ‘neurons which fire together, wire 
together’ (1, 2), has led to most of our understanding on the mechanisms of activity-
dependent plasticity (3-5). In other words, neural cells are capable of forming 
functional connections, which allow for the encoding of new information. 
Neuroplasticity can explain how certain neuronal connections can become 
strengthened, while unused ones can be lost. Neuroplastic mechanisms are therefore 
mediating complex, activity dependent cognitive processes, such as learning and 
memory, that ultimately impact human behavior. Many mental and neurological 
disorders are characterized by dysregulation of neuroplastic mechanisms, for example 
when part of the brain is damaged (such as in brain injury or stroke), degrades (such 
as in cognitive decline or dementia), or has aberrant connectivity to other parts of the 
brain (such as major depressive disorder (MDD) or schizophrenia).  
Neuroplasticity can be studied at the molecular and cellular levels, but also at the 
whole-brain level. Dysregulated gene/protein expression can result in altered 
neuronal morphology and activity, leading to changes in neuronal firing that can be 
manifested at the whole-brain network level, and may result in altered human 
behaviour.  
At the microscopic level, it is important to understand the molecular and cellular 
mechanisms underlying neuroplasticity. It is equally important to understand, at the 
macroscopic level, how these neuroplastic changes can lead to certain behavioural 
effects.  
This thesis takes an interdisciplinary approach to investigating human neuroplastic 
mechanisms; from the microscopic to macroscopic level. This thesis focuses on how 
the non-invasive brain stimulation tool, transcranial magnetic stimulation (TMS), is 
able to induce neuroplastic effects in human neurons. At the microscopic level, 
human neurons are modelled using SH-SY5Y human neuroblastoma-derived cells. 
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These cells can be grown in a dish, and used to investigate molecular TMS-induced 
plasticity changes. At the macroscopic level, humans (both healthy and clinical 
participants) are stimulated with TMS, to indirectly measure plasticity changes in 
specific parts of the human brain. The overall aim of the series of studies presented in 
this thesis is to unravel the underlying mechanisms of neuroplastic changes induced 
by TMS, using both an in vitro model of human neurons, as well as healthy and clinical 
populations of human participants.  
Transcranial Magnetic Stimulation (TMS) 
TMS is a non-invasive form of brain stimulation, which uses electromagnetic pulses to 
induce an electric field in the underlying cortex, through stimulation which can pass 
through the intact skull (6). Electromagnetic pulses are delivered through a TMS coil, 
which is made of wound copper wires, the shape of which determines the depth and 
focality of the stimulation area (7, 8). In the most commonly used setup, electricity is 
sent through the TMS coil, generating a magnetic field of about 2 Tesla, which lasts 
about 100 μs (6, 7). Each TMS pulse reaches a depth of only a few centimetres, 
activating the outermost layer of the cortex directly below the stimulating coil (9). 
Computational modeling has shown that the TMS-induced electric field can directly 
activate axons in the stimulated area (10), causing an immediate, excitatory response 
in a focal area of proximal neurons (11).  
In humans, a single TMS pulse delivered to the motor cortex can activate corticospinal 
circuits, resulting in a visible finger movement. Electrodes placed on the finger can 
quantify the amplitude of this movement as a measure of cortical excitability, called a 
motor-evoked potential (MEP) (12).  
Interestingly, when multiple pulses are repeated in a certain pattern, as repetitive 
TMS (rTMS), lasting, neuroplastic effects on cortical excitability have been reported. 
The effects of different rTMS protocols on cortical excitability are often assessed 
indirectly, for example through MEPs. To do this, MEP amplitudes are compared 
before and after an rTMS protocol delivered to the motor cortex. rTMS protocols 
which decrease the amplitude of MEPs are considered to be inhibitory, and ones that 
increase the amplitude of MEPs, excitatory. 
Low frequency rTMS refers to pulses delivered at 1 Hz or lower, which have been 
shown to have inhibitory aftereffects (13).  Stimulation at frequencies higher than 5 
Hz are considered high frequency protocols, and have been shown to be excitatory 
(14-16). These classical high and low frequency stimulation protocols require 
stimulation sessions of about 20-30 minutes, with aftereffects lasting about 30 
minutes (17, 18). In 2005, a set of protocols called the theta burst stimulation (TBS) 




effects lasting between 20 and 60 minutes (19). The TBS protocols were adapted from 
theta burst patterns used to induce plasticity in animal research (20, 21). These 
patterns consist of triplet pulses delivered at 50Hz between pulses, with triplets 
repeated at theta frequency (5Hz) (19). Two rTMS TBS protocols were introduced; the 
first, intermittent TBS (iTBS), requires only 3 minutes of stimulation time, and has 
shown excitatory effects lasting around 20 minutes (19). In contrast, continuous TBS 
(cTBS) requires only 40 seconds of stimulation, with effects lasting about 60 minutes 
(19). A visualization of the stimulation pulse parameters be seen in Figure 1B. Due to 
their short duration and opposite effects on cortical excitability in humans, the TBS 
protocols have been widely used both in research and in clinical applications over the 
past 15 years. All experiments in this thesis use the TBS protocols to induce 
neuroplasticity, Chapters 3 and 4 use iTBS and cTBS, and Chapters 6-8 use iTBS.  
Recently however, several studies have been unsuccessful in attempts to replicate the 
expected effects of TBS protocols, namely that iTBS induces excitatory and cTBS 
inhibitory changes in excitability (22-25). This may be due to variability of MEPs as an 
indirect measure of cortical excitability. A large review of the range of variation in 
MEPs within healthy research subjects found that experimental factors such as coil 
placement, stimulation intensity, and pulse waveform, as well as biological factors 
such as skull thickness and brain volume, contribute to this variability (26).  
Other factors such as the internal state of the brain at the time of stimulation can also 
influence MEP variability (27, 28). For example, the brain is in a dynamic state of 
neural network and excitability fluctuations, which occur spontaneously but also as a 
result of previous neural activity (such as a cognitive task, motor activity, or even prior 
brain stimulation) (28-30). One way to monitor and account for the impact of brain 
state in rTMS experiments is to record ongoing neuronal oscillations using 
electroencephalography (EEG) (29, 31-33).  
Another benefit to recording simultaneous EEG in TMS experiments is to measure 
induced excitability changes in cortical areas other than the motor cortex. In addition 
to the intra and inter subject variability, another limitation of using MEPs as an 
outcome measure is that they are restricted to the motor cortex. Many research and 
clinical protocols apply rTMS to other cortical areas such as the dorsolateral prefrontal 
cortex (DLPFC), and assume that the effects are the same as in motor cortex. EEG-
recorded responses to single TMS pulses are called TMS-evoked EEG potentials (TEPs), 
and show peaks at predictable latencies immediately following the TMS pulse (34-36). 
Early TEP components (within 100ms of the TMS pulse) are thought to represent 
neuroplastic processes (34, 37). In contrast to MEPs, TEPs have been shown to be 
highly reproducible (36, 38), but confounds exist with this outcome measure as well. 
For example, the loud ‘click’ of the TMS pulse activates auditory and somatosensory 
processes, which are also represented in both early and late TEP components (39).  
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Additionally, few studies have used TEPs to assess plasticity changes after rTMS, and 
more research is required to better understand the capacity for TEPs as an outcome 
measure for rTMS-induced plasticity.  
In this thesis, Chapter 6 describes the use of MEPs to assess motor cortex excitability 
following repeated iTBS in healthy human participants. Chapter 7 combines MEPs and 
TEPs as outcome measures to assess neuroplasticity after iTBS. Finally, Chapter 8 
moves from the motor cortex to the DLPFC and examines the neuroplastic effects of 
iTBS in this cortical region.  
Microscopic: Cellular Studies with TMS 
In the first chapters of this thesis, exploratory experimental steps have been taken 
towards understanding the underlying molecular mechanisms of iTBS/cTBS induced 
plasticity in a human neuron model. The necessary background information, derived 
largely from research in animal and cellular model, is summarized in this section. 
What is plasticity? 
Neural plasticity refers to activity-dependent changes which can occur at the 
neuronal, neural network, and whole brain levels. At the molecular level, 
neuroplasticity is initiated by an influx of calcium, which can trigger signalling 
cascades, promote immediate and longer lasting gene expression changes, and result 
in protein expression and structural changes at the neuron/synapse (41, 42).  Briefly, 
an activity-induced calcium influx activates a series of calcium dependent signalling 
cascades, triggering rapid changes in the expression of genes which can act as 
transcription factors to regulate the expression of important later-response plasticity 
genes (42, 43). These later-response genes can lead to alterations of neuron or 
synapse structure and excitability (43). Such structural alterations can include neurite 
outgrowth (axonal or dendritic), synapse formation or elimination, spine density, and 
changes to the excitatory/ inhibitory balance (44, 45).  
The neuroplastic effects of rTMS are thought to work through long-term potentiation 
(LTP) or long-term depression (LTD) like mechanisms (17, 46, 47). LTP and LTD are 
among the most commonly studied forms of activity-dependent synaptic plasticity, 
and provide a mechanistic explanation to Hebb’s theoretical postulate, which 
proposed that if a neuron repeatedly causes another neuron to fire, this connection 
will become strengthened (1, 3), i.e. “neurons which fire together, wire together” (2). 
For example, with LTP, a synapse that is repeatedly stimulated will be strengthened 
(4). With LTD, a synapse which is not stimulated frequently, will be weakened (48). 
The pattern (frequency) of stimulation determines whether LTP or LTD will be 




electrical stimulation protocol widely used to induce LTP in vitro is a 4-pulse burst at 
100Hz, repeated at 5Hz for 10 bursts (21, 50).  
Mechanisms such as intracellular signalling and synapse modifications are thought to 
underly neural plasticity effects. Such activity-dependent strengthening/weakening of 
specific synapses are thought to underlie the neural encoding of information, and may 
represent the fundamental mechanisms of learning and memory (51). Both LTP and 
LTD work through activation of N-methyl-D-aspartate (NMDA) receptors at the post 
synapse, which trigger calcium signalling and complex intracellular cascades. These 
changes result in post synaptic modifications, such as α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptor trafficking which alter the synapse strength 
(48, 51-54).  
Hypothesized rTMS-induced plasticity effects 
Research in animal models and human pharmaceutical studies have provided 
evidence for rTMS induced neuroplasticity working through LTP/LTD like mechanisms. 
In humans, pharmaceutically blocking the NMDA receptor completely abolished TBS 
effects (59). Since the NMDA receptor is critical for LTP/LTD (59-61), this finding 
supports the hypothesis that TBS effects are related to LTP/LTD-like synaptic plasticity 
(59). The complex signalling pathways underlying rTMS induced neuroplastic effects 
have mainly been researched in animal models, or in brain tissue derived from 
rodents, either in organotypic slice cultures, or dissociated into neural cell cultures. 
Research has mainly been focused on two main neuron types: excitatory 
glutamatergic neurons, and inhibitory GABAergic neurons (46, 47, 62, 63).  
About 80% of neurons in the neocortex are excitatory glutamatergic projection 
neurons which send axons to other, often remote, brain areas (64) and are known to 
be important in neuroplasticity (51). The remaining approximately 20% of the 
neocortex is comprised of interneurons, which, in contrast to excitatory projection 
neurons, have local connections and are mostly inhibitory, thereby modulating the 
activity of excitatory projection neurons (64). Interneurons are highly diverse, and can 
be classified based on several parameters such as the presence of different calcium 
binding proteins (CaBPs) (65).  Neurons expressing calbindin D-28K (CB) are important 
in synaptic plasticity, those expressing calrectin (CR) exhibit control over other 
inhibitory interneurons, and neurons expressing paravalbumin (PV) are largely 
responsible for the output and synchronization of action potentials of large groups of 
excitatory projection neurons (65).  
Studies in animal models such as rodents and non-human primates, mainly 
investigating effects on glutamatergic or GABAergic neurons (expressing different 
CaBPs), have uncovered a range of plasticity-related changes in calcium signalling, 




As briefly mentioned above, an initial rise in calcium levels and the resulting induction 
of calcium signalling is a critical first step in activity-dependent plasticity (66). During 
LTP/LTD, a transient increase in intracellular calcium can initiate calcium signalling, 
leading to synaptic modifications which can alter synaptic strength, thereby 
underlying activity dependent plasticity (48, 51-54). Measuring the change in 
amplitude of these immediate calcium transients can indicate that a particular 
intervention successfully induced plasticity changes, altering the responsiveness 
(excitability) of the neuron. An immediate increase in the amplitude of calcium 
transients can indicate LTP, while smaller amplitude changes can indicate LTD (67).  
In animal organotypic slice cultures, single TMS pulses (68), as well as pulses delivered 
in a sequence as rTMS (69), were able to promote an immediate calcium release from 
intracellular stores of excitatory neurons (68, 69). Different patterned rTMS protocols 
(10Hz, cTBS) with different expected excitability effects (10Hz excitatory, cTBS 
inhibitory), both promoted an increase in intracellular calcium release (69). In this 
study, the intensity of stimulation was too low to induce an action potential, and yet 
stimulation induced a release of intracellular calcium (69). Intracellular calcium 
release independent of an action potential can indicate plasticity effects (70), 
providing support for the potential of rTMS  to induce plasticity.  
Few studies have investigated immediate calcium release in human neural cultures 
after iTBS or cTBS. Changes in intracellular calcium levels can be measured in living 
neurons through fluorescence probes, which bind to calcium and be visualized with 
fluorescence microscopy (41). In Chapter 3, the immediate effects of iTBS and cTBS on 
calcium activity in human neuron-like cells are measured. In this chapter, Fluo-4AM 
(F14201, ThermoFisher) fluorescence calcium indicator was used to visualize changes 
in calcium levels. This was done by quantifying fluorescence intensity immediately 
before and after iTBS, cTBS or sham stimulation, as well as after chemical 
depolarization with KCl. Fluorescence levels were measured before stimulation as an 
indicator of baseline fluorescence, after stimulation to visualize any spontaneous 
calcium activity indued by stimulation, and most importantly, after chemical 
depolarization, to measure the stimulation-induced change to neural responsiveness.  
An example of the increase in fluorescence which can be visualized following chemical 
depolarization in the human neuron-like model used can be seen in Figure 1C. These 
calcium effects detected immediately following stimulation are important first 
outcome measures in understanding rTMS-induced neuroplasticity, as an initial rise in 
calcium influx is a necessary first step in plasticity induction (66).  In the next chapter 
(Chapter 4), plasticity effects such as gene expression and structural neuronal changes 





LTP can be divided into two phases, the early phase (E-LTP) and the late phase (L-LTP). 
E-LTP occurs immediately following stimulation, and is induced by transient calcium 
influx and NMDA receptor activation (52). E-LTP is protein-synthesis independent, and 
works largely through the activation of enzymes and protein kinases such as 
Ca2+/calmodulin -dependent protein kinase II (CaMKII) (56, 71). It is induced by brief 
stimulation and effects can last 1-3 hours. L-LTP can be induced with stronger or 
repeated stimulation, and the effects can last at least 24 hours (55, 57, 58). L-LTP 
requires protein synthesis, and can lead to longer lasting structural changes at the 
synapse (55-58). These changes rely on the activation of signalling cascades, and lead 
to the structural remodelling of synapses, which are thought to be the molecular 
events responsible for long term memory (45, 71). In contrast to live calcium imaging, 
changes in gene expression are measured from extracted tissue or cells, and the 
quantification of expression of single genes can be determined by quantitative PCR. 
Immediately after an activity-induced calcium influx, for example in the induction of 
LTP, early gene expression effects are often measured in the levels of immediate early 
genes (), which are rapidly upregulated and do not rely on new protein synthesis (72-
74). IEGs can act as transcription factors, which regulate the expression of other later 
response genes. These later response genes are often responsible for longer lasting 
plasticity effects (43). For example, LTP-inducing stimulation results in an immediate 
increase in the expression of the IEG early growth response 1 (EGR1) (76). EGR1 
expression is also critical in the switch from E-LTP to L-LTP (73), and initiates the 
expression of other plasticity genes (77).  
In animal models, rTMS has been shown to alter the expression of genes important in 
cell firing activity (79-82), as well as genes involved in cell survival, cytoskeletal 
remodeling (69), and neuronal growth and regeneration (83). High frequency rTMS, 
thought to be excitatory (16), has been shown to increase the expression of the 
GLUR1 subunit of the AMPA receptor (84), which is known to be involved in synapse 
modifications during LTP/LTD (85). rTMS was also shown to increase the expression of 
brain-derived neurotrophic factor (BDNF) (82, 86, 87) important in LTP (88-90).  rTMS 
has also been shown to increase the expression the neurotrophic tyrosine receptor 
kinase B (TrkB), the high-affinity receptor of BDNF, as well as several other genes 
involved in synapse formation (91).   
In Chapter 4, changes in the expression of BDNF and TrkB, as well as downstream 
signalling targets in the BDNF-TrkB signalling pathway are investigated. When BDNF 
binds to TrkB, several intracellular signalling cascades are activated (71). A simplified 
diagram of important targets in this signalling pathway (adapted from Minichiello 
(2009) (71)) can be seen in Figure 1D. Gene expression changes in these three 
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pathways are responsible for effects such as plasticity behaviour, synaptic plasticity 
and growth and differentiation (71).  
Structural Changes 
Activity-induced calcium influx can regulate differential patterns of gene expression, 
which can lead to protein-synthesis dependent structural changes in neurons (45).  
Structural changes can include axon or dendritic growth, synapse strengthening or 
maturation, and dendritic spine density, all of which alter the strength and number of 
connections between neurons (44, 45). Structural changes in neurons are commonly 
measured in fixed cells or extracted tissue, using fluorescence microscopy to visualize 
the distribution of a particular protein of interest; for example, a protein known to be 
involved in plasticity effects. Important in this thesis are plasticity changes to the 
cytoskeleton, which consists of several proteins capable of re-organize in response to 
activity such as LTP-induction (93). Cytoskeletal remodelling, in particular of the 
protein F-actin, is thought to be important in LTP and memory consolidation, as well 
as involved in the conversion from E-LTP to L-LTP (94). These structural effects can be 
immediate (within 30 minutes of stimulation, but can also last for hours or days (45). 
The effects of rTMS on neuron morphology have been studied in both animal and 
cellular models. High frequency rTMS has been shown to affect dendrites closest to 
the soma (cell body) of excitatory neurons (96). Using electrophysiological recordings, 
the synaptic responses were shown to be AMPA receptor-mediated, further 
supporting the hypothesis that rTMS effects are LTP/LTD plasticity-like. Additionally, 
high frequency rTMS has been shown to strengthen glutamatergic neurons through 
remodeling of small dendritic spines (97). This provides further support for LTP-like 
plasticity effects after high frequency rTMS, as the rTMS-induced changes involved the 
NMDA receptor, and resulted in an accumulation of AMPA receptors (97).   
In addition to excitatory neurons, TMS can also alter the level of inhibition on 
excitatory neurons (63, 98-104). This has been shown following 10Hz stimulation, 
which is assumed to be excitatory (16), by measuring a reduction of inhibitory 
synaptic strength on excitatory neurons (105). iTBS has also been shown to affect the 
strength of inhibitory GABAergic interneurons (99). 
The effects of iTBS on the expression on different inhibitory interneurons (PV, CB, or 
CR interneurons), was shown in rat studies to differ depending on the strain of rat 
(101). This is thought to be due to different basal expression patterns of CaBP’s, which 
contribute to differences in cortical network properties. The maturity of PV 
interneurons was also shown to parallel iTBS effects, suggesting that iTBS may have 
different effects depending on when stimulation is applied during neurodevelopment 
(103, 106). iTBS has also been shown to specifically decrease the activity of PV-




Interestingly, these effects were abolished by co-application with an NMDAR 
antagonist (100), aligning with human pharmacological studies showing NDMAR-
dependence of iTBS effects (59).  
In summary, in animal models, iTBS has been shown to affect not only the structure of 
excitatory neurons but also the strength of inhibition of interneurons on excitatory 
neurons (98, 99, 101, 106, 108). TMS affects excitatory neurons at excitatory synapses 
closest to the cell body (96), and enlarges small excitatory dendritic spines (97). 
Additionally, iTBS specifically reduced PV-expressing interneurons, which are 
important for synchronizing activity of pyramidal cells (65). These effects were 
strongest after 2400 pulses (108), were rat-strain dependent (101), and thought to 
relate to neuronal growth and maturation, indicating an age-dependency of iTBS 
effects in rats (102, 103, 106).  
In Chapter 4 the effects of iTBS and cTBS on cytoskeletal re-organization in two 
important cytoskeletal proteins: βIII-Tubulin and microtubule associated protein 2 
(MAP2) are investigated. βIII-Tubulin is the most dynamic of the six tubulin isotypes 
found in mammals, and is largely involved in axonal guidance and maturation (109, 
110). βIII-Tubulin is predominantly expressed in axons, while MAP2 is expressed 
mainly in dendrites (111). In our human neuron-like model, βIII-Tubulin was very 
strongly expressed, in contrast to MAP2. Therefore, analyses on structural changes 
after iTBS/cTBS were done using βIII-Tubulin only. An example of the distribution of 
these two cytoskeletal proteins (βIII-Tubulin in green, MAP2 in red) can be seen in 
Figure 1A, showing the differentiation process, and Figure 1E, which shows the two 
proteins side by side and in a merged image.  
Human Neuron-Like Model 
While animal models have proven incredibly valuable in understanding the 
neuroplastic changes induced by TMS, there are limitations to the use of animals as 
models for the human brain. For example, there is often poor transferability of rodent 
models to specific human neurological disorders (113). In addition, human neuronal in 
vitro models may be able to more accurately represent human neuronal networks 
than rodent neurons (114). In order to fully understand the underlying mechanisms of 
rTMS, a reliable, human in vitro neuronal setup would be beneficial. A human 
neuronal model could both verify the evidence of neuroplasticity changes from 
studies on animals, and confirm that rTMS is capable of directly inducing 
neuroplasticity in human neurons. In light of the above-mentioned difficulty 
replicating the established effects of the TBS protocols (22-25), due largely to the 
variability of indirect outcome measures (MEPs) used to assess them, verification of 
the neuroplastic effects in a human neuronal setup is important.  
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However, only two studies have investigated TMS-induced neuroplasticity effects in a 
human neuronal cell culture model prior to Chapters 3 and 4. One used high 
frequency (5Hz) stimulation and reported an increase in the expression of cFOS and 
phosphorylated CREB, both of which are activity markers and indicate increased 
plasticity effects following stimulation (115). Another study looked specifically at the 
effects of different stimulation frequencies on catecholamine release, finding a 
decrease in dopamine, L-DOPA and norepinephrine after 3Hz stimulation and an 
increase in norepinephrine after 9Hz stimulation (116).  
Both these studies were carried out on SH-SY5Y cells, a commonly used human 
neuronal cell line. These cells were originally derived from a neuroblastoma, and can 
be fully differentiated to a mature, neuronal-like state (92, 117-120). Once 
differentiated, SH-SY5Y cells express a catecholaminergic phenotype, and are 
commonly used to model Parkinson’s disease (121). In addition, differentiated SH-
SY5Y cells form functional synapses, and have therefore been extensively used to 
investigate human neuronal plasticity (92, 117, 120, 122-125). SH-SY5Y cells express 
many genes of interest for investigating TMS-induced neuroplastic effects such as 
those involved in synaptic plasticity and the BDNF-TrkB pathway (92, 120, 124, 126). 
They also express important morphological markers of plasticity, such as βIII-Tubulin 
and MAP2, which allow for the visualization of neuronal cytoskeletal structure (120). 
Figure 1A shows an example of SH-SY5Y cell morphology before and after 
differentiation. Functional effects can also be measured, with electrophysiology or live 
calcium imaging (120, 122, 127).  
The main aim of the first three chapters of this thesis was thus to better understand 
the functional and molecular plasticity changes induced by rTMS in a human neuronal 
cell culture model, specifically at the level of calcium imaging, gene expression and 
morphology. The effects of rTMS on plasticity genes and morphological markers 
associated with plasticity were investigated, therefore it was important to first 
confirm that the cell growth and differentiation conditions would not interfere with 
(or potentially mask) our intended outcome measures.  SH-SY5Y cells are derived from 
a tumour cell line, and consist of both neuron- and epithelial-like cells (128). To 
reduce the epithelial-like and promote the growth of neurons in the culture, SH-SY5Y 
cells are differentiated through addition of specific molecules such as retinoic acid 
(RA) and often by reducing the concentration of supplemented serum in the culture 
media, for example from 10% to 3% (117-119). Once differentiated, there is 
considerable variability in the pre-experimental handling of these cells, for example 
some completely remove all supplemented serum (the remaining 3%). This is done to 
prevent confounding effects of the molecular growth factors in the serum, as well as 
to ensure cells are all in the same phase of the growth cycle before experimentation 
(129, 130). However, since supplemented serum is removed to promote 




result in molecular changes which could potentially interfere with the outcome 
measures we intended to measure following rTMS. In Chapter 2, the effects of 
removing supplementary serum from SH-SY5Y cell growth medium on gene 
expression and morphological markers of plasticity are described. We hypothesized 
that if serum supplementation has a strong effect on the gene expression and 
morphological outcome measures following TMS, this may confound the results and 
mask TMS-related plasticity effects. In Chapter 3, differentiated SH-SY5Y cells are used 
to visualize immediate effects of rTMS on calcium activity, and in Chapter 4 to 
investigate the effects of rTMS on gene expression and morphological markers of 
neuroplasticity.  A visualization of the progression of these first chapters can be seen 
in Figure 1 A-E. 
Link to Human Studies 
While the first half of this thesis focuses on the effects of rTMS in a living human 
neuron-like model, the second half investigates the neuroplastic effects of iTBS on 
living human subjects. To connect the cellular studies described in Chapters 2-4 to the 
human studies described in Chapters 6-8, a mini review (Chapter 5) is included.   
Chapter 5 reviews homeostatic metaplasticity and brain stimulation, providing a link 
between animal/cellular research and human brain stimulation studies. It is important 
to understand the underlying mechanisms induced by TMS, and the time scale of 
plasticity-promoting mechanisms. This chapter describes a way to harness metaplastic 
mechanisms to optimize research and clinical stimulation protocols.  
Macroscopic: Human Studies with TMS 
The range of cellular studies described so far are crucial for understanding and 
optimizing rTMS protocols for use in humans. In research, rTMS is used in humans to 
induce reversible neuroplastic changes non-invasively, for example to perturb and 
investigate the involvement of a brain area in a particular task or function, or to probe 
connectivity between different nodes in a neural network (7). rTMS also has many 
important clinical applications, for example in the treatment of depression (135-137). 
The neuroplastic effects of iTBS in healthy humans are investigated in Chapters 6 and 
8 and in a patient population with type II diabetes mellitus (T2DM) in Chapter 7. 
Clinically, rTMS is a valuable treatment option for a range of psychiatric and 
neuropsychological disorders (137).  It is most commonly used as a treatment option 
for major depressive disorder (MDD), where large, multi-centre clinical trials have 
shown beneficial results with a 37.5 minute, 10Hz stimulation protocol to the DLPFC 
(136, 138). Recently, iTBS has been shown to be equally as effective as the 10Hz 
protocol, indicating a time-effective alternative (139). This is beneficial to clinical 
treatment centres, as it increases the number of patients that can be treated per day 
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by a single TMS machine and TMS specialist. However, MDD treatment normally 
requires daily stimulation, with patients having to come to the clinic five days a week 
for four to six weeks. Such a treatment schedule is rather inconvenient for patients, 
certainly if they live far from treatment centres. To increase antidepressant response, 
and to decrease the number of days that patients have to come to the clinic, studies 
have begun testing protocols that condense multiple stimulation sessions into one 
treatment day. These protocols are called ‘accelerated rTMS protocols’, and have 
recently been shown to be safe and well tolerated by patients (140, 141). iTBS 
protocols are particularly interesting for accelerated protocols, due to their short 
stimulation duration.  
Several studies have examined the efficacy of accelerated iTBS protocols for treating 
MDD, finding a decrease in the Hamilton Depression Rating Scale (HDRS-17) (142, 
143), a score of depressive symptom severity that is often used to assess treatment 
responses in MDD. This clinical effect is intriguing, and prompts research in the 
neuroplasticity effects of accelerated iTBS protocols. As described earlier, these 
effects can be assessed indirectly in humans by measuring MEPs before and following 
a particular rTMS protocol. The results of such an experiment are described in 
Chapter 6 of this thesis. Different stimulation conditions are compared: accelerated 
iTBS (consisting of five times the traditional iTBS protocol) with either i) 8, or ii) 15 
minutes between each iTBS, iii) single iTBS, and iv) sham stimulation (Figure 1F). MEPs 
were assessed before and 90 minutes after the stimulation paradigms. This chapter 
provides valuable information on the neuroplastic effects of accelerated iTBS with 
varying (short) time intervals between iTBS sessions in the motor cortex.  
While TMS is most commonly used in the treatment of MDD, it can also be used as a 
diagnostic tool in other clinical applications where neuroplasticity may be affected by 
disease progression. A rather unexpected example is the use of TMS in T2DM 
patients. T2DM is an increasingly prevalent disease worldwide, characterized by 
insulin resistance, and resulting in serious comorbidities such as cardiovascular 
disease (144), renal failure (145) and hypertension (146).  In addition, damage to the 
central nervous system is present in the majority of T2DM patients, which is reflected, 
at least partly, in signs of altered neuroplasticity (147, 148). 
Interestingly, T2DM patients are at a much higher risk of developing cognitive 
impairment and dementia (149-153), including Alzheimer’s disease (154-158).  This is 
likely a result of both altered glutamatergic neurotransmission and NMDA receptor-
dependent LTP-like plasticity, which are affected at the earliest stages of insulin 
resistance (147). Further, T2DM patients have shown altered responses to iTBS and 
TMS-related methods of assessing cortical excitability (159). For example, the MEP 




plasticity, and cognitive decline was confirmed with lower verbal learning scores on 
cognitive tests (148).  
However, T2DM patients with normal TMS-related measures and non-T2DM patients 
with impaired fasting glucose levels may be less likely to develop dementia (148). 
Therefore, TMS offers an excellent opportunity to diagnose patients with impaired 
neuroplasticity mechanisms at an early stage of insulin resistance. If these patients 
show abnormal reactivity to plasticity-inducing protocols (iTBS) or alterations in TMS-
based outcome measures (i.e. MEPs or TEPs) before they show clinical manifestation 
of cognitive decline, this could serve as a potential ‘biomarker’ of T2DM-related 
cognitive impairment or even dementia. In Chapter 7, iTBS is used to assess 
neuroplasticity in patients with clinically diagnosed T2DM, as well as control group of 
participants with high BMI and no clinical diagnosis of T2DM. To characterize 
participants as having ‘insulin resistance’, blood samples were taken to calculate the 
degree of insulin resistance (using the homeostatic model assessment for insulin 
resistance (HOMA-IR) score). Participants are subjected to iTBS or sham stimulation 
over their motor cortex, followed by MEPs and TEPs to assess neuroplasticity effects 
across sessions. These measures are then compared across groups (insulin resistant 
versus matched control), and evaluated for an association between insulin resistance 
and plasticity measures.  
This chapter adds several important dimensions to the overall main aim of assessing 
neuroplasticity induced by rTMS in an interdisciplinary approach in this thesis. First, it 
uses iTBS, the rTMS protocol used across all chapters in this thesis, both in humans 
and in cell culture. Secondly, it combines the outcome measure used in Chapter 6 
(MEPs) with simultaneous EEG to assess TEPs, and third, assesses neuroplasticity 
measures in a patient population known to have altered neuroplasticity mechanisms 
(147). The advantages of a multi-modal (combined TMS-EEG and fMRI) approach are 
further exploited in the last chapter of the thesis.  
Multimodal TMS-EEG-fMRI 
Finally, this thesis concludes with a chapter that brings several methods and 
techniques together to assess neuroplasticity in healthy human participants. As 
described in earlier sections, the neuroplasticity effects of rTMS can be examined at 
different human cellular to whole brain levels: for example, with calcium activity, gene 
expression, and neuronal morphology, as well as indirect measures of neural 
excitability such as with MEPs and TEPs. However, there are some limitations to both 
of these approaches. Cell culture in vitro modeling for example, lacks the complex 
structural organization of the human cortex. The use of MEPs, as described above, is 
hindered by substantial inter- and intra- subject variability (23-25). TEPs may be a 
more reliable alternative (36, 38), but are confounded by auditory and somatosensory 
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processes (39), and are not yet commonly used to assess neuroplastic changes after 
rTMS protocols.  
Additionally, as was briefly mentioned earlier in the introduction, MEPs can only be 
assessed over the motor cortex. This is a major limitation when studying clinical 
applications, such as MDD, as rTMS is often delivered to the left DLPFC (135, 136). The 
choice for this area is based on imaging studies, which found that patients with MDD 
show altered functional connectivity within particular frontal areas and with deeper 
cortical networks (160-163). It is suggested that excitatory (10Hz or iTBS) rTMS to the 
left DLPFC has a facilitatory effect on frontal areas, and that antidepressant efficacy is 
related to functional connectivity to deeper cortical targets such as the subgenual 
anterior cingulate cortex (sgACC) (164, 165). It has been shown that single TMS pulses 
to the DLPFC can activate subcortical structures such as the (sg) ACC (166, 167), 
however, there is little evidence of any iTBS-induced modulation of such activation. In 
addition, the effect of ongoing brain state on how effective single pulses to DLPFC can 
propagate signal to ACC is relatively unknown.  
In Chapter 8, TMS, EEG recordings, and fMRI are combined in a multimodal setup, 
aimed to activate and probe signal propagation through deeper cortical structures. 
Both rTMS and single TMS pulses are used. First iTBS is delivered to left DLPFC to 
induce neuroplastic changes, and then single TMS pulses are delivered to the left 
DLPFC, while in the MRI and simultaneously measuring the blood oxygenated level 
dependent (BOLD) signal. EEG adds another important dimension to the 
measurement, by assessing ongoing neural oscillatory firing patterns. Neurons firing 
at alpha frequency (~ 10Hz), have been shown to be related to response to TMS 
stimulation (32, 168), making this frequency particularly interesting for understanding 
whether brain state plays a role in TMS signal propagation.  
Combining TMS-EEG-and fMRI in this final chapter makes it possible to answer several 
important questions regarding the neuroplastic potential of iTBS in the human brain.  
It allows for the investigation of whether iTBS stimulation is able to induce 
neuroplastic changes in network activity, and in deeper cortical structures, whether 
these neuroplastic iTBS effects can be probed by single TMS pulses to DLPFC, and 
finally whether TMS pulses delivered at high or low power of the ongoing alpha 
oscillation are capable of improving signal propagation. This final chapter adds an 
additional method for measuring human brain activity (fMRI), completing the thesis 
which consists of a range of research samples (cellular, human), techniques, and 





Outline of the Thesis 
The interdisciplinary approach taken in this thesis has the overall aim of unravelling 
the underlying neuroplastic mechanisms of rTMS; progressing from human neuronal 
in vitro experiments to human in vivo experiments. Experimental chapters range from 
studying the molecular neuroplastic events induced by iTBS/cTBS in cell culture, to 
measuring the macroscopic effects of iTBS in human participants.  
In Chapter 2, the human neuronal cell culture model, SH-SY5Y cells is introduced. This 
chapter is critical in describing the pre-experimental conditions of the human neuron-
like model used in subsequent chapters. 
In Chapter 3, the immediate effects of iTBS/cTBS are quantified using live calcium 
imaging. This chapter introduces the setup of stimulating living human neurons (SH-
SY5Y cells) with rTMS, as well as uses an immediate outcome measure (calcium 
imaging), capable of detecting early neuroplastic-like changes in cell activity.   
Chapter 4 moves past the immediate effects described in chapter 3 and quantifies the 
effects of iTBS, cTBS and sham stimulation on gene expression and morphological 
markers of plasticity, for up to 24 hours after stimulation. This is one of the first 
studies to investigate neuroplasticity-induced mechanisms after TBS in human 
neuron-like cells. 
Chapter 5 links chapters 2-4 (the in vitro human neuron studies) to chapters 6-8 (the 
in vivo human studies) in a mini-review of metaplasticity in brain stimulation. It 
specifically discusses how evidence from animal and cell culture studies can be used 
to optimize rTMS protocols for use in research and clinics.  
Chapter 6, is the first chapter involving healthy human participants, who were 
stimulated with accelerated (5x) iTBS over the motor cortex. Accelerated iTBS is a 
promising stimulation protocol for clinical applications, but the neuroplastic effects 
had yet to be established in healthy participants. This chapter is important to validate 
the neuroplastic effects of accelerated iTBS, and to optimize parameters for future 
clinical applications.   
In Chapter 7, TMS is used to assess neuroplasticity in a clinical population (T2DM 
patients), known to have altered neuroplastic mechanisms due to severe insulin 
resistance (147). The main aim of this chapter was to use TMS-based measures of 
neuroplasticity and excitability to find a potential ‘biomarker’ of early cognitive 
decline in insulin-resistant patients.  
Finally, in Chapter 8, a TMS-EEG-fMRI multimodal setup is used to measure the 
neuroplastic effects of iTBS stimulation on cortical and subcortical structures after 
stimulation of the left DLPFC. EEG signal is used to determine whether signal 
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propagation effects are dependent on brain state. This final chapter combines several 
techniques to assess neuroplasticity induced by iTBS in the human brain.   
Finally, the general discussion summarizes the findings of the six experimental 
chapters and one mini-review chapter, and discusses these findings in the broader 
context of neuroplasticity induced by TMS. It considers both the strengths and 
limitations of the techniques and methods used, and proposes future studies, which 
can build on these findings to improve, optimize and even personalize the future of 
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Figure 1: Visual progression of thesis chapters. A. Differentiation of SH-SY5Y cells, 
from immature cells to a mature, neuron-like cell phenotype with long neurite 
extensions. Blue=DAPI (cell nucleus), Green=βIII-Tubulin, Red=MAP2. B. Theta burst 
stimulation protocols. Continuous theta burst stimulation (cTBS) is a 40 second 
protocol, assumed to be inhibitory. Intermittent theta burst stimulation (iTBS) is a 190 
second protocol, assumed to be excitatory (19). The electric field induced within the 
cell culture dish, modelled using SimNIBS (169) using the cell culture dish parameters 
shared by (104). C. An example cell showing an increase in fluorescence-labelled 
calcium during the addition of 1M KCl. The background is turquoise, and pink indicates 
an increase in calcium (increase in cell activity). D. An adapted simplification of the 
BDNF-TrkB pathway (71) of interest in this thesis for gene expression in Chapter 4. E. 
An example neuron showing the proteins used for immunocytochemical analysis. 
Green=βIII-Tubulin, Red=MAP2, Yellow=Merge of both images. F. Stimulation setup 
for Chapter 6; accelerated iTBS. Stimulation with iTBS (5 times), with either 8 or 15 
minutes between. For single iTBS, only the last iTBS was real, for sham, all stimulation 
was placebo. G. An example of an MEP, a TEP, and the distribution of the strength of 
the EEG signal (30ms after TMS pulse, in µV). H. Stimulation setup for chapter 8. iTBS 
was delivered offline (outside the MRI), followed by single TMS pulses every 15-17 
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Chapter 2  
The effects of serum removal on gene 
expression and morphological plasticity markers 
in differentiated SH-SY5Y cells 
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Despite the widespread use of the SH-SY5Y human neuroblastoma cell line in 
modelling human neurons in vitro, protocols for growth, differentiation and 
experimentation differ considerably across the literature. Many studies fully 
differentiate SH-SY5Y cells before experimentation, to investigate plasticity measures 
in a mature, human neuronal-like cell model. Prior to experimentation, serum is often 
removed from cell culture media, to arrest the cell growth cycle and synchronize 
cells. However, the exact effect of this serum removal before experimentation on 
mature, differentiated SH-SY5Y cells has not yet been described. In studies using 
differentiated SH-SY5Y cells, any effect of serum removal on plasticity markers may 
influence results. The aim of the current study was to systematically characterize, in 
differentiated, neuronal-like SH-SY5Y cells, the potentially confounding effects of 
complete serum removal in terms of morphological and gene expression markers of 
plasticity. We measured changes in commonly used morphological markers and in 
genes related to neuroplasticity and synaptogenesis, particularly in the BDNF-TrkB 
signaling pathway. We found that complete serum removal from already 
differentiated SH-SY5Y cells increases neurite length, neurite branching, and the 
proportion of cells with a primary neurite, as well as proportion of βIII-Tubulin and 
MAP2 expressing cells. Gene expression results also indicate increased expression of 
PSD95 and NTRK2 expression 24 hours after serum removal. We conclude that serum 
deprivation in differentiated SH-SY5Y cells affects morphology and gene expression, 
and can potentially confound plasticity-related outcome measures, having significant 
implications for experimental design in studies using differentiated SH-SY5Y cells as a 
model of human neurons. 





SH-SY5Y cells are a human neuroblastoma-derived cell line used to model human 
neurons in vitro. The original cells were derived from a bone marrow biopsy in 1970, 
and were cloned to produce the neuron-like SH-SY5Y cells that are used in a wide 
range of research applications today (1). These cells synthesize various 
neurotransmitters, express neural markers, and can be further differentiated in vitro 
to a mature human neuronal phenotype (2-5). Once differentiated, SH-SY5Y cells 
express a catecholaminergic phenotype, with the potential to synthesize both 
dopamine and noradrenaline (6). They can be used to study synapse modifications 
and functional cellular activity with live calcium imaging or electrophysiology (2, 7, 8). 
They are often used as a cell model for Parkinson’s Disease (9), as well as Alzheimer’s 
Disease (10), neuropathogenesis of viruses (11), screening for neurotropic properties 
of pharmaceuticals (12, 13), neurotoxicity (14, 15), and even as a multicellular 3D 
culture (16, 17).  
With the widespread use of this cell line to study human neuron synapse activity and 
neuronal plasticity in vitro, it is important to understand the effects of cell handling, 
such as the removal of serum before experimental manipulation in fully 
differentiated cells.  
SH-SY5Y cells are grown in a basic medium containing Dulbecco’s Modified Eagle’s- 
Medium (DMEM), glucose, antibiotics, and supplemented with 10-20% Fetal Bovine 
Serum (FBS) (9). The use of FBS in culture media to promote growth of cells and to 
maintain tissues in vitro was introduced in 1958 (18). This serum supplementation is 
vital for the growth and maintenance of cell lines, as it contains many crucial 
proteins, vitamins, hormones and growth factors important for cell survival and 
proliferation (19).  
To induce differentiation of SH-SY5Y cells to a more mature neuronal phenotype, the 
serum concentration is commonly reduced to 1% or 3%, along with the addition of 
retinoic acid (3, 9). After 5-20 days, depending on the differentiation protocol, the 
cells reach their maximum differentiation state (2-4). Prior to experimental 
manipulation, e.g. exposure to potential pharmaceutical compounds, serum is often 
completely removed from the cultures. This is done to ensure all cells are in the same 
growth cycle phase before manipulation (20), and to prevent confounding effects of 
the myriad of proteins and other molecular factors present in serum, which differ by 
serum batch and therefore introduce phenotypic variations in cell cultures (21). 
Serum components may also mask certain intrinsic growth factor (e.g. brain-derived 
neurotrophic factor, BDNF) effects, therefore serum may be removed to assess the 




Despite the common practice of serum removal before experimental manipulation in 
already differentiated SH-SY5Y cells, the effects of removing serum from culture 
media on plasticity-related gene expression and morphology markers have not yet 
been examined. Understanding the effects of serum removal is essential in 
standardizing pre-experimental protocols. If serum removal has strong effects on 
gene and morphological markers in already differentiated cells, any effect of 
experimentation may be confounded.  
Here we aim to systematically characterize the effects of completely removing serum 
from differentiated SH-SY5Y culture media on gene expression markers of plasticity, 
specifically related to an important pathway in synaptic plasticity and long-term 
potentiation, the BDNF-TrkB signaling pathway (23-28). We also investigated the 
effects of serum removal on cytoskeletal markers of neuron morphology by 
visualizing changes in MAP2 and βIII-Tubulin. 
Methods 
Cell Culture 
Cells were obtained from ATCC® (CRL2266™, RRID:CVCL_0019) and were maintained 
and expanded according to the provided protocol. For experiments, cells were not 
used above passage 26.  
Undifferentiated cells were cultured in DMEM/ F12, GlutaMAXTM Supplement 
(GibcoTM, Thermo Scientific) supplemented with 10% heat inactivated Fetal Bovine 
Serum (FBS, Merck), 1% penicillin-streptomycin (P/S) and 1% L-Glutamate at 37°C and 
5% CO2, and split at 80-90% confluency.  
Differentiation 
All cells were fully differentiated to a mature neuronal-like state before 
experimentation. For differentiation, cells were plated in 6-well culture plates 
(Greiner CELLSTAR®, Merck) at approximately 2.4x104 cells per well. Serum 
concentration was decreased to 3% FBS three days prior to the addition of 10µM 
retinoic acid (RA; Sigma-Aldrich, R2625). A stock solution of RA was prepared in 
dimethylsulphoxide (DMSO; Sigma-Aldrich, 41640) at 10mM, and stored at -20°C until 
dilution in cell culture media to a final concentration of 10µM. Starting from the day 
RA was added, medium with 3% FBS supplementation was replaced every two days 
for a total of ten days.  
Serum Deprivation 
Differentiated SH-SY5Y cells were used for serum removal experiments. Medium 
containing 3% serum (FBS) was removed, and the cell surface was rinsed with PBS 
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(warmed to 37°C) to remove all remaining serum. Next, medium without 
supplemented serum (0% FBS), or medium with serum (3% FBS) was added for 1, 3, 6 
or 24 hours. In total there were 8 different conditions; serum and no serum for each 
of the 4 time points (1, 3, 6, 24 hours).   
Microscopy 
Cells were grown on 12mm glass coverslips (VWR, 631-1577) coated with 100µg/mL 
Poly-L-Ornithine (Sigma, P4957) and 1µg/mL Laminin (Sigma, L2020) and 
differentiated as described above.  
At the specified collection time points following complete serum removal, cells were 
washed in PBS (warmed to 37°C), and fixed for 10 minutes in cold 4% 
paraformaldehyde. To stop fixation, cells were washed 3 times 5 minutes in cold PBS 
and stored in PBS at 4°C for a maximum of two days before antibody incubation. Cells 
were then blocked in PBS-Tween 20, prepared with 0.2% Tween-20, and 10% donkey 
serum. Antibodies for visualizing neurite outgrowth (βIII-Tubulin; Cell Signaling, Cat 
#5568S, RRID:AB_10694505), and dendrites (MAP2; Sigma, Cat #M2320, AB_609904) 
were used. Both markers were chosen as they are often combined to capture all 
neuronal processes (29), and they have consistently been used as markers of 
differentiation in experiments with SH-SY5Y cells (2-4, 29, 30). Following primary 
antibody incubation, cells were washed in alternating PBS and PBS-Tween 20 and 
incubated with secondary antibodies donkey anti-rabbit Alexa 488 (Invitrogen, Cat 
#A-21206 RRID:AB_141708), donkey anti-mouse Alexa 594 (Invitrogen, Cat #A-21203, 
RRID:AB_141633), and cell nuclei were stained with DAPI (CarlRoth, Cat #6843.3). 
Following secondary antibody incubation, coverslips were washed in cold PBS and 
mounted on glass microscope slides. Fluorescence imaging was done with the 
Olympus BX51WI microscope and disc spinning unit. Pictures were taken using the 
20X objective lens. Micro-Manager software (31)(RRID:SCR_016865) was used to 
collect images. Further details on the primary and secondary antibody dilutions as 
well as microscope exposure times can be found in the Supplementary Material 
(Table S1 and S2).  
qRT-PCR 
Cells in 6-well plates were first rinsed with PBS at 37°C and then kept on ice for the 
rest of the extraction. RNA was extracted with TRIzol (Invitrogen, 15596026) 
according to the manufacturer’s protocol. RNA concentration was determined using 
the NanoDrop™ spectrophotometer, and cDNA was synthesized using RevertAid H 
Minus First Strand cDNA Synthesis Kit (Thermo Scientific, K1632). RNA was stored at -





Primers for qPCR were designed using NCBI gene reference database and Primer-
BLAST (National Library of Medicine). The following primers were analyzed: Activity 
Regulated Cytoskeleton associated protein (ARC,Gene ID: 23237), Early Response 1 
(EGR1, Gene ID: 1958), cAMP Responsive Element Binding Protein 1 (CREB1, Gene ID: 
1385), B-cell lymphoma 2 (BCL2, Gene ID: 596), BCL2- Associated X (BAX, Gene ID: 
581), Brain Derived Neurotrophic Factor (BDNF, Gene ID: 627), Neurotrophic 
Receptor Tyrosine Kinase 2 (NTRK2, GeneID: 4915), Discs Large MAGUK scaffold 
protein 4 (DLG4 also known as PSD95, GeneID:1742), Synaptophysin (SYP, 
GeneID:6855), in conjunction with three House Keeping Genes (HKG’s): 
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH, GeneID:2597), TATA-box 
Binding Protein (TBP,GeneID:6908), Peptidylprolyl Isomerase B (PPiB, GeneID:5479). 
Primer sequences can be found in Supplementary Material Table S3. Primers at 
600nM concentration were mixed with Fast Start Universal Sybr Green Master ROX 
(Roche,491385001). Samples were run in 384-well qPCR plates (Roche,4TI-0382), 
using the LightCycler 480 Real-Time PCR system (Roche Life Sciences). qPCR program 
details are described in Supplementary Material Table S4. 
Analysis 
Microscopy 
Image processing and analysis was done in Fiji (ImageJ version 1.52i, 
RRID:SCR_002285) (30). A DAPI nucleus staining was used to count total cells in each 
image. Neurite length and branching was measured in the 488 (βIII-Tubulin) channel, 
using the segmented line tool at 20X magnification. Per condition 70-100 neurites 
were measured. Typically, in differentiated SH-SY5Y cultures, many cells have only 
one or no neurites. Therefore, from each cell, we measured the length of the primary 
neurite, defined as the single neurite, or the longest neurite for cells having more 
than one neurite. An example of tracings of primary neurites as well as cells without 
neurite extensions can be seen in Figure 2A. The NeuronJ plugin (33) was used to 
quantify neurite length and neurite branching. For each image, primary neurites and 
branches were semi-automatically traced, and manually labeled as either primary 
neurites, or branches. The number of branches were divided by the total neurons 
(counted with DAPI), to give the number of branches per neuron in each image. An 
example neuron with branching can be seen in Figure 2B. To identify whether the 
proportion of total cells with a primary extension changes due to serum deprivation, 
the number of primary neurites was also divided by total number of neurons (as 
counted with DAPI).  
Total fluorescence of βIII-Tubulin staining was quantified using the 488 channel. First, 
the fluorescence threshold was set with the minimum intensity as the maximum 
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background intensity. The total fluorescence intensity in the image was then 
measured, and corrected for cell area by dividing by the total area of cells in the 488 
channel.  
βIII-Tubulin stained cells were counted manually by setting the brightness contrast 
settings to 834 (min) and 7474 (max). Cells with visible green neurites were counted. 
MAP2 was manually counted in the 594 channel, at brightness contrast settings of 
596 (min) and 6007 (max). These cell counts were divided by the total cells to 
calculate the proportion of βIII Tubulin or MAP2 cells. 
Gene Expression 
A standard curve was used to calculate relative concentrations of gene expression per 
gene. An average of technical duplicates was made, and normalized to the average of 
3 HKGs (TBP, PPiB, GAPDH). Analyses were performed with LightCycler 480 software 
version 1.5.1.62 (Roche Life Sciences) and Excel.  
Statistics 
Statistical analysis and graphs were made with Prism 5 (Graphpad Software, USA, 
RRID:SCR_002798) and IBM Statistics 24 (SPSS for windows version 24.0, Armonk, 
NY:IBM Corp). Data collected from 2 independent experiments were pooled for 
statistical analysis. This resulted in a total of 4-14 images per condition being included 
in statistical analysis. For analysis of neurite length, an average neurite length per 
image was calculated from 70-100 neurites, for a total of 8 images per condition 
included in the 2-way ANOVA. For the analysis of primary neurites per neuron and 
neurite branching per neuron, the number of primary neurites in an image (between 
30-100 per image) were divided by the total neurons in the image (between 210-250 
cells per image), with 4-6 images per condition included in the 2-way ANOVA. For 
analysis of βIII-Tubulin Immunoreactivity, a total of 10-14 images per condition were 
included in the 2-way ANOVA. A 2-way ANOVA with factors Serum (serum, no serum) 
and Time (1,3,6, 24 hours) was used for all comparisons of microscopy quantification 
and HKG normalized expression values. Bonferroni-corrected post-hoc tests were 
done in the case of significant interaction events. Reported results are mean ± 
standard error of the mean. Figures show bar graphs of the HKG normalized mean 
expression values; error bars are standard errors of the mean.  
Results 
Differentiation 
Differentiation was verified as explained previously (34). Representative images 





Figure 1. Visual representation SH-SY5Y cells A. Undifferentiated cells B. Neuron-like cells at 10 
days differentiation.  
Microscopy 
Full statistical results of main effects (Time, Serum) and Time x Serum interaction 
effects for each parameter (Neurite Length, Neurite Branching, Primary Neurites, βIII-
Tubulin immunoreactivity, and βIII-Tubulin and MAP2 positive cells) can be found in 
Supplementary Material Table S5. In case of significant main or interaction effects, 
the p-value of Bonferroni-corrected post hoc tests are reported below. An example of 
the parameters measured can be seen in Figure 2.  An example of the morphology of 
cells immediately following serum removal can be seen in Supplementary Figure 2. 
 
Figure 2. Morphological parameters analysed A. Tracing of primary neurite extension in purple. 
An example of cells showing no neurite extensions are indicated with red arrows B. An example 




We found a significant effect of Serum (p<0.0001), but no significant effect of Time 
(p=0.382), or Time x Serum interaction (p=0.338) on neurite length. Serum deprived 
neurons had significantly longer outgrowths than neurons with serum at 3 hours 
(54.93±20.22 μm vs. 45.43±17.76 μm, p=0.03) and at 24 hours (65.53±27.74μm vs. 
46.89±18.24 μm, p<0.0001) (Figure 3A). 
Neurite Branching 
There was a significant effect of Time (p=0.0105) and Serum (p<0.0001), but not a 
significant Time x Serum interaction (p=0.062) on neurite branching. Serum deprived 
neurons had significantly more branches per neuron at 3 hours (0.058±0.008 vs. 
0.011±0.003, p<0.0001), 6 hours (0.041±0.007 vs. 0.015±0.003, p<0.028), and at 24 
hours (0.033±0.008 vs. 0.0045±0.003, p<0.028) (Figure 3B). 
Primary Neurites 
Similarly, we found a significant effect of Time (p=0.0368), Serum (p=0.0006), but not 
a significant Time x Serum interaction (p=0.109). At 3 hours, serum deprived neurons 
showed a greater proportion with a primary neurite (0.45±0.034 vs 0.25±0.020, 
p=0.001) (Figure 3C). 
βIII-Tubulin Immunoreactivity 
A significant effect of Serum (p=0.0006) and a Time x Serum interaction (p=0.0035) 
was found, but no effect of Time (p=0.14) on βIII-Tubulin immunoreactivity. There 
was a significant increase in βIII-Tubulin immunoreactivity in the serum deprived cells 
at 3 hours (120.23±25.58 vs. 37.03±4.96, p<0.01) and 6 hours (110.49±28.55 vs. 
22.94±3.03, p<0.01) (Figure 3D). 
βIII-Tubulin and MAP2 Positive Cells 
There was a significant effect of Time (p<0.0001), Serum (p<0.0001), and a Time x 
Serum interaction (p=0.0012), on cells expressing βIII-Tubulin after serum 
deprivation. Serum deprived neurons showed a significant increase in the percentage 
of βIII-Tubulin expressing cells at 3 hours (42.04±4.92% vs. 23.16± 3.78%, p=0.009) 
and 6 hours (30.80±2.77% vs. 17.40±2.21%, p=0.023), and 24 hours (26.69±2.41 vs. 
8.90±2.35, p=0.00012) (Figure 3E). 
There was also a significant effect of Time (p<0.0001), Serum (p<0.0001), and a Time 
x Serum interaction (p=0.0011), on percentage of cells expressing MAP2 after serum 
deprivation. Serum deprived cells also showed a significant increase in percentage 
MAP2 expressing cells at 3 hours (29.08±5.02% vs. 15.30±2.28%, p<0.01), 6 hours 
(23.65±2.12% vs. 12.51±1.87%, p<0.05), and 24 hours (19.85±2.50 vs. 7.27±2.21, 





Figure 3. Morphological Parameters. A. Neurite Length B. Neurite Branching C. Primary 
Neurites D. βIII-Tubulin immunoreactivity E. Proportion βIII-Tubulin positive cells F. Proportion 
MAP2 positive cells. (Significant post hoc comparisons are indicated as *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001). 
Gene Expression 
We were most interested in gene expression changes following serum deprivation, 
specifically in genes related to IEG expression (ARC, EGR1), apoptosis (BCL2, BAX), 
plasticity (BDNF, NTRK2, CREB1) and synaptogenesis (PSD95, SYP). Full statistical 
results of main (Time, Serum) and Time x Serum interaction effects can be found in 
Supplementary Material Table S6. In case of significant main or interaction effects, p-
values and Bonferroni-corrected post hoc tests are reported in the text. Graphs show 
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mean HKG normalized expression levels for each condition, error bars are standard 
error of the mean.  
Immediate Early Gene Expression 
We measured the expression of IEG’s ARC and EGR1, finding high expression levels in 
both genes in the 1-hour serum condition only. Expression levels were low in all other 
samples (3,6 and 24 hours), many of which were too low to detect (Ct value ≥34). 
Gene expression results can be found in Supplementary Material and Supplementary 
Figure 1.  
Apoptosis Markers 
BCL2 Expression: We also found no significant main effects of Time (p=0. 362), Serum 
(p=0.618), or Time x Serum interaction (p=0.216) on BCL2 expression (Figure 4A). 
BAX Expression: We found no significant main effect of Time (p=0.169), Serum 
(p=0.380), or Time x Serum interaction (p=0.228) on BAX expression (Figure 4B). 
 
Figure 4. Results of gene expression analysis of A. BCL2 mRNA and B. BAX mRNA. Expression 
values have been normalized to the average of 3 housekeeping genes (TBP, PPiB, GAPDH). 
Expression of BDNF Signaling 
BDNF Expression: We found a significant effect of Time (p<0.001), Serum (p<0.001) 
and Time x Serum interaction (p<0.001) on BDNF expression. There was a significant 
decrease in BDNF expression in the serum deprived cells at 1 hour (p<0.0001), 3 
hours (p<0.0001), and 6 hours (p<0.0001). Compared to time-matched serum 
controls, serum deprived cells express 25.71±5.76% BDNF at 1 hour, 8.07±1.35% at 3 
hours, 12.01±0.61% at 6 hours and 94.58±5.89% at 24 hours (Figure 5A). 
NTRK2 Expression:  There was also a significant effect of Time (p=0. 008), Serum 
(p=0.006), and Time x Serum interaction (p=0.021) on NTRK2 expression. There was a 
significant increase in expression of NTRK2 mRNA at 24 hours (p<0.01), with serum 
deprived cells expressing 242.11±33.00% of the NTRK2 expressed in serum controls 




CREB Expression: There was no significant main effect of Time (p=0. 393) or Serum 
(p=0.942), on CREB expression. However, there was a Time x Serum interaction effect 
(p=0.043). Initially, there is a decrease in CREB expression in serum deprived cells at 1 
hour (to 65.25±1.26% serum controls), at 6 hours this is reversed (164.71±30.31% 
serum controls) (Figure 5C). None of these time points are significant in Bonferroni-
corrected post hoc tests. 
 
Figure 5. Results of gene expression analysis of A. BDNF mRNA and B. NTRK2 mRNA, and C. 
CREB mRNA. Expression values have been normalized to the average of 3 housekeeping genes 
(TBP, PPiB, GAPDH). Significant post hoc comparisons are indicated as, **p<0.01, 
****p<0.0001. 
Synaptogenesis Genes 
PSD95 Expression: There was a significant effect of Time (p=0.001), and a Time x 
Serum interaction (p=0.020), but no effect of Serum (p=0.153), on PSD95 expression. 
There was a significant increase in expression in the serum deprived cells at 24 hours 
(p<0.01). Serum deprived cells express 192.85±17.78% of the serum controls at 24 
hours (Figure 6A). 
SYP Expression: Again, we found a significant effect of Time (p=0.017), but no effect 
of Serum (p=0.575). We found a trend towards a significant Time x Serum interaction 




Figure 6. Gene expression analysis of A.PSD95 mRNA and B. SYP mRNA. Expression values have 
been normalized to the average of 3 housekeeping genes (TBP, PPiB, GAPDH). Significant post 
hoc comparisons are indicated as, **p<0.01. 
Discussion 
In this study we aimed to systematically characterize, in fully differentiated SH-SY5Y 
cells, the effects of complete serum removal on several morphological and gene 
expression markers of plasticity. We found that serum removal, over 24 hours, 
increased primary neurite length as well as neurite branching when compared to 
serum controls. Serum deprived neurons also showed higher levels of βIII-Tubulin 
immunoreactivity, and a greater proportion of βIII-Tubulin- and MAP2-positive 
neurons. MAP2 is mainly localized in mature dendrites (35), and βIII-Tubulin is a 
widely used neuronal maturity marker (36). These findings suggest that in fully 
differentiated cells, complete serum removal may promote additional plasticity-like 
effects. This can be seen as early as 3 hours following removal of serum, and lasts at 
least 24 hours. 
We also found that complete serum removal has a specific effect on the expression of 
several genes involved in BDNF-TrkB signaling and synaptogenesis. Serum deprivation 
resulted in a significant increase in the expression of NTRK2, PSD95 and SYP over 
time, with the strongest effect on the expression of NTRK2 and PSD95 mRNA at 24 
hours following deprivation. NTRK2, the gene coding for the TrkB receptor, has been 
shown to be important in activity dependent plasticity leading to long term 
potentiation (LTP) (24, 37). PSD-95 is an important scaffolding protein, regulating the 
strength of excitatory synapses (38), and the SYP gene codes for synaptophysin, an 
important protein involved in neurotransmitter release (39, 40). An increase in the 
expression of NTRK2, PSD95 and SYP mRNA over time in serum-deprived cells 
therefore aligns with our morphology results. Our results suggest that complete 
serum removal induces an increased expression of genes and morphological markers 
of plasticity and synaptic strength, potentially confounding experiments interested in 




While these observations are in line with the differentiation-inducing effect of serum 
deprivation (2-4, 41), these cells are already fully differentiated, therefore the 
additional changes in morphological markers that we present here may indicate 
additional, confounding plasticity effects. Indeed, systematic transcriptomic profiling 
SH-SY5Y cells has identified NTRK2 as well as many genes involved in neurogenesis 
and cytoskeletal reorganization as upregulated in differentiated compared to 
undifferentiated cells (42). However, once cells have been differentiated, the 
expression of these genes is stable over time; in contrast to the serum removal 
effects we report here. This semi-acute increase in plasticity-related gene expression 
and morphological markers is problematic in studies using these genes or 
morphological plasticity markers as outcome measures.  
Interestingly, we also report a strong effect of serum on the expression of BDNF, ARC 
and EGR1. BDNF expression increased in the in the serum control cells after 1, 3 and 6 
hours, returning to low expression levels at 24 hours. The serum control cells 
underwent a regular medium change, including a PBS wash step. This increase in 
BDNF mRNA in the serum condition is surprising, but may be related to the addition 
of fresh medium and serum. In serum-deprived cells, this temporary increase is 
absent, likely due to the disruption of growth and protein production as a 
consequence of serum withdrawal (43-46). We also report an increase in expression 
of the immediate early genes ARC and EGR1 in the serum condition at 1 hour after 
PBS wash and serum replacement. The removal and re-addition of serum could have 
induced an immediate but transient increase in the expression of ARC and EGR1 
mRNA, in line with the expected expression pattern of an immediate early gene (47, 
48).  
We did not find any effects of serum deprivation on the expression of genes linked to 
apoptosis, BAX and BCL2. Encinas et al. (2000) showed that SH-SY5Y cells show signs 
of apoptosis 6 and 24 hours after serum removal as measured by caspase activity and 
TUNEL assay (3). Encinas et al. (2000) used cells that were treated with RA for only 
five days and in medium containing 15% FBS. The shock of serum removal in the not-
fully differentiated cells is likely much stronger compared to our protocol, and may 
explain the different finding. Based on the gene expression markers in our 
experiments, we cannot confirm that serum starvation influences apoptotic 
processes after 24h in in fully differentiated SH-SY5Y cells. 
Conclusion 
Despite being common practice to remove serum from the culture medium of already 
differentiated SH-SY5Y cultures before experimentation, the effects on morphology 
and gene expression had not been systematically characterized. Here, we show that 
complete serum deprivation has an effect on commonly used morphological and 
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gene expression markers of cellular and synaptic plasticity in differentiated SH-SY5Y 
cells, and may thus confound results when examining plasticity-related outcome 
measures. For future research involving differentiated SH-SY5Y cells as a model of 
human neural plasticity, our findings provide some key considerations for 
experimental design. Studies interested in measuring plasticity effects in 
differentiated SH-SY5Y cells should either refrain from complete serum deprivation 
24 hours before experimentation, or include appropriate controls, e.g. cells which 
were not serum deprived, to confirm serum deprivation had no confounding effects 
on outcome measures.  
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Supplementary Material Chapter 2 
Table S1. Exposure times for fluorescence microscopy. Olympus BX51WI microscope and DSU 
spinning unit used. Pictures were taken using the 20X objective lens. 





βIII Tubulin Cell 
Signaling 
5568S 1:300 Neurons; 
Axon guidance and 
maturation 









Invitrogen A21203 1:1000 MAP2 
DAPI CarlRoth 6843.3 1:800 Nucleus 
Table S2. Primary and secondary antibody dilutions used for immunocytochemistry. 
  
Excitation/Emission Marker of Exposure Time (ms) Color 
358/461 DAPI (nuclei) 10 Blue 
493/519 βIII-Tubulin 500 Green 




GAPDH FWD CCAAATGCGTTGACTCCGA 
GAPDH REV GCATCTTCTTTTGCGTCGC 
TBP FWD TGCACAGGAGCCAAGAGTGAA 
TBP REV CACATCACAGCTCCCCACCA  
PPiB FWD GTTTGAAGTTCTCATCGGGG 
PPiB REV AAAACAGCAAATTCCATCGTG 
ARC FWD GGAGTACTGGCTGTCCCAGA 
ARC REV ACTCCACCCAGTTCTTCACG 
EGR1 FWD CCCCGACTACCTGTTTCCAC 
EGR1 REV GACAGAGGGGTTAGCGAAGG 
CREB1 FWD CCCCAGCACTTCCTACACAG 
CREB1 REV CTCGAGCTGCTTCCCTGTTC 
BCL2 FWD ACATCGCCCTGTGGATGACT 
BCL2 REV CCGTACAGTTCCACAAAGGC 
BAX FWD GGGGACGAACTGGACAGTAA 
BAX REV CAGTTGAAGTTGCCGTCAGA 
BDNF  FWD ATAGAGTGTGGGAGTTTTGGGG 
BDNF  REV TGGTGGAACTTTTCAGTCACTACT 
NTRK2  FWD TGGATGCATATCGTGCTCCG 
NTRK2  REV GTGCTTGGTTCAGCTCTTGC 
PSD95 FWD CCCCAGGATATGTGAACGGG 
PSD95 REV CCGATGTGTGGGTTGTCAGT 
SYP FWD CACTGATGACTTCCCAGAACTGT 
SYP REV CTGGGCTTCACTGACCAGAC 
Table S3. Primer Sequences, 5’ to 3’ orientation. All primers were designed using the NCBI gene 
















None Pre-Incubation 1 95 None 0:10:00 4.8 
Quantifica
tion Amplification 45 95 None 0:00:10 4.8 
   
60 single 0:00:45 2.5 
Melting 
Curves Melting Curve 1 95 None  0:00:15 4.8 
   
60 None 0:00:30 2.5 
   
97 
Continuou
s   0.11 
None Cooling 1 60 None 0:00:10 2.5 
Table S4. qRT-PCR program. Run in 384 well qPCR plates (Roche,4TI-0382) using LightCycler® 





Full Statistical Results 
Parameter Time Serum Time x Serum 
Interaction 

























































































Table S6. Gene expression main and interaction effect results. Significant main effects in bold. 
Immediate Early Gene Expression Results 














ARC Expression: We found a significant main effect of Time, Serum, and a Time x 
Serum interaction on ARC expression. Post-hoc analysis showed that cells that were 
serum deprived show a significant decrease in HKG normalized ARC expression 
compared to serum cells at 1 hour (p<0.0001). When normalized to the ARC 
expression in serum time-matched controls, serum deprived cells expressed 
3.23±0.40% of the ARC mRNA at 1 hour, 11.76±1.60% at 3 hours, 76.74±26.40% at 6 
hours, and 97.38±10.89% at 24 hours (Supplementary Figure 1A). 
EGR1 Expression: Again, we found a significant main effect of Time, Serum, and a 




decrease in expression in the serum-deprived cells at 1 hour (p<0.001). Compared to 
the serum condition, EGR1 expression in serum-deprived cells was 0.92±0.04% at 
1hour, 5.18±0.60% at 3 hours, 54.10±10.03% at 6 hours, and 167.93±61.40% at 24 
hours (Supplementary Figure 1B). 
 
Supplementary Figure 1. Gene expression levels of A. ARC and B. EGR1. Expression levels are 
normalized to the average of 3 Housekeeping genes. Significant post hoc comparisons are 
indicated ****p <0.0001. 
 
Supplementary Figure 2. A. Example morphology neurons immediately following serum 
removal (A-C) compared to neurons in serum-containing media(D-F). Nucleus (DAPI) in blue, 
βIII-Tubulin in green, MAP2 in red. A. Serum-deprived cells, merge of all channels, B. Serum-
deprived cells, DAPI and βIII-Tubulin C. Serum-deprived cells, DAPI and MAP2 D. Cells in serum, 






Transcranial Magnetic stimulation (TMS) 
modulates functional activity of SH-SY5Y cells: 
An in vitro model provides support for assumed 
excitability changes 
 
Based on: Thomson, A.C.,  de Graaf, T.A., Schuhmann, T. Kenis, G.*, Sack, A.T.*, 
Rutten, B.P.F.*(2020). Transcranial Magnetic stimulation (TMS) modulates functional 
activity of SH-SY5Y cells: An in vitro model provides support for assumed excitability 
changes. Available as preprint: bioRxiv 2020.08.19.257295; 
https://doi.org/10.1101/2020.08.19.257295 









Repetitive transcranial magnetic stimulation (rTMS) is an established 
neuromodulation technique that, depending on stimulation parameters, can lead to 
lasting neural excitability changes. Intermittent and continuous theta burst 
stimulation (iTBS, cTBS), in particular, are increasingly popular rTMS protocols with 
widespread applications in both research and therapy. Most studies use in vivo 
neuroimaging measures such as fMRI, or neurophysiological recordings such as motor 
evoked potentials (MEPs) or simultaneous EEG signals to assess the lasting effects of 
rTMS/TBS on cortical excitability. However, these in vivo effects of TBS have shown 
substantial variability, arising from factors such as the complex structural organization 
of the human brain, the physiological-state dependence and/or the cortical network 
properties interacting with the external stimulation. Therefore, the assumed 
excitability effects of iTBS/cTBS have proven difficult to replicate on the single 
subject/patient level.  We here describe a direct method of imaging rTMS effects in a 
human in vitro neuron model; differentiated SH-SY5Y cells. We use live calcium 
imaging to assess changes in neural activity following stimulation, through quantifying 
fluorescence response to chemical depolarization. We found that iTBS and cTBS have 
opposite effects on fluorescence response; with iTBS increasing and cTBS decreasing 
response to chemical depolarization. These results provide support for the assumed 
rTMS after-effects in an in vitro model of human neurons. Future work can build on 
this foundational evidence, for example using more complex human neuron models, 
to uncover where, between unorganized neuron-like cell cultures as here, and highly 
complex in vivo human cortical circuitry, the inter-subject variability of these rTMS 
protocols starts to affect their reliability, as a means to develop and evaluate 
subject/patient-specific brain stimulation protocols.  
Keywords: Transcranial Magnetic Stimulation (TMS), Calcium Imaging, Intermittent 
Theta Burst Stimulation (iTBS), Continuous Theta Burst Stimulation (cTBS), Neuronal 




Transcranial brain stimulation describes all forms of neuromodulation in which neural 
activity is stimulated noninvasively by applying electric or electromagnetic pulses 
through the intact skull into the brain. In transcranial magnetic stimulation (TMS), 
magnetic pulses are applied transcranially to induce action potentials (1). When 
multiple TMS pulses are administered in a particular pattern/frequency (repetitive, 
rTMS) lasting effects on cortical excitability have been described (2, 3). Depending on 
parameters, a targeted cortical brain region can either show lasting increases or 
decreases of cortical excitability, having widespread implications both in research and 
the clinic. rTMS has proven effective as a treatment for various mental disorders; such 
as treatment resistant depressive disorder (4), offering a cost-efficient, painless 
alternative to pharmaceutical treatment with minimal side effects and risk (5, 6). 
However, to fully deliver on this potential, the modulatory effects of rTMS protocols 
must be understood, reliable, and ideally personalized. 
Theta burst stimulation (TBS) is the prime example of a rapid rTMS protocol in which 
opposing neuroplastic effects can be induced depending on the chosen 
frequency/pattern of stimulation. “Theta burst” refers to triplet bursts (50 Hz) of 
magnetic stimulation administered at theta frequency (5 Hz). It has been shown that 
intermittent TBS (iTBS) increases, whereas continuous TBS (cTBS) decreases cortical 
excitability, for up to 1 hour following stimulation (2). However, recent reports have 
emphasized the difficulty of replicating the effects of these different TBS protocols (7-
10), raising questions about their robustness and replicability, and subsequently about 
the generally assumed cellular basis of TBS-induced neuroplastic changes.  
Currently in humans, cortical excitability and its modulation by rTMS are almost 
exclusively measured through motor-evoked potentials (MEPs), a contralateral muscle 
twitch which represents cortico-spinal excitability at the time of stimulation (11). 
However, this approach is hindered by large inter and intra subject variability (7, 9). 
Alternatively, rTMS-induced changes in cortical excitability can be assessed with EEG; 
for example with TMS-evoked potentials (TEPs) or resting state neuronal 
power/synchronization. However, substantial confounds exist with this method as 
well (12). This variability is difficult to control for, as rTMS effects are influenced by 
many biological and genetic factors (13-15), as well as brain state at the time of 
stimulation (16, 17). One alternative approach is to assess rTMS systematically, 
starting from a simple, unorganized in vitro human neuronal model, and building up 
to the complex circuitry of the human cortex.  
Here, we took a first step in developing an in vitro model to assess the effects of 
rTMS/TBS. We perform functional imaging in SH-SY5Y human neuroblastoma cells, 
which we use as a model for neuronal activity and excitability following rTMS 




mature neuron-like state, developing functional synapses and expressing many 
markers of mature human neurons (18-21). We therefore opted to first test our setup 
in these cells, with the aim of moving to a more complex human neuronal in vitro 
setup in the future.  
We used calcium imaging to measure changes in neuron activity following cTBS and 
iTBS stimulation, and, crucially, to model effects on excitability through response to 
chemical depolarization. To measure calcium activity, we used Fluo-4 AM (F14201, 
Thermo Fisher), a fluorescent indicator which binds intracellular calcium, to quantify 
changes in calcium concentration in the 100nM-1mM range (22). In a neuron, the 
resting calcium levels range between 50-100nM, which can increase 100-fold during 
electrical activity (23). Therefore, we expected to measure low fluorescent signal at 
baseline, and an increase in signal intensity with cellular activity. To assess effects on 
excitability, or ‘evoked’ functional activity, we measured responses to 1M Potassium 
Chloride (KCl), which has been shown to immediately induce cellular activity during 
calcium imaging in differentiated SH-SY5Y cells (18).  
Mature SH-SY5Y neurons were incubated with Fluo-4 AM dye, and imaged for 
baseline activity with fluorescence microscopy. We then stimulated our human 
neuron model with commonly used stimulation protocols: iTBS, cTBS, or sham, at an 
intensity of 100% Maximum Stimulator Output (MSO) and a distance of 1 cm from the 
dish surface. This has been done previously in in vitro and animal studies of rTMS 
effects (24, 25).  The stimulation setup can be seen in Figure 1A. The distribution of 
the electric field (V/m) induced by rTMS within the cell culture dish from several 
viewpoints can be seen in Figure 1B-D, modelled with SimNIBS (26) using the cell 
culture dish mesh generously shared by the authors of (27). Post stimulation activity 
was the measured, followed by the addition of 1M KCl to induce cellular activity. A 
time-series montage showing an example of the increase in fluorescence in 1 cell as 
the KCl is added can be seen in in Figure 1E. We measured fluorescence intensity in 4 
separate 2-minute blocks; 1. Baseline, 2. Post-stimulation, 3. During the addition of 
1M KCl to induce depolarization, and 4. Post-KCl. 
Methods 
Experimental model 
SH-SY5Y (ATCC® CRL2266™) neuroblastoma cell line, were used.  Freezing and thawing 
of cell batches were performed according the provided protocols. Cells were not used 
above passage number 26. For all experiments, cells were grown in DMEM/Nut Mix 
F12 with Glut-L (GibcoTM, Thermo Scientific, 31331-028) at 37°C and 5% CO2.  For 
maintenance and expansion of cell cultures, media was supplemented with 10% heat 
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inactivated Fetal Bovine Serum (FBS, MERCK), 1% penicillin-streptomycin (P/S) and 1% 
L-Glutamate.   
For differentiation, cells were plated in round 35mm Poly-D-Lysine coated 10mm 
diameter glass bottom MatTek dishes (Matex Corp., P35GC-0-10-C) at approximately 
2.4x104 cells per well. FBS supplementation was decreased to 3% FBS 3 days prior to 
the addition of 10 µM retinoic acid (RA; Sigma-Aldrich, R2625). During differentiation, 
RA-supplemented media was replaced every 2 days for 10 days. This differentiation 
protocol has been shown to establish a mature neuron-like phenotype (28). While it 
has been reported that the addition of BDNF can promote differentiation and cell 
survival (28), we did not find this method to be superior to the addition of RA alone 
(data not shown).    
Functional Imaging 
For each condition, 6 separate cell dishes were measured. Cells were incubated in 
5µM cell permeant calcium indicator Fluo-4 AM (F14201, Thermo Fisher) and 0.02% 
Pluronic Acid (ThermoFisher,P6867) made in RA-supplemented culture media for 20 
minutes at 37°C and 5% CO2.  Cells were washed 3 times for 5 minutes in RA-
supplemented culture media, the first wash containing 0.00002% Propidium Iodide 
(Molecular Probes, P3566) and 0.00001% Hoechst (Sigma, B2261). After washing, 1ml 
of Hank’s Balanced Salt Solution (HBSS) was added to each dish for imaging.  
Cells were imaged with the 10X magnification lens of an Olympus IX81 microscope 
(Olympus Nederland B.V), EXi Blue Fluorescence Camera (Q Imaging, Canada), and X-
Cite 120 series fluorescent illuminator (EXFO Photonic Solutions Inc, Canada). A Pecon 
Tempcontrol 37-2 Digital 2-Channel heating plate (Meyer Instruments, Houston) was 
used to ensure cell dishes were kept at 37°C during imaging. Imaging was recorded 
using micromanager open-source software (29). To visualize the change in calcium 
response over time, 60 images with 2 seconds between each image were recorded 
per recording block: Baseline, Post Stimulation, KCl Addition and Post KCl. Following 
baseline recording, cells were removed from the microscope chamber and stimulated 
with rTMS as described below. Dishes were marked before removal in order to place 
them back in approximately the same position. 
Magnetic Stimulation 
Cells were placed 1 cm below the centre of a Cool-B65 figure 8 coil (Magventure, 
Denmark) and stimulated at 100% Maximum Stimulator Output (MSO) with a MagPro 
X100 with MagOption stimulator (Magventure, Denmark). Each stimulation session 
consisted of the Huang (2005) published protocol of 50Hz triplets repeated at 5 Hz. 
iTBS consisted of 2000ms trains with 8000ms inter-train intervals, while cTBS 
consisted of continuous triplets; both for 600 pulses (2). For the cTBS condition, cells 




were out of the incubator for the same amount of time. For the sham condition, cells 
were placed under the coil for 190 seconds. The field induced within the dish was 
calculated using the SimNIBS toolbox (26). Electrical conductivities used in the 
simulation were the same as in Lenz et al., (2016), and the electric dish model used for 
modelling was generously shared by the authors (27). The rate of change of the coil 
current was 143 A/μs, corresponding to an intensity of 100% MSO. The resulting 
normalized electric field induced within the dish from several viewpoints can be seen 
in Figure 1B-D.  
KCl addition 
KCl was added drop by drop into the dish through a needle attached to a large 200ml 
plastic syringe, to reach a final KCl concentration in the dish of 1 M. This caused an 
approximately 200-fold increase in the extracellular potassium concentration. This 
high concentration of KCl required to visualize calcium activity in SH-SY5Y cells has 
been described previously in the literature (18).  The 1 M KCl was left on the cell 
cultures, and a multi-channel image was then taken to quantify ROI’s after KCl and to 
visualize cell morphological response to high KCl concentration, followed by another 
video to quantify stable KCl response for 2 minutes following addition. Fluorescence 
levels remained high in this measurement block, as has been shown previously in SH-
SY5Y cells (18).  
Quantification of Functional Imaging 
Fiji (ImageJ, version 1.52i, RRID:SCR_002285 ) open source software (30) was used to 
analyze microscope-acquired images. Each condition (iTBS, cTBS, or sham), was 
measured from a different cell culture dish. The data is separated into 4 measurement 
blocks; 1. Baseline, 2. Post-stimulation, 3. During the addition of 1M KCl, and  4. Post-
KCl.  
First, 20 circular ROI’s (width: 25, height: 25 pixels) of responding cells were randomly 
selected from the  4th (Post KCl) block, and used to measure pixel intensity over time 
for every prior block of the measurement. Since the cell culture dish was removed 
between the baseline and post-stimulation blocks, these ROI’s were shifted between 
the blocks and if possible, they were adjusted manually to quantify the same cell. 
Analysis was performed blinded to the condition. Measured intensity values were 
exported to excel and Prism 5 (Graphpad Software,USA, RRID:SCR_002798.) for 
statistics and graphing. 
Intensity values were normalized to the average of the baseline intensity at each time 
point. All 20 ROI’s in the baseline block were averaged, to calculate a baseline average 
at each time point (BaseAv(Tx)). Each intensity value for each ROI was then divided by 
the average baseline intensity at that time point (Intensity (Tx)/BaseAv(Tx))*100 to 
give a percent change from baseline.  
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This mean baseline normalized intensity of 20 ROI’s for each time point, with error 
bars as standard error of the mean can be seen in Figure 1F. ROI outliers which were 
2.5 standard deviations above the mean were removed.  
Statistical Analysis 
Analysis was done in Prism 5 (Graphpad Software,USA, RRID:SCR_002798) combining 
data from all 6 independent experiments. 2-way ANOVA with Bonferroni-corrected 
post-hoc comparisons were used to test the effect of CONDITION (iTBS, cTBS, sham) 
and TIME (60 time point measurements per block) on normalized fluorescence 
intensity in each of the measurement blocks; 1. Baseline 2. Post-stimulation, 3. 
Addition of KCl, 4. Post-KCl.  
Results 
We found that neurons which had been stimulated with iTBS, a protocol assumed to 
increase excitability, showed greater increase in fluorescence response to KCl than 
those which had been sham stimulated. In striking contrast, neurons which had been 
stimulated with cTBS, a protocol assumed to decrease excitability, showed the 
opposite response to KCl, i.e. a decreased response. A representative plot of the mean 
% change from baseline fluorescence during the entire experiment (error bars are 
standard error of the mean) is shown in Figure 1F. 
We repeated this experiment in 6 independent cell cultures per stimulation condition 
(iTBS, cTBS, or sham). For statistical analysis, data from all experiments were 
combined. The mean normalized intensity of 20 cells per experiment was calculated 
for each time point, for each experiment, to give an n of 6, each with 60 time points 
per block.  On the group level in block 2 (Post Stimulation), a two way ANOVA with 
factors condition (iTBS, cTBS, sham) and time reveals a significant effect of condition 
(F(2,660)=83.53, p<0.0001), and no effect of time (F(59,660)=0.01716, p=1.00) or 
interaction (F(118,660)=0.01366, p=1.000). Post-hoc Bonferroni corrected planned 
comparisons to normalized intensity after sham stimulation (101.4±0.23%) show a 
minor but significant decrease (p<0.0001) in baseline intensity after cTBS 
(99.27±0.08%), but no significant increase (p=0.1287) after iTBS (102.0±0.23%). Thus, 
cTBS/iTBS had very small, though significant, effects on ‘baseline’ neuronal activity as 







Figure 1.  A. Position of the cell culture dish 1 cm below the center of the coil. B-D. Simulation 
of the induced electric field (V/m) within the cell culture dish. SimNIBS (26) was used to 
calculate the electric field induced within the cell culture dish, during TMS stimulation at 100% 
MSO. The simulation parameters (cell culture dish model and conductivity values) were 
generously shared by (27). B. A cross section of the cell culture dish, showing the gradient of 
induced electric field within the dish. The electric field is strongest (red) at the top of the dish, 
closest to the coil.  Coil orientation shown beside. C. The bottom surface of the cell culture dish 
(furthest away from the coil, where the cells are plated) and D. Tilted view of the dish from the 
top surface.  E. Example live cell fluorescence response to 1M KCl stimulation. Each of the 60 
squares is a picture of the cell at 2 second intervals, for a period of 2 minutes as the KCl is 
added. Pink indicates an increase in fluorescence. F. Change in fluorescence intensity over time. 
Each line represents a different cell culture dish. Each data point is the mean percentage 
baseline intensity of 20 cells, error bars are standard error of the mean. Block 1 (0-120s): 
Baseline measurement. After this, cells were removed from the microscope and stimulated with 
iTBS, cTBS or sham, and placed back into the microscope. Block 2 (120-240s): Post Stimulation 
measurement. Block 3 (240s-360s): Addition of 1M KCl during recording. Block 4 (360-480s): 
Post KCl addition.  
As hypothesized, TBS modulations were particularly apparent on ‘evoked’ neuronal 
activity. This functional activity was captured by the neuronal response to chemical 
depolarization (KCl), in block 4. We found a greater increase in fluorescence response 
to KCl in neurons stimulated with iTBS (125.4±0.44%) as compared to sham 
(122.2±0.42%). Neurons stimulated with cTBS instead showed a decreased 
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fluorescence response to KCl (114.8±0.65%). A two-way ANOVA of baseline-corrected 
intensity following KCl addition confirms a statistically significant, strong effect of 
condition (F(2,840)=91.46, p<0.001), but no effect of time (F(59,840)=0.04, p=1.000) 
and no interaction (F(118,840)=0.035, p=1.000). iTBS and cTBS comparisons to sham 
stimulated neurons showed statistically significant differences (p<0.001, Bonferroni-
corrected). See Supplementary Material for 2-way ANOVA results of each block.  
Discussion 
Taken together, these findings suggest that rTMS was able to modulate human 
neuronal response to chemical depolarization with KCl; with iTBS facilitating, and cTBS 
inhibiting this response, compared to sham stimulation. This provides support for the 
hypothesized iTBS and cTBS effects on neuronal excitability on the human cell level.  
These findings, which provide support for the positive and negative modulation of 
human neuronal calcium activity by iTBS and cTBS respectively, are reassuring. While 
they do not explain reported unreliability of TBS effects on other human excitability 
measures (e.g. MEP/TEP), they 1) validate at least on the cell level foundational 
assumptions about the mechanistic underpinnings of these globally implemented 
treatment/research protocols, and 2) demonstrate the value of in vitro human 
neuronal models for studying cellular effects of TMS (and potentially for other 
interventions and exposures linked to the onset or treatment of mental disorders). 
Therefore, this functional imaging setup of stimulated living human neurons in a dish 
provides a direct method for testing the immediate functional activity changes of 
human neurons following TMS.  
Animal studies have previously provided support for the hypothesized opposing 
neuroplastic effects of iTBS and cTBS (31, 32), as well as an immediate effect of rTMS 
on intracellular calcium release (33, 34). Computational modelling of calcium-
dependent plasticity effects following rTMS in a neural field model have shown that 
during iTBS/cTBS stimulation, the first burst of stimulation within a train causes an 
increase in calcium concentration, resulting in potentiation (35). In an iTBS protocol, 8 
second breaks between trains of stimulation bursts allow for the maintenance of this 
potentiating increase in calcium concentration. In cTBS, the accumulation of calcium 
concentration results in an overall depressive effect (35). Previous studies have also 
discussed the importance of the intervals between stimulation trains in the iTBS 
protocols for its faciliatory effect (15). We also report an immediate depressive effect 
of cTBS and an immediate faciliatory effect of iTBS on calcium concentration, as 
measured by a response to KCl using fluorescence microscopy.  
We modelled the induced electric field within the cell culture dish using SimNIBS as 




which is stronger than what is typically used for human cortex stimulation. In our cell 
culture dish, all neurons were affected by an electric field greater than 200V/m, while 
in models of the human cortex effected by stimulation, only a very superficial layer of 
cortex directly under the coil is affected by an electrical field of approximately 100V/m 
(36, 37). However, other rTMS animal and cell culture studies have reported using 
these stimulation parameters (24, 25), and in this first, exploratory setup we wanted 
to measure changes in response to the highest stimulation intensity possible.  
One of the main limitations of this study, is the use of SH-SY5Y cells as a model for 
human neurons. SH-SY5Y cells are a human-derived neuroblastoma cell line, which 
can be differentiated to neural-like cells in a relatively short amount of time (28, 38, 
39). They are well characterized, have been shown to develop functional synapses (18, 
40), synthesize neurotransmitters (21), and are used as a model for various human 
neuropsychiatric and neurodegenerative disorders (41-43). However, they are not 
glutamatergic or GABAergic neurons, which are thought to be the primary cortical 
neurons affected by rTMS (44).  SH-SY5Y cells have been shown to express many 
genes involved in axonal guidance and synaptic plasticity (18-20, 42), specifically in the 
BDNF-TrkB pathway, known to be involved in LTP (45). Therefore, while not the 
perfect human neuron model, we chose to first test our setup with SH-SY5Y cells as 
they are quick to culture, resulting in relatively reliable and stable phenotypes and 
they have been used as a model for human synaptic plasticity in vitro.  
Additionally, we used a very high concentration of KCl to chemically induce 
depolarization in our differentiated SH-SY5Y cells. This has been done previously in 
calcium imaging of SH-SY5Y cells (18), however it is important to note that 1M KCl is a 
highly non-physiological concentration. This high concentration of KCl likely increases 
osmotic pressure, which may cause dehydration and shrinking of the cells as has been 
reported in SH-SY5Y cells previously (18). Therefore, an increase in calcium may also 
be explained by an increase in cytosolic calcium levels, due to an osmotically driven 
decrease in cytosolic volume. It is important to confirm our results using different 
methods, for example using potassium channel blockers such as 4-
Aminopyridine (4AP) to depolarize the cells, or by lowering the KCl concentration. 
Recently, brain-state has been suggested as a factor contributing to the variability of 
individual responses to rTMS protocols (17). rTMS is thought to lead to LTP/LTD-like 
synaptic plasticity effects, however, on a meta-plastic level, homeostatic mechanisms 
work to stabilize neural systems, keeping the threshold at which synaptic plasticity is 
induced within a physiologically relevant range (46-49). These metaplasticity 
mechanisms are thought to adjust this threshold for synaptic plasticity based on 
previous neural activity (50, 51), therefore brain-state is extremely influential in 
determining the excitability effects induced by rTMS. In our cell culture model, we did 
not test for the influence of metaplastic or homeostatic plasticity mechanisms, as we 
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were interested in 1.) establishing an in vitro setup capable of measuring excitability 
changes following rTMS in a human neuron model, and 2.) using this setup to quantify 
the immediate effects of iTBS and cTBS. Additionally, we have not yet proven that the 
functional activity effects we find are related to synaptic plasticity, which would be a 
necessary next step in establishing the presumed meta- or homeostatic plasticity 
effects of rTMS. Based on our work, future studies can be designed to specifically test 
the effects history of neural activity on TMS-induced plasticity changes in a human 
neural network model. 
Looking ahead, this human neuron model has the potential to allow laboratory 
evaluation and optimization of rTMS protocols for individual patients, particularly 
when using patient-derived cells (e.g. skin-derived fibroblasts or peripheral blood 
mononuclear cells) and induced pluripotent stem cell (iPSC) reprogramming (52). For 
example, using iPSC techniques, individualized neuron models can be established by 
reprogramming skin cells taken from a treatment resistant patient into neurons which 
contain the genetic composition of that patient (52, 53). This can be taken one-step 
further with the cerebral organoid, as these patient specific neurons can organize into 
a 3D cell culture system to model whole cortical structures in-vitro (54). With this 
setup, patient-specific human neural models can be stimulated with rTMS, using 
calcium imaging to measure that patient’s responsiveness to particular rTMS 
protocols. Further application and development of this model may enable assessment 
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Figure S1. Group Results. Group results combining all independent experiments. Each data 
point is the mean of all percent baseline intensity values across the 6 experiments, error bars 






Figure S2. Change in Image Intensity over time in a single ROI. Image montages of change in 
fluorescence over time in an example cell selection for each stimulation condition (sham, iTBS, 
and cTBS). Each small purple-bordered box is one image in the time series, taken 2 seconds 
apart for a total of 60 images per measurement block. There are no increases in fluorescence in 
the pre stimulation block, as well as no large increases after stimulation. In the KCl Addition 
block; there is a visible increase in fluorescence (in purple) after about 20 seconds. This quickly 
reaches a maximum and is maintained throughout the Post KCl block. The mean intensity (a.u.) 
over the 60 images in the Post KCl block is stronger in the cells which had been stimulated with 
iTBS (3781.8±14.8), compared to sham stimulated (3449.9±9.74). The mean intensity is less in 
the previously-cTBS stimulated cells (3417.4±8.1).  
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2-way ANOVA results 
1. Pre-Stimulation 
Due to missing data, 6 independent experiments were included from the iTBS and 
sham conditions, and 5 from the cTBS condition. There was no effect of CONDITION 
F(2,840)=0.260,p=0.7642, TIME F(59,840)=0.8191,p=0.8318, or interaction 
F(118,840)=0.9871,p=0.5233 in the pre-stimulation block.  
2. Post Stimulation  
Data from 6 independent experiments for the iTBS and cTBS conditions were included, 
and 2 for the sham condition. There was a significant effect of CONDITION 
F(2,660)=83.53,p<0.0001, and no effect of TIME F(59,660)=0.01716,p=1.00 or 
interaction F(118,660)=0.01366,p=1.000. Post-Hoc Bonferroni corrected comparisons 
show a significant increase in percentage baseline intensity after iTBS (102.0±0.18%) 
compared to cTBS (99.27±0.08%) t(660)=12.66,p<0.0001 and a significant decrease 
after cTBS (99.27±0.08%)compared to sham (101.4±0.23%) t(660)=6.922,p<0.0001. 
There was no significant difference between iTBS and Sham (p=0.1287).  
3. Addition of KCl  
Data from 6 independent experiments for the iTBS and cTBS condition were included, 
and 3 independent experiments from the sham condition. As expected, since the 
measurement was during the addition of the KCl, there was a significant effect of 
TIME F(59,720)=6.655,p<0.001. There was also a significant effect of CONDITION 
F(2,720)=124.2,p<0.0001 but no interaction (F118,720)=0.4828,p=1.000. All 
Bonferroni-corrected post-hoc comparisons were significant (p<0.0001). 
4. After KCl 
Finally, in the last block, data from 6 independent experiments for the cTBS and sham 
conditions were included, and 5 from the iTBS condition. There was a significant effect 
of condition F(2,840)=91.46, p<0.001, but no effect of time F(59,840)=0.04,p=1.000 
and no interaction F(118,840)=0.003, p=1.000. Bonferroni corrected Post Hoc 
Comparisons revealed all comparisons (Sham-cTBS, Sham-iTBS, iTBS-cTBS) to be 
significant, p<0.001.There was a significant increase in percentage baseline intensity 
in cells which had been stimulated with iTBS (125.4±0.44%,N=60) compared to sham 
(122.2±0.42%,N=60) t(118)=3.925,p=0.0003. There was also a significant increase in 
percentage baseline intensity in cells that had been stimulated with 
iTBS(125.4±0.44%,N=60)  compared to cTBS (114.8±0.65%,N=60) 
t(118)=12.99,p<0.0001, and a decrease in cells which had been stimulated with cTBS 
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Key Resources Table 
REAGENT or RRESOURCE SOURCE IDENTIFIER 
Chemicals, Peptides, and Recombinant Proteins 
Fluo-4, AM, cell permeant Invitrogen Cat# F14201 
Propidium Iodide stain Molecular Probes Cat# P3566 
Bisbenzimide Hoechst 
33342 
Sigma-Aldrich Cat# B2261 
Pluronic™ F-127 ThermoFisher Cat# P6867 
Experimental Models: Cell Lines 
Homo sapiens; SH-SY5Y  ATCC  Cat# CRL-2266 
RRID:CVCL_0019 
Software and Algorithms 
Fiji (ImageJ) Schindelin et al., 20121 http://fiji.sc 
RRID:SCR_002285 
Prism version 5.0  GraphPad Prism www.graphpad.com 
RRID:SCR_002798 
Micro-Manager software Edelstein et al., 20142 http://micro-
manager.org/ 
RRID:SCR_016865 
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Transcranial magnetic stimulation (TMS) is a form of non-invasive brain stimulation, 
used to alter cortical excitability both in research and clinical applications. The 
intermittent and continuous theta burst stimulation (iTBS and cTBS) protocols have 
been shown to induce opposite after-effects on human cortex excitability. Animal 
studies have implicated synaptic plasticity mechanisms long-term potentiation (LTP, 
for iTBS) and depression (LTD, for cTBS). However, the neural basis of TMS effects has 
not yet been studied in human neuronal cells, in particular at the level of gene 
expression and synaptogenesis.  To investigate responses to TBS in living human 
neurons, we differentiated human SH-SY5Y cells towards a mature neural phenotype, 
and stimulated them with iTBS, cTBS, or sham (placebo) TBS. Changes in a) mRNA 
expression of a set of target genes (previously associated with synaptic plasticity), 
and b) morphological parameters of neurite outgrowth following TBS were 
quantified. We found no general effects of stimulation condition or time on gene 
expression, though we did observe a significantly enhanced expression of plasticity 
genes NTRK2 and MAPK9 24 hours after iTBS as compared to sham TBS. This specific 
effect provides unique support for the widely assumed plasticity mechanisms 
underlying iTBS effects on human cortex excitability. In addition to this protocol-
specific increase in plasticity gene expression 24 hours after iTBS stimulation, we 
establish the feasibility of stimulating living human neuron with TBS, and the 
importance of moving to more complex human in vitro models to understand the 
underlying plasticity mechanisms of TBS stimulation. 
Keywords: Theta Burst Stimulation (TBS), Brain Stimulation, Cortical Excitability, Long 





Transcranial magnetic stimulation (TMS) is a widely used neuromodulation technique, 
where electromagnetic pulses can non-invasively stimulate cortical structures (1, 2). 
Multiple pulses administered in a certain frequency (repetitive TMS: rTMS), can have 
effects on cortical excitability lasting beyond the period of stimulation (3, 4). In 
humans, such effects are often revealed with physiological outcome measures, such 
as motor-evoked potentials (MEPs) (5). For example, the commonly used theta burst 
stimulation (TBS) protocols intermittent and continuous TBS (iTBS and cTBS) have 
been shown to increase or decrease MEPs for up to 1 hour following stimulation, 
respectively (4). Still, large inter and intra subject variability have been associated 
with the use of MEP’s as an outcome measure (6). Several reports on the difficulty of 
replicating the assumed iTBS/cTBS effects have cast doubt on the efficacy of these 
protocols (7-10). A method to reliably verify rTMS effects, for example in an in vivo 
model, is urgently needed. 
A widespread assumption is that such after-effects are attributable to neuronal 
plasticity mechanisms, such as long-term potentiation (LTP) and long-term depression 
(LTD) (11). Indeed, administering an N-methyl-D-aspartate receptor (NMDAR) 
antagonist to participants prior to iTBS/cTBS stimulation has been shown to 
completely abolish the after-effects on MEP amplitude, relating NMDAR-dependent 
LTP/LTD to TBS effects in humans (12).  
LTP is a well-studied form of synaptic plasticity, often induced ex vivo through high 
frequency stimulation directly to individual neurons or groups of neurons (13). It can 
be divided into two phases, early-LTP, which is protein-synthesis independent, and 
occurs immediately after stimulation, and late-LTP, which requires protein synthesis 
and can lead to structural and functional changes lasting at least 24 hours in vitro (14-
17). The phenomenon of late LTP depends heavily on brain-derived neurotrophic 
factor (BDNF) binding to its high affinity receptor, tyrosine kinase receptor B (TrkB), 
and initiating a series of signaling proteins leading to changes in expression of 
plasticity related genes (18-21).  
In cultured mouse neurons, rTMS has been shown to activate this BDNF-TrkB 
signaling pathway (22-24), as well as to induce an immediate release of calcium from 
intracellular stores (25, 26), which is important in the induction of synaptic plasticity 
(27). In rats, high and low frequency rTMS stimulation showed differential activation 
of the immediate early genes C-FOS (a general marker for excitatory cell activity) and 
EGR1 (a presumed marker of LTP or LTD induction) (28). In addition, iTBS and cTBS 
showed dose-dependent and protocol specific effects on the synthesis of these two 
proteins (29). iTBS and cTBS also differentially change the synthesis of calcium 




(30-33), which has a functional impact on neuronal electrical activity, with iTBS, but 
not cTBS, enhancing spontaneous neuronal firing and EEG gamma band power (30).  
In sum, several lines of cellular evidence from animal studies implicate different 
aspects of late LTP mechanisms in the after-effects of rTMS. But such plasticity effects 
of rTMS at the cellular and molecular level have mainly been examined in rodent-
based models. Given the rapid development and increasingly widespread and 
accepted use of rTMS, particularly TBS, for both experimental and clinical applications 
in human volunteers and patients, it seems crucial to study and understand the 
cellular effects of TBS in human neurons. In vitro studies with human neurons could 
validate the animal results, and contribute to our understanding of the mechanisms 
of action underlying different TBS protocols that are already, and increasingly, 
(clinically) applied worldwide.  
To our knowledge, only two previous studies have used human SH-SY5Y 
neuroblastoma cells to measure responses to rTMS in vitro, and both used classical 
high and low frequency protocols. One study reported protocol-specific effects of 
high (9Hz) and low (3Hz) frequency rTMS stimulation on catecholamine levels and 
neurotransmitter metabolism (34), and the other showed increased intracellular 
cAMP and CREB activation with high (5Hz) frequency rTMS (35). These studies 
provide the first evidence of the feasibility of using SH-SY5Y cells in this type of study. 
However, to date no study has used SH-SY5Y cells to investigate neural responses to 
TBS protocols.   
Here, we developed an in vitro human neuron model to assess protocol-specific 
effects of iTBS/cTBS on plasticity markers of gene expression and neurite outgrowth. 
We chose to investigate changes in the BDNF-TrkB signaling cascade, given its 
importance in plasticity mechanisms, and because previous animal studies have 
shown an rTMS-induced effect on protein expression in this pathway [16-18]. We 
focused on hypothesis-driven gene expression targets in this pathway, to identify 
immediate effects to help tailor future protein or genome-wide screening analysis.  
We also wanted to quantify any structural changes to neurite morphology with 
commonly used cytoskeletal markers βIII-Tubulin and MAP2, which may indicate 
neuroplastic effects. We differentiated SH-SY5Y cells into a mature neuron-like 
phenotype, applied different TBS protocols, and collected cells immediately, 3 hours, 
6 hours and 24 hours after stimulation. While in humans TBS effects have been 
shown to be strongest up to 30 minutes after stimulation (4), we chose these time 
points to capture the plasticity-dependent processes requiring longer periods of time 
(36-38).  
We report a protocol-specific effect on expression of genes in the BDNF-TrkB 
pathway, with an increase in expression of NTRK2 and MAPK9 24 hours after iTBS 
stimulation, but no change in cell count, neurite length, neurite branching, or levels 
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of neurite proteins. In a separate report, we showed that these TBS procedures, using 
the same in vitro model, did affect excitability as hypothesized. This suggests that the 
results reported here did originate from functionally active cell cultures, that 
responded to TBS as hypothesized (39). The current results, positive as well as 
negative, thus demonstrate the feasibility and value of in vitro human neuron studies 
to unravel plasticity mechanisms induced by TMS. 
Methods 
Cell culture 
SH-SY5Y cells were obtained from ATCC® (Cat #CRL2266™, RRID:CVCL_0019) and 
were maintained and expanded according to ATCC® recommendations. For 
experiments, cells were not used above passage 26. Cells were grown in DMEM/Nut 
Mix F12 with Glut-L (GibcoTM, Thermo Scientific) supplemented with 10% heat 
inactivated fetal bovine serum (FBS, MERCK), 1% penicillin-streptomycin (P/S) and 1% 
L-Glutamate at 37°C and 5% C02. Experiments were conducted on differentiated cells 
plated in round 35mm dishes at approximately 2.4x104 cells per well. Differentiation 
was induced over a period of 13 days; FBS supplementation was decreased to 3% 3 
days prior to the addition of 10 μM retinoic acid for 10 days (RA; Sigma-Aldrich, 
R2625). Medium was replaced every 2 days. 
Magnetic Stimulation 
Cells were placed 1 cm below the center of a Cool-B65 figure of 8 coil (Magventure, 
Denmark) and stimulated at 100% Maximum Stimulator Output (MSO) with a MagPro 
X100 with MagOption stimulator, realized output 143 A/µS (Magventure, Denmark). 
The setup is illustrated in Figure 1A. Each stimulation consisted of the Huang et al. 
(2005) published protocol of 50Hz triplets repeated in a 5 Hz rhythm. cTBS was a 
continuous train, while iTBS was a 2 second train of pulses, with an inter-train interval 
of 8 seconds, both for 600 pulses (4). 
Cells stimulated with cTBS remained under the coil for an additional 150 seconds, and 
cells in the sham condition were placed under the coil for 190 seconds, to ensure that 
cells in all TBS conditions (cTBS, iTBS, sham) were out of the incubator for the same 
amount of time. The electrical field induced in the dish, with the stimulation 
conditions described above (100% MSO, dish placed 1cm below the coil), was 
simulated using the SimNIBS toolbox (40). The cell culture dish mesh was generously 
shared by the authors of (41). The distribution of the electric field (V/m) within the 
dish from several viewpoints can be seen in Figure 1B-D. The stimulation protocol is 





Figure 1. Experiment Setup. A. Position of the cell culture dish 1cm below the center of the 
coil.). B-D. Simulation of the induced electric field (V/m) within the cell culture dish. SimNIBS 
(40) was used to calculate the electric field induced within the cell culture dish, during TMS 
stimulation at 100% MSO. The simulation parameters (cell culture dish model and conductivity 
values) were generously shared by (41). B. A cross section of the cell culture dish, showing the 
gradient of induced electric field within the dish. The electric field is strongest at the top of the 
dish, closest to the coil.  Coil orientation shown beside. C. Shows the bottom surface of the cell 
culture dish (furthest away from the coil, where the cells are plated) and D. Is a tilted view of 
the dish from the top surface. E. Stimulation protocols used for stimulation, iTBS has been 
shown to increase cortical excitability (measured in motor evoked potentials), and cTBS to 
decrease it for up to 1 hour following stimulation (4).  
qRT-PCR 
Cells were collected immediately, 6 hours or 24 hours after stimulation. In humans, 
the maximal TBS effects are expected in the first 30 minutes after stimulation (4). 
However, we chose to measure at later time points because we were specifically 
interested in plasticity-dependent gene expression, which require hours or even days 
(36) While the rapid expression of immediate early genes could be effected by TBS 
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within the first 30 minutes (42, 43), most of the genes of interest in our study are 
expressed at later time points following plasticity-inducing protocols (37).RNA was 
extracted with TRIzol (Invitrogen,15596026) according to the manufacturer’s 
instructions. Nanodrop was used to quantify the amount of RNA in each sample, and 
cDNA was synthesized using RevertAid H Minus First Strand cDNA Synthesis Kit 
(Thermo Scientific, K1632). RNA was stored at -80°C, cDNA at -20°C. Eight biological 
replicates were collected per stimulation condition per time point, derived from at 
least two undifferentiated cell batches for differentiation. Due to quality of extracted 
RNA, some samples had to be discarded, leaving between four and eight biological 
replicates per condition. Each biological replicate was run in technical duplicates for 
qRT-PCR. A complete list of biological replicates and differentiation batches for each 
sample can be found in the Supplementary Material (Table S1). 
Primers for qPCR were designed using the NCBI gene reference database and Primer-
BLAST (National Library of Medicine). The following genes were analyzed (see 
Supplementary Material Table S2 for sequences): NTRK2, BCL2, MAPK9, TUBB3, 
EGR1, CREB1, and GAPDH, PPiB, and TBP were used as housekeeping genes (HKGs). 
Primers, 600 nM, were mixed with Fast Start Universal Sybr green ROX 
(Roche,491385001). Samples were run in 384 well qPCR plates (Roche,4TI-0382) using 
the LightCycler® 480 Real-Time PCR system (Roche LifeScience). qPCR program details 
are described in Supplementary Material (Table S3).  
Microscopy 
Cells were grown on 12mm round glass cover slips (VWR,631-1577), coated with 
1µg/mL Laminin (Sigma,L2020) and 100 µg/mL Poly-L-Ornithine (Sigma,P4957), and 
cultured as described above.  
Fluorescence microscopy was used to visualize morphological changes 3 hours, 6 
hours, and 24 hours after stimulation. Again, this because these structural changes 
require longer time windows to visualize effects. Axonal reorganization has been 
shown to require several hours (2-6) to begin to show signs of microtubule 
movement (38). Cells were washed in PBS and fixed for 10 minutes at room 
temperature in 4% paraformaldehyde. Fixed and PBS-washed cells were blocked in 
PBS-T (PBS + 0.1% Tween-20) and 10% donkey serum followed by primary antibody 
incubation. Antibodies for marking neurite outgrowth (βIII-Tubulin (Cell Signaling, Cat 
#5568S, RRID:AB_10694505)) and axons (MAP2 (Sigma, Cat #M2320, AB_609904)) 
were used.  Cells were washed in alternating PBS-T and PBS, and incubated with 
secondary antibodies donkey-anti-rabbit Alexa 488 (Invitrogen, Cat #A-21206 
RRID:AB_141708), donkey-anti-mouse Alexa 594 (Invitrogen, Cat #A-21203, 
RRID:AB_141633), and with DAPI (CarlRoth, Cat #6843.3). The glass cover slips were 
then mounted on glass microscope slides and imaged with an Olympus BX51WI 




Further details on primary and secondary antibodies and microscope settings are 
listed in the Supplementary Material (Tables S4 and S5). This experiment was 
repeated twice, with 4 images of each replicate analyzed. In total, 8 images per 
stimulation condition time point were included; with each image containing on 
average 163±73 cells.  
Analysis 
Gene expression 
A standard curve was used to calculate relative concentrations of gene expression per 
gene. An average of technical duplicates was made, and normalized to the average of 
the 3 housekeeping genes (GAPDH, PPiB, TBP). Data were analyzed with LightCycler 
480 software version 1.5.1.62 (Roche Life Sciences) and Microsoft Excel, and graphs 
were made in Prism 5 (GraphPad Software,USA, RRID: SCR_002798).  
Microscopy 
Images were processed and analyzed with Fiji (ImageJ version 1.52i, 
RRID:SCR_002285) (44). Cells in each picture were counted with the analyze particle 
tool, using the DAPI stain for the cell nuclei. Fluorescence intensity (immunoreactivity 
of βIII-Tubulin) was quantified by measuring the total 488 channel intensity in each 
image. This was then divided by the total fluorescence intensity in the 350 channel, to 
give a corrected fluorescence for the number of cells in the image. Neurite length and 
branching were quantified by tracing outgrowths in the 488 (βIII-Tubulin) channel. 
Neurite length was measured with the segmented line tool, at 20x magnification and 
quantifying 20 cells per image. From each cell only the primary neurite length was 
counted. The NeuronJ plugin (45) was used to quantify neurite branching. For each 
image, all neurites were semi-automatically traced, and manually labeled as either 
primary, secondary, or tertiary extensions. The number of branches (secondary or 
tertiary extensions) were divided by the total number of neurons (counted with 
DAPI), to give the number of branches per neuron in each image. Graphs were made 
with Prism 5 (GraphPad Software, USA, RRID:SCR_002798). 
Statistical Analysis 
Statistical analysis was done using IBM SPSS 24 (SPSS for Windows version 24.0. 
Armonk, NY: IBM Corp). SH-SY5Y differentiation was verified through independent 
samples t-tests comparing undifferentiated and differentiated cells. Biological 
replicates were used for statistical analysis. For gene expression analysis, a 2-way 
ANOVA was used to first test housekeeping genes for an effect of stimulation 
condition or time on expression. None of the genes showed any significant effects 
(complete results in Supplementary Material). Since there was no significant effect of 
stimulation condition on expression of any genes at the immediate time point 
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(complete results in Supplementary Material) these levels were averaged across 
stimulation conditions, and used to calculate % immediate expression levels for the 6 
and 24-hour time points. 
Due to the small number of biological replicates and unequal variances across 
samples, non-parametric Kruskal Wallis testes were done for condition and time 
separately. However, using these non-parametric statistical tests did not allow for 
testing of interaction effects. We had expected gene expression effects to be 
strongest at one of the time points, therefore we performed hypothesis-driven 
analyses for the 6 hour and 24-hour time points separately, using the Kruskal-Wallis 
test for a significant difference in gene expression between stimulation conditions.  
Reported gene expression and microscopy results are presented as mean ± standard 
error of the mean. Bonferroni correction was used for post-hoc comparisons. Figures 
show bar graphs of the mean, error bars are standard error of the mean.  
Results 
SH-SY5Y differentiation 
Differentiation status of SH-SY5Y cells was verified through visual inspection of 
increased neurite length, and confirmed by a significant increase in TrkB expression 
(NTRK2) at day 10 of differentiation (t(7)=8.657, p<0.0001), as reported previously 
(46, 47) (see Figure 2). Expression of all genes of interest was verified at day 10 of 
differentiation (Figure 2 G, H.). Complete results of t-tests are reported in 
Supplementary Material. Neurite outgrowth increased from day 0 to day 10 of 
differentiation (37.9 ± 2.8 μm and 112.3 ± 11.8 μm, respectively; t(26)=6.163, 





Figure 2. SH-SY5Y cell differentiation. Cells were marked for nucleus DAPI (blue), MAP2 (red) 
and βIII-Tubulin (green) in an undifferentiated state (A-C) or after 10 days of differentiation (D-
F). A selection of neurons in the image were chosen to split by channel (βIII-Tubulin or MAP2), 
identified by the white box in C. and F. A. Selection of undifferentiated cells, βIII-Tubulin. B. 
Selection of undifferentiated cells, MAP2.  C. Full image undifferentiated cells, merge of βIII-
Tubulin and MAP2. D. Selection of 10 days differentiated cells, βIII-Tubulin. E. Selection of 10 
days differentiated cells, MAP2. F. Full image of 10 days differentiated cells; merge of βIII-
Tubulin and MAP2.G. RT-qPCR analysis was used to assess the expression of the indicated 
genes in differentiated and undifferentiated cells. H. Significant increase in NTRK2 expression 
at day 10 of differentiation. I. Significant increase in primary neurite outgrowth at day 10 of 
differentiation. Values represent mean ± SEM (*p<0.05, ****p <0.001, Student’s t-test). 
Effects of stimulation condition on gene expression 
We were interested in gene expression changes in the BDNF-TrkB signaling cascade, 
specifically in downstream targets related to plasticity. Therefore, we focused on the 
following genes involved in this pathway: Mitogen-Activated Protein Kinase 9 
(MAPK9, GeneID: 5601), Neurotrophic Regulator Tyrosine Kinase 2 (NTRK2, GeneID: 
4915), B-cell lymphoma 2 (BCL2, Gene ID: 596), Tubulin Beta Class III (TUBB3, Gene 
ID: 10381), cAMP Responsive Element Binding Protein 1 (CREB1, Gene ID: 1385). We 
also included Early Growth Response 1 (EGR1, Gene ID: 1958), which is considered an 
immediate early gene. 
98 
 
We found no significant effect of stimulation condition or time on several of the 
genes tested; BCL2 (Condition: H(2)=0.125, p=0.940, Time: H(1)=2.626, p=0.105); 
TUBB3 (Condition H(2)=1.060, p=0.589, Time H(1)=1.298, p=0.255); and CREB1 
(Condition H(2)=0.651, p=0.722, Time H(1)=0.006, p=0.936).  
We found no significant effect of condition on EGR1 expression (H(2)=1.926, 
p=0.382), but an effect of time (H(1)=9.195, p=0.002), with a decrease in the 
expression (% immediate) at 24 hours (54.5±5.6%) compared to 6 hours (77.4±5.0%) 
(Figure 3A). Similarly for MAPK9 we find no significant effect of condition (H(2)=1.043, 
p=0.594) but an effect of time (H(1)=4.152, p=0.042), as well as for NTRK2 expression 
(Condition H(2)= 0.905, p=0.636, Time H(1)=4.022, p=0.045).  
BCL2 expression: There was no effect of stimulation condition at 6 hours (H(2)=1.024, 
p=0.985). However, at 24 hours, we observed a borderline statistically significant 
effect of stimulation condition on BCL2 expression (H(2)=5.981, p=0.050); i.e. we 
observed an increase in BCL2 expression in cells which had been stimulated with iTBS 
(119.8±18.7%) compared to cTBS (95.0±10.1%) and sham (77.2±3.2%), however none 
of the post-hoc comparisons were significant (p>0.05) (Figure 3B). 
NTRK2 expression: We find no effect of stimulation condition at 6 hours (H(2)=2.12, 
p=0.346). At 24 hours we find a statistically significant effect of stimulation condition 
on NTRK2 expression (H(2)=8.010, p=0.018). We observed an increase in expression 
in cells which have been iTBS stimulated compared to sham stimulated cells 
(139.7±30.85% and 83.8±5.2%, respectively; p=0.036) (Figure 3C). 
MAPK9 expression: Again, we find no effect of stimulation condition at 6 hours 
(H(2)=0.030, p=0.985). When analyzing the 24 hour time point separately, we 
observed a statistically significant effect of stimulation condition (H(2)=8.640, 
p=0.013). MAPK9 expression levels were significantly higher in iTBS stimulated cells, 
compared to sham stimulated cells (127.9±13.4% and 89.0±5.3%, respectively; 





Figure 3. Gene Expression results 6- and 24-hours following stimulation. Values are normalized 
by the average of 3 Housekeeping Genes (GAPDH,TBP,PPiB) and divided by the average 
immediate expression. Bars shown are % immediate time point expression. A. Expression of 
EGR1 B. Expression of BCL2 C. Expression of NTRK2 D. Expression of MAPK9.Significant 
Significant bonferroni-corrected post hoc tests are indicated with a * (p<0.05), n=4-8, see 
supplementary material for exact replicate numbers per condition.  
Effect of Stimulation Condition on Neuron Morphology 
Cell count: We found no significant effect of condition (H(2)=0.815, p=0.665) or time 
(H(2)=3.37, p=0.185) on cell count (Figure 4A).  
βIII-Tubulin immunoreactivity: There was no significant effect of stimulation 
condition on total fluorescence intensity of βIII-Tubulin (H(2)=1.19, p=0.55). There 
was however a significant effect of time (H(2)=6.61, p=0.037), with an increase at 24 
hours (1.23±0.05) compared to 6 hours (1.17±0.05) and 3 hours (1.09±0.007) (Figure 
4B).  
Neurite outgrowth: There was no significant effect of stimulation condition on 
primary neurite length (H(2)=0.336, p=0.85). There is a significant effect of time 
(H(2)=22.320, p<0.001). Neurites were longer at 3 hours (66.56±2.35μm) compared 
to 6 hours (49.82±2.00μm) and 24 hours (47.92±2.48μm) (Figure 4C).  
100 
 
Neurite Branching: There was no significant effect of stimulation condition on neurite 
branching (H(2)=1.580, p=0.45). There is a significant effect of time (H(2)=13.901, 
p=0.001). There were more branches per neuron at 3 hours (0.031±0.0044) compared 
to at 6 hours (0.018±0.0023), and 24 hours (0.012±0.0026) (Figure 4D).  
 
Figure 4. Morphological outcome parameters over time for each stimulation condition. A. Cell 
count B. Total fluorescence in the βIII-Tubulin channel (488), normalized to the DAPI channel 
(350). C.  Primary neurite length D. Neurite branching. N=8 images per stimulation condition. 
Discussion 
To date, the molecular and cellular mechanisms underlying TMS have been mainly 
studied in living rodents or animal brain slices (11, 48). Here, we set out to investigate 
TMS induced plasticity mechanisms in an in vitro human neuron-like model, through 
stimulating differentiated SH-SY5Y neuroblastoma cells with either iTBS, cTBS, or 
sham stimulation. Previous animal and human TBS studies have suggested that 
iTBS/cTBS may rely on activity-dependent plasticity mechanisms of LTP/LTD (12, 29, 
49-51). To investigate these changes in living human neurons, we focused on 
molecular (in particular genes related to BDNF/TrkB signaling) and morphological 




modelled using the SimNIBS toolbox (40), not with the aim of comparing stimulation 
strength to that usually achieved with TMS in a human brain, but only to confirm that 
stimulation was capable of depolarizing neurons. Our high-intensity stimulation 
parameters were based on other rTMS animal and cell culture studies (35, 52), with 
the primary goal of ensuring sufficient depolarization to induce excitations in our 
cells. Indeed, this was successful, as in another report (39) we could show that these 
procedures/parameters affected excitability in identically treated cell cultures as 
hypothesized: demonstrating after-effects in opposite directions for iTBS and cTBS as 
previously observed in animal and human in vivo studies. 
We found that, compared to sham stimulation, iTBS increased the expression of 
NTRK2 and MAPK9 after 24 hours. MAPK9, also known as JNK2, has been shown in 
mice to be important in hippocampal synaptic plasticity (53, 54). MAPK9 knockout 
mice had impaired late but not early LTP, suggesting that MAPK9 may be 
instrumental in the switch from early to late LTP (51). This switch is important, as late 
LTP is responsible for plasticity effects lasting at least 24 hours, requiring protein 
synthesis and structural changes (15, 16, 55). In humans, several studies have shown 
that repeating iTBS (9) or cTBS (56) at spaced intervals consolidates LTP/LTD-like 
effects, providing evidence for late-LTP or late-LTD mechanisms only after repeated 
iTBS/cTBS sessions. Our results showing an increase in MAPK9 mRNA expression at 24 
hours following iTBS could indicate this critical shift from early to late LTP 
mechanisms. Measuring MAPK9 mRNA expression after repeated iTBS of SH-SY5Y 
cells could further support the evidence from human studies, that repeating iTBS 
sessions results in late-LTP mechanisms in humans. 
Similarly, NTRK2, the gene that codes for the high affinity BDNF-receptor TrkB, is 
thought to be a critical regulator of hippocampal LTP (36). Mice lacking TrkB 
receptors showed reduced TBS-induced LTP, indicating the importance of this 
receptor in regulating synaptic plasticity (57). An increase in NTRK2 mRNA expression 
indicates that the BDNF-TrkB signaling cascade may be upregulated 24 hours after 
iTBS. This supports the assumption that iTBS promotes LTP-like plasticity, specifically 
through up-regulation of the BDNF-TrkB pathway.  
We also found a slight effect of condition at 24 hours following stimulation in 
expression of BCL2. This indicates an effect of TBS on the expression of this gene, but 
since no post-hoc comparisons were significant, we cannot conclude that this 
expression is protocol-specific. This expression of BCL2 is similar to the expression of 
MAPK9 and NTRK2, with iTBS stimulated cells showing increased expression 
compared to sham stimulated cells. BCL2 is an integral outer mitochondrial 
membrane protein, and an important regulator of apoptosis (58). Its expression is 
strongly induced by BDNF-TrkB signaling, and has been shown to affect plasticity 
mechanisms (59). In other words, the increase in BCL2 expression that we report may 
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be related to enhanced plasticity and neuroprotective mechanisms 24 hours after 
TBS. More specific apoptosis assays would be required to confirm this. Altogether, 
our gene expression findings support the hypothesis that the iTBS protocol enhances 
plasticity mechanisms induced by BDNF-TrkB signaling, confirming evidence from 
animal experiments. We also found a time effect for the expression of EGR1, an 
important neuronal immediate early gene, functioning as a transcriptional regulator 
for genes involved in differentiation and neuroplastic changes (60). This increase in 
EGR1 expression is critical for the induction of LTP, as an initial increase in EGR1 
expression within 10 minutes to 2 hours after stimulation is required for protein-
synthesis dependent late-LTP mechanisms (42, 43, 61). In other words, an increase in 
EGR1 expression immediately after stimulation supports TBS-induced plasticity 
mechanisms.  
To examine possible effects of TBS on neuronal morphology, we used 
immunocytochemistry to visualize neurite outgrowths (βIII-Tubulin) and dendrites 
(MAP2). These are widely used as mature, neural cytoskeletal markers in studies of 
SH-SY5Y cells (46, 62-66). βIII-Tubulin is an important protein of the microtubule 
cytoskeleton, expressed primarily in neurons and is critical for axonal guidance and 
maintenance in mammals (67). We found, on average 30% (±10%) of neurons 
expressed βIII-Tubulin, 11.3% (±4.6%) MAP2 and 9.8% (±3.5%) expressed both 
markers. Representational images of neuron morphology after each stimulation 
condition, and each time point, can be seen in Supplementary Material 
(Supplementary Figure 2). Using qPCR as described above, we found no change in the 
mRNA expression of TUBB3, the gene coding for βIII-Tubulin protein, which aligns 
with our βIII-Tubulin immunoreactivity findings. We did observe a small decrease of 
axonal length and branches per neuron over time, but without an effect of 
stimulation condition. This might be related to manipulation of the cell cultures 
during the stimulation paradigm. Whether TBS induces structural plasticity changes 
should be further investigated over longer time periods. 
In contrast to previous animal studies showing protocol specific changes in plasticity 
markers following TBS (29, 33, 68), we did not see any effects of cTBS on gene 
expression or neuron morphology. Additionally, the effects on gene expression that 
we did see were subtle, and in just two plasticity genes. Importantly, however, the 
protocol-specific effects reported in these animal studies were found in different 
cortical areas, therefore it is difficult to compare these results to cell culture which 
contain a single functional cell type in a single spatial organization. Animal models or 
slice cultures also contain a functionally relevant organization of different neuron 
types, such as a mix of inhibitory interneurons and excitatory pyramidal neurons. This 
neuronal organization might be important, as these studies suggest that iTBS/cTBS is 




interneurons) (29, 30, 49). Indeed, as computational modelling has shown, the TMS-
induced electric field depends critically on the complex microscopic and macroscopic 
anatomy of the human cortex (69-71). In light of this requirement for complex 
neuronal organization, our null results become more important, as they might begin 
to inform us on the minimal level of neuronal organization complexity required for 
TBS effects on expression of certain genes. 
In addition, animal studies often use different stimulation parameters, for example 
repeating the established Huang 2005 TBS protocol up to five times (29, 33, 68). This 
greater number of stimulation pulses in these animal studies could also explain why 
we did not replicate any of the protocol specific changes described in the animal 
literature. On the other hand, as mentioned, in another set of experiments (39) we 
did successfully use calcium imaging to reveal the hypothesized TBS effects in our cell 
cultures, suggesting that our TBS protocols were at least sufficiently strong to induce 
excitability changes.  
We opted to use SH-SY5Y neuroblastoma cells, a human-derived cell line widely used 
as an in vitro model of human neurons. These cells express a variety of neural 
markers, and can be further differentiated to a more mature neuronal phenotype, 
having longer neurite outgrowths, increased expression of mature neuron markers, 
and the formation of mature synapses (46, 62, 72). Differentiated SH-SY5Y cells have 
also been shown to produce action potentials (46, 73-75), and are therefore 
functionally active neural cells. We have also recently demonstrated TBS protocol-
specific functional effects on SH-SY5Y cells using calcium imaging (39). They are a 
widely used model for a range of research applications such as Parkinson’s disease 
(76), pathogenesis of viruses (63), drug efficacy and toxicity (64, 77, 78), and as a 3D 
cell culture (65, 66). These cells can also be used in the study of human neuron 
plasticity and synapse formation (46) for example in the context of examining 
treatment targets of depression (79, 80). They are also relatively easy to handle, 
making them a good candidate to investigate plasticity mechanisms following rTMS.  
However, as these cells were derived from malignant tumors (72), cultures may 
contain two morphologically distant phenotypes, neuroblast-like and epithelial-like 
(81). While differentiation protocols aim to establish the most neuron-like phenotype 
among all cells (46, 62, 82), there are often inconsistencies among the proportion of 
phenotypes within each culture. Experimental conditions may also influence the 
consistency of differentiation or cellular phenotypes in our cultures. For example, 
removing the cells from the incubator for stimulation, and having a prolonged 
incubation for the 24-hour time point may have contributed to the time effects seen 




We chose to measure changes in gene expression, specifically in the BDNF-TrkB 
signaling cascade, shown to be important in LTP-dependent plasticity mechanisms 
(36, 57, 83). However, investigation of relevant changes at the protein level following 
stimulation are also important. For example, future studies could expand on our 
findings by focusing on protein phosphorylation in the BDNF-TrkB signaling cascade, 
or investigating whether these plasticity mechanisms are NMDA-receptor dependent. 
We have taken first steps towards investigating TBS-induced changes in human 
neurons in vitro, but more studies are needed to better understand the underlying 
mechanisms of TBS. Future studies in more advanced human neuron models such as 
(patient-specific) neuronal cultures derived from induced pluripotent stem cells 
(iPSC’s) (84) or cerebral organoids (85), could help improve our understanding of 
individual differences in responsiveness to stimulation protocols. 
Conclusion 
The molecular mechanisms of rTMS remain largely undiscovered, and most of the 
evidence for plasticity effects following stimulation comes from animal models. In this 
study, we stimulated living human neurons (SH-SY5Y cells) with iTBS and cTBS 
protocols, and investigated changes in gene expression and morphology. We found 
evidence for a protocol specific increase in the expression of plasticity genes in the 
BDNF-TrkB pathway at 24 hours following iTBS, relative to sham. In this human 
neuron model, we show the feasibility of studying rTMS effects in vitro, and we 
identify several gene expression changes that support iTBS-induced plasticity. These 
findings pave the way to develop more complex in vitro models, such as neuronal 
cultures from patient-derived iPSCs, in order to better examine the molecular effects 
of TBS, which in turn is necessary to further optimize the stimulation parameters for 
human rTMS.  
Data Availability Statement 
The raw data supporting the conclusions of this manuscript is available through the 
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Supplementary Material Chapter 4 
Immediate Time Point One-Way ANOVA  
Each gene was analyzed separately, to test for an immediate effect of stimulation on 
gene expression. MAP2: F(14)=1,438, p=0.276, BCL2:F(14)= 0.488, p=0.625, EGR1: 
F(17)= 0.174, p=0.842, CREB1: F(17)=0. 659, p=0. 532, TUBB3: F(17)= 0.074, p=0.926, 
NTRK2: F(14)= 0.857, p=0.449. 
Differentiation analysis Gene expression 
Independent samples student’s t-tests (2-tailed) were performed for each gene 
separately, comparing expression levels between undifferentiated and 10 day 
differentiated cells. MAP2: t(14)=-2.679, p=0.018, BCL2:t(14)=-2.769, p=0.017, EGR1: 
t(14)=-1.537, p=0.147, CREB1: t(14)=-1.389, p=0.186, TUBB3: t(14)=0.095, p=0.926, 
NTRK2: t(14)=-8.636, p<0.0001. 
Effect of Stimulation on Housekeeping Genes 
There was no significant effect of Time or Condition, or Interaction, on any of the 
housekeeping genes used to normalize gene expression values for further analysis. 
Housekeeping genes used: TBP Condition(F(2,30)=0.685, p=0.513), 
Time(F(1,30)=0.001, p=0.977), Interaction(F(2,30)=0.587, p=0.563); GAPDH 
Condition(F(2,30)=0.091, p=0.913), Time(F(1,30)=0.111, p=0.741), 
Interaction(F(2,30)=0.058, p=0.944); PPiB Condition(F(2,30)=0.269, p=0.766), 
Time(F(1,30)=0.839, p=0.367), Interaction(F(2,30)=0.009, p=0.991). An average of 
these 3 genes was made, which was also not significant for Condition, Time or 









Supplementary Figure 1.Gene Expression of all genes (MAPK9, BCL2, EGR1, CREB1, 
TUBB3, NTRK2) of interest in each of the conditions (cTBS, iTBS, sham) at the 
immediate time point (collected immediately after stimulation). None of the genes 








Supplementary Figure 2. Representative images of neuron morphology at each time point 
following each stimulation condition. DAPI (cell nucleus) in blue, βIII-Tubulin in green, and 
MAP2 in red. Each condition/time point image has 1 large merged image on the left (βIII-
Tubulin and MAP2), and on the right 1 small βIII-Tubulin image, and 1 small MAP2 image. From 
Top to bottom, 3 hours, 6 hours, 24 hours. From left to right: A. Sham stimulation, B. iTBS 




Condition Time Biological 
Replicates 
Differentiation batches 
cTBS Immediate 6 4 
iTBS Immediate 7 4 
Sham Immediate 5 4 
cTBS 6h 8 2 
iTBS 6h 7 2 
Sham 6h 6 2 
cTBS 24h 5 2 
iTBS 24h 4 2 
Sham 24h 6 2 





Name Fwd/Rev Sequence 5’→3’ 
NTRK2  Forward TGGATGCATATCGTGCTCCG 
NTRK2  Reverse GTGCTTGGTTCAGCTCTTGC 
BCL2 Forward ACATCGCCCTGTGGATGACT 
BCL2 Reverse CCGTACAGTTCCACAAAGGC 
MAPK9 Forward TGGGCTACAAAGAGAACGTTGA 
MAPK9 Reverse GTGCCTTGGAATATCACACAACC 
TUBB3 Forward GGGGCCTTTGGACATCTCTTC 
TUBB3 Reverse GTGTAGTGACCCTTGGCCC 
EGR1 Forward CCCCGACTACCTGTTTCCAC 
EGR1 Reverse GACAGAGGGGTTAGCGAAGG 
CREB1 Forward CCCCAGCACTTCCTACACAG 
CREB1 Reverse CTCGAGCTGCTTCCCTGTTC 
GAPDH Forward CCAAATGCGTTGACTCCGA 
GAPDH Reverse GCATCTTCTTTTGCGTCGC 
PPiB  Forward GTTTGAAGTTCTCATCGGGG 
PPiB  Reverse AAAACAGCAAATTCCATCGTG 
TBP Forward TGCACAGGAGCCAAGAGTGAA 
TBP Reverse CACATCACAGCTCCCCACCA  






















Incubation 1 95 None 0:10:00 4.8 
Quantification Amplification 45 95 None 0:00:10 4.8 
   




Curve 1 95 None  0:00:15 4.8 
   
60 None 0:00:30 2.5 
   
97 
Contin
uous   0.11 
None Cooling 1 60 None 0:00:10 2.5 






Name Company Order 
number 






5568S 1:300 Neurons; 
Neurite 
outgrowth 
donkey anti rabbit 
Alexa 488 
(Invitrogen, A-21206) 
MAP2 Sigma M2320 1:300 Neurons; 
Dendrites 
donkey anti mouse 
Alexa 594 
(Invitrogen, A-21203) 
Table S4: Secondary Antibody Information  
 
Wavelength Marker of Exposure Time Color 
350 DAPI(nuclei) 10ms Blue 
488 βIII-Tubulin 500ms Green 
594 MAP2 300ms Red 
Table S5: Fluorescence Microscopy Detection. Olympus BX51WI microscope and DSU spinning 




Key Resources Table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Chemicals, Peptides, and Recombinant Proteins 








Cat # M2320 
RRID:AB_609904 








Experimental Models: Cell Lines 
Homo sapiens; SH-SY5Y  ATCC  Cat# CRL-2266 
RRID:CVCL_0019 
Software and Algorithms 
Fiji (ImageJ) Schindelin 
et al., 2012 
http://fiji.sc; 
RRID:SCR_002285 




Micro-Manager software Edelstein 








How to design optimal accelerated rTMS 
protocols capable of promoting therapeutically 




Based on: Thomson, A.C & Sack, A.T (2020). How to design optimal accelerated rTMS 
protocols capable of promoting therapeutically beneficial metaplasticity. Front. 









Repetitive transcranial magnetic stimulation (rTMS) can induce longer lasting synaptic 
plasticity changes within the stimulated brain regions, similar to processes described 
by the theory of Hebbian plasticity. Hebbian synaptic plasticity works through post-
synaptic modifications, such as NMDA receptor activation, calcium signaling, and 
AMPA receptor trafficking, leading to long-term potentiation (LTP) or long-term 
depression (LTD). Under Hebbian plasticity, a synapse which is repeatedly stimulated 
will undergo synaptic strengthening, i.e. LTP. This increases efficacy of signal 
transmission between specific synapses and is thought to underlie the molecular 
encoding of information, leading to learning and memory formation. However, if 
unregulated, this neural connection will be continuously strengthened, driving the 
synapse to an extreme maladaptive excitation level. Metaplasticity acts against this, 
regulating neuronal excitability by adjusting the threshold for LTP/LTD depending on 
previous neural activity. Homeostatic metaplasticity is a specific form of metaplasticity 
which acts to stabilize this LTP/LTD-threshold within a physiologically relevant range. 
These principles of (homeostatic) metaplasticity can be utilized to explain and 
optimize the effects of repetitive (rTMS) protocols on cortical excitability and synaptic 
plasticity. For example, reports have shown that the direction of the plasticity effects 
induced by a given rTMS protocol can be reversed by priming it with an identical 
stimulation intervention applied immediately before. This switch in direction of rTMS-
induced plasticity provides indirect support for homeostatic metaplasticity, 
counteracting the (potentially maladaptive) additive metaplasticity effects of two 
stimulation protocols applied in quick succession. Recently, repeating stimulation 
protocols several times per treatment session (accelerated rTMS) has shown 
therapeutic potential, promoting stronger and longer lasting clinical outcomes. 
However, the time interval between repeated stimulation protocols is thus critical 
when developing optimal accelerated rTMS protocols, as homeostatic metaplasticity 
potentially works against the intended rTMS stimulation effects. The million-dollar 
question in this context refers to the optimal time interval between the repeated 
treatment sessions of accelerated TMS protocols for promoting additive while 
avoiding homeostatic plasticity. We here discuss animal and cellular models showing 
that longer time intervals may be needed between rTMS protocols in order to avoid 
stabilizing homeostatic metaplasticity mechanisms and to promote additive 
metaplastic effects. We argue that this may form the basis for developing optimal 
accelerated rTMS protocol intervals capable of promoting therapeutically beneficial 
metaplasticity.  
Keywords: Metaplasticity, Homeostatic Plasticity, Hebbian Plasticity, Transcranial 





Our brain is comprised of billions of neurons, which can connect via synapses that rely 
on electrical signaling and the release of chemical messengers to communicate and 
propagate signals through neural networks. By forming such networks, neurons are 
capable of monitoring previous firing activity, and using this information to adapt 
subsequent firing rate. This so-called activity-dependent plasticity is critical for the 
encoding of new information, and the tuning of (low activity) connections (1-3). The 
physiological mechanisms of synaptic plasticity have largely been attributed to long-
term potentiation (LTP) (4, 5), and long-term depression (LTD) (6-8), which result from 
molecular processes such as receptor trafficking or synaptic scaling (3). Both LTP and 
LTD are induced by postsynaptic NMDA receptor activation, which lead to an influx of 
calcium into the postsynaptic dendrites (8-10). This triggers a complex series of 
intracellular signaling cascades, resulting in synaptic modifications such as AMPA 
receptor trafficking (11, 12). The pattern of stimuli delivered to the post synapse 
determines whether LTP or LTD will occur; low frequency stimulation induces LTD, 
whereas high frequency stimulation induces LTP (8, 13). These processes underlie 
much of our knowledge on the molecular mechanisms of learning and memory.  
However, if the principles of Hebbian synaptic plasticity (LTP, LTD) alone were to drive 
the strengthening and weakening of synaptic connections, activity would, over time, 
be driven towards destabilization. This is because continuously firing synapses could 
only become stronger (driven to saturation) and unused synapses quiescent (until 
completely lost) (14). Consider a synapse that is strengthened by LTP; meaning the 
presynaptic neuron becomes more effective at depolarizing the postsynaptic neuron. 
With each continued stimulation, the postsynaptic neuron will be more easily 
depolarized, in a positive feedback loop, resulting in a hyperexcitable postsynaptic 
neuron. Over time, not only will the original presynaptic connection be strengthened, 
but other unrelated presynaptic inputs could cause a depolarization of the 
hyperexcitable postsynaptic neuron, resulting in unregulated synaptic transmission 
(15). Therefore, other mechanisms must exist, which regulate synaptic plasticity on a 
global network level to maintain stability of synapses and maintain specificity of 
neural activity (16, 17).  
Metaplasticity refers to any change in the direction or degree of synaptic plasticity (ex. 
LTP, LTD) based on prior neural activity (18). While both synaptic and metaplasticity 
are dependent on previous neural activity, metaplasticity does not directly alter the 
efficacy of synaptic transmission (as LTP/LTD), but it adjusts the neurons’ ability to 
induce LTP/LTD with subsequent neural activity. Metaplasticity in some sense can be 
considered as the plasticity of synaptic plasticity, e.g. maintaining the dynamic nature 
of a neuron’s firing threshold, when this neuron reaches a certain firing rate (16, 18, 




NMDA receptor activation and modification (20), and changes in calcium signaling 
triggering complex signaling cascades (18).  Metaplastic modifications, for example at 
NMDA receptors, can occur either at specific synapses or across the whole neuron, 
and on time scales from minutes to weeks (19). Depending on the temporal pattern 
and strength of previous neural activity, metaplastic mechanisms can be additive; for 
example promoting increased synaptic strengthening through repeated excitatory 
(LTP-inducing) stimulation. Metaplasticity can also be stabilizing; for example acting 
against subsequent synaptic strengthening when repeating excitatory (LTP-inducing) 
stimulation (19, 21). This stabilizing form of metaplasticity is often referred to as 
homeostatic metaplasticity, as it specifically regulates the dynamic threshold of 
synaptic plasticity to maintain equilibrium, or homeostasis (16, 17).  We hypothesize, 
based on research from human and animal studies, that the timing between 
excitatory stimulations are what differentiate between promoting additive or 
homeostatic metaplasticity.  
We focus on the role of metaplasticity in transcranial magnetic stimulation (TMS). We 
describe the recent use of accelerated (repeated) stimulation protocols, both in 
research and clinical applications, and the molecular mechanisms required to promote 
either homeostatic or additive metaplastic effects. Finally, we showcase the 
therapeutic potential of accelerated stimulation, and hypothesize that increasing the 
currently practiced stimulation intervals may be more efficacious in promoting 
additive metaplastic effects in various clinical applications of rTMS in rehabilitation, 
neurology, psychiatry, and cognitive decline. 
Metaplasticity in TMS 
TMS is a widespread and increasingly popular non-invasive brain stimulation 
technique, where electromagnetic pulses allow stimulation to pass non-invasively 
through the skull (22). When pulses are applied in a certain pattern, as repetitive TMS 
(rTMS), protocols can have lasting excitatory or inhibitory effects (23-25). Two 
commonly used stimulation protocols are intermittent theta burst stimulation (iTBS), 
requiring only 3 minutes of stimulation time, resulting in a lasting increase of cortical 
excitability, and continuous theta burst stimulation (cTBS), requiring only 40 seconds 
of stimulation for a lasting decrease in cortical excitability (26). The after effects of 
these protocols have been shown for up to 1 hour following stimulation (26, 27). 
While iTBS is normally an excitatory protocol, causing an increase in cortical 
excitability of the stimulated brain region, it has been shown that when applied twice 
in quick succession iTBS effects switch from excitatory to inhibitory (28). Conversely, 
when cTBS (an inhibitory protocol) is applied for double the normal duration, its 
effects switch from inhibitory to excitatory (28). Several studies have reported similar 
effects of repeating iTBS or cTBS stimulation protocols, with the timing between 
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protocols being an important factor in the magnitude and direction of aftereffects (19, 
29, 30). For example, using a ‘priming’ iTBS protocol which does not induce plasticity, 
followed by a ‘test’ iTBS protocol has shown that short intervals of 5 minutes between 
priming and test resulted in homeostatic-like changes in excitability, i.e. an opposite 
effect. Interestingly, longer breaks of 15 minutes resulted in an increase in MEP 
amplitude after the test iTBS (30). However, 15 minutes between priming and test 
iTBS/cTBS has also been shown to induce in homeostatic-like metaplastic effects (29). 
While the timing between repeated TBS sessions is clearly important, the optimal 
interval is less clear. 15 minutes between iTBS sessions has shown to promote both 
homeostatic (29) and MEP enhancement after the second iTBS (30), while 10 minutes 
between priming and test iTBS has shown enhancement of MEP amplitude (31), but 5 
and 20 minutes between iTBS sessions did not (32).  Therefore, when 2 iTBS sessions 
are repeated with short (less than 30 minutes) between, conflicting effects on MEP 
amplitude have been reported.  
‘Accelerated’ protocols, which consist of multiple stimulation sessions on a single day, 
have recently been introduced for the treatment of depression (33-37). Due to their 
short duration, the TBS protocols, in particular iTBS, have been promising candidates 
for accelerated protocols (38). Also, a large trial recently found that iTBS was not-
inferior to the classical 10Hz rTMS protocol, confirming the clinical potential of this 
shorter stimulation protocol to treat depression (39). Indeed, several studies have 
shown additional benefits for accelerated iTBS protocols in the treatment of severe, 
treatment resistant depression (40, 41). In the clinic, an interval of 15 minutes is often 
used between iTBS sessions, with these sessions repeated up to 5 times on a single 
treatment day (40, 42).  
We recently conducted a study investigating the effects of accelerated iTBS over 
motor cortex, consisting of 5 repeated iTBS sessions in a single day. iTBS with 8- or 15-
minutes time interval between sessions were delivered to healthy participants in a 
fully within subject design; where participants received 4 different conditions 
(accelerated iTBS with 8-minute intervals, accelerated iTBS with 15-minute intervals, 
single iTBS and sham). (43). We compared change in motor evoked potential (MEP) 
amplitude up to 90 minutes following stimulation, across the stimulation conditions.  
We found that there was no difference in the effects of accelerated iTBS on MEP 
amplitude, also when compared to sham stimulation, and thus no additive 
metaplasticity induced by five stimulation sessions applied successively in 8- or 15-
minutes intervals. We argue that such intervals between iTBS protocols are likely too 
short to avoid processes of homeostatic plasticity. With only 8 or 15 minutes between 
sessions, homeostatic mechanisms may be working against additive metaplastic 
effects to maintain network stability and therefore result in a net effect of no change 





In agreement with this notion, animal studies in rats and rat hippocampal slices have 
shown that a sufficiently long pause between excitatory stimulation sessions was 
necessary for additive (LTP) plasticity effects to occur (44-46). This may have to do 
with the time required for metaplasticity mechanisms, for example synapse 
strengthening with AMPA receptor trafficking (15). 
It has been well established in animal studies, that a single round of TBS (a 4-pulse 
burst at 100Hz, repeated at 5Hz for 10 bursts) is effective at inducing LTP in CA1 
hippocampal pyramidal neurons (47, 48). TBS has since then been used extensively to 
reliably induce LTP in vitro (49). Interestingly, repeating this single TBS protocol with a 
time interval of greater than 40 minutes, was capable of almost doubling the 
potentiation compared to the first TBS alone (44). This additional potentiation is 
thought to work through strengthening the smaller synapses which weren’t 
strengthened by the first TBS protocol (44). This may have to do with the number of 
AMPA receptors; smaller synapses contain fewer AMPA receptors and therefore don’t 
generate a response to trigger a depolarization following a single TBS (44). Several 
other studies have provided evidence for increased potentiation by spaced TBS, 
however the magnitude and duration of the effects depended on a series of factors 
such as rat strain, rat age, and the time interval. In adult Wistar rats, adult Long-Evans 
(LE) rats, and young LE rats, 4 hours was required between TBS to induce additional 
potentiation (45, 46). However, in young Sprague Dawley (SD) rats, a single TBS 
repeated at 1-hour intervals could induce further potentiation, following up to 3 
repeated TBS stimulations (4 did not produce additional potentiation) (44, 46). These 
different studies used different stimulation intensities; Frey et al. (1995) (45) found 
that reducing stimulation intensity in the second stimulation was effective for 
promoting potentiation 4-hours later, while Cao & Harris (2014) (46) and Kramár et al. 
(2012) (44) kept stimulation intensities constant. However, these studies consistently 
show that additional potentiation following repeated TBS in animal slices is possible. 
Enhanced, additive LTP-like plasticity may be promoted when repeating TBS with 50-
60 minutes between sessions (44, 46).  After 3 TBS protocols, spaced 60 minutes 
apart, potentiation had been raised to 150% baseline, which is about three times 
higher than if just one protocol was given (44, 49). This suggests that 3 TBS protocols 
repeated at 60 minute-intervals may be effective at promoting maximal, additive 
metaplasticity effects (Figure 1A). If there is less time between TBS protocols, for 
example 10 minutes, homeostatic metaplasticity mechanisms may dominate, 




Figure 1: Theoretical stimulation setup and effects in response to different spacings between 
repeated stimulations. A. Repeating excitatory (iTBS) stimulation 3 times, with 60 minutes 
between sessions, promotes additive strengthening of stimulated synapses. Overall, the 
repeated stimulation increases potentiation (this has been shown in animals using a different 
TBS protocol (44, 46)). B. Repeating the same 3 iTBS stimulations, but with only 10 minutes 
between sessions results in stabilization (homeostatic metaplasticity) and no change in overall 
plasticity.  
Discussion  
Activity-dependent metaplasticity is considered to be homeostatic if the first 
stimulation protocol alters the threshold for subsequent LTP/LTD in the opposite 
direction, thereby stabilizing (network) brain activity (50). Interestingly, this reversal 
of aftereffects has been shown specifically when stimulation protocols were given 
with a short (0-5 minutes) interval (28, 30), providing support for homeostatic 
metaplasticity mechanisms in rTMS protocols (19). While homeostatic metaplasticity 
mechanisms are important for stabilizing network activity, they can be counteractive 
when promoting plasticity effects through rTMS. In fact, when applying rTMS 
protocols, the explicit goal is not stabilization but promotion of additive, increased 
plasticity effects. 
Animal studies have shown that timing is important in the molecular mechanisms 
underlying metaplasticity. While there is overlap between the mechanisms of additive 
and homeostatic metaplasticity, there are temporal differences which may 
differentiate between both principles at the molecular level. Based on evidence form 
animal models, leaving 60 minutes between excitatory stimulation protocols may 
promote additive rather than homeostatic metaplastic effects in accelerated TMS 





If longer intervals between iTBS sessions are capable of promoting additive 
metaplasticity, as has been shown in animal studies (44) as well as improving clinical 
outcomes in the treatment of depression (51), longer spaced intervals between iTBS 
sessions will likely be beneficial for other therapeutic applications of iTBS. iTBS is 
increasingly being used as a treatment in a range of clinical applications such as 
rehabilitation, as well as neurological and psychiatric disorders. For example, to 
promote motor recovery after stroke (52), for managing spasticity associated with 
multiple sclerosis (MS) (53), and decreasing obsessive symptomatology associated 
with obsessive compulsive disorder (OCD) (54), just to name a few. These protocols all 
must adhere to the established safety guidelines (55), and recommendations for 
clinical TMS use (56, 57). These include total pulse number, interval between TBS 
session, intensity of stimulation, and cumulative weekly applications (55). Accelerated 
iTBS has been successfully and safely used in the treatment of depression (38, 40, 42), 
with patients receiving a total of 32400 pulses at 110% resting motor threshold, over 
20 sessions (5 sessions per day, 15 minutes between sessions) in 4 days (41). 
Therefore, while following the established safety guidelines is the upmost priority, 
and local health authorities should always approve each stimulation protocol (55), 
delivering three iTBS sessions on a single day with 1 hour between sessions should 
theoretically be safe and tolerable for most patients.  
rTMS is also used as a treatment for the cognitive decline associated with 
neurodegenerative disorders such as dementia, and Alzheimer’s disease (AD) (58-62). 
However, there are ethical implications of using rTMS for cognitive enhancement, in 
particular in healthy participants (63). It is important to maintain the consensus 
ethical requirements that 1.) participants/patients provide informed consent, 2.) the 
benefit of the research outweigh the risks, and 3.) there is equal distribution of 
burdens and benefits across patients (this is violated if a particular group of patients 
with different economic, physical or social conditions (55).  
Importantly, the here described principles of additive and homeostatic metaplasticity 
not only apply to the here discussed accelerated TMS treatments and the question of 
optimal time interval between its repeated stimulation sessions, but likewise can be 
used to explain and optimize other forms of plasticity-inducing TMS protocols such as 
paired associated-stimulation (PAS) or paired-coil TMS (pcTMS). 
In humans, neural excitability and synaptic plasticity can be probed by TMS to 
peripheral nerves and motor cortex (64, 65). In such a transcortical loop, timings of 
afferent (muscle/nerve to brain), cortical, and efferent (brain to muscle) responses 
can be used to quantify central motor excitability (64). For example, delivering a 
conditioning TMS pulse to an afferent tract (ex. the wrist), followed (10-48ms) by 
stimulation of the efferent tract (motor cortex), will alter motor evoked potentials 
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(MEP’s) measured from thumb flexor muscles (64). It has been shown that wrist 
stimulation 20-22 msec preceding motor cortex stimulation elicits a facilitated MEP, 
with a latency of about 1 ms, compared to MEPs given without the conditioning wrist 
stimulation (64). Repeating this afferent (wrist) efferent (motor cortex) stimulation, in 
paired associated stimulation (PAS), can induce lasting effects on motor cortex 
excitability (65, 66), providing evidence for synaptic plasticity. Interestingly, evidence 
of homeostatic and additive metaplastic responses has also been recorded using PAS 
stimulation (67, 68). When two LTP-inducing PAS protocols were separated by 30 
minutes, a decrease in MEP amplitude was measured, indicating a homeostatic 
(stabilizing) metaplastic responses (67). Similarly, LTD-inducing PAS immediately 
preceding a motor-learning task facilitated motor-learning (68), again providing 
support for homeostatic plasticity mechanisms dominating at early time points 
following stimulation.  
Additionally, the effects of brain stimulation are not only localized to the site of 
stimulation, but can also spread to different areas through complex cortical networks. 
Similarly to PAS, this has been shown using paired-coil TMS (pcTMS), where multiple 
coils are used to probe different cortical areas and assess connectivity (69, 70). For 
example, a single TMS pulse to motor cortex can cause a depression of the MEP 
measured following a subsequent (6-30ms) TMS pulse to contralateral motor cortex 
(71). Therefore, TMS can also be used to assess connectivity between brain areas (69). 
In other words, TMS stimulation can propagate to different cortical regions, having 
both local and remote effects on (meta) plasticity. This has valuable clinical 
implications, where inducing plasticity effects in a cortical network are important (70). 
In stroke patients for example, localized damage can disrupt connectivity and can 
have functional consequences (70), therefore stimulation effects should promote 
network plasticity, rather than localized plasticity. Similarly, in the treatment of 
depression, superficial stimulation uses cortical connectivity to influence deeper 
cortical structures, resulting in improvement of clinical symptoms (72, 73). Therefore, 
it is important to use TMS to strengthen connectivity, and to promote additive, 
metaplastic changes also on the network activity level.  
With the increasing and widespread application of rTMS protocols in the clinic, it is 
important to optimize protocols to maximize their effects, while remaining within 
established safety and ethical guidelines for use in the clinic (55, 57). Single iTBS has 
proven promising, but accelerated iTBS at longer time intervals (60 minutes) between 
sessions could maximize clinical outcomes through additive metaplasticity, preventing 
homeostatic metaplasticity from stabilizing stimulation effects. Clinical efficacy of PAS 
and pcTMS protocols may be similarly increased by optimizing the timing between 
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Intermittent theta burst transcranial magnetic stimulation (iTBS) can non-invasively 
increase cortical excitability beyond the duration of stimulation itself, having valuable 
research and clinical applications. However, recent reports suggest that such effects 
are not always reliable (1-3). Given its short duration, iTBS can be administered 
repeatedly (‘accelerated iTBS’), which might stabilize and/or amplify neuroplastic 
effects. These accelerated iTBS protocols have been applied in depression treatment 
with positive results (4, 5). Yet, their efficacy has not been empirically demonstrated 
through objective, neurophysiological measures in healthy volunteers. We evaluated 
the effects of 1 (standard) or 5 (accelerated) iTBS, the latter with different short inter-
protocol intervals, on primary motor cortex excitability as assessed with motor-
evoked potentials (MEPs). 20 healthy participants were tested in a within-subject 
design of 4 pseudo-randomized conditions on different days; 1) standard iTBS, 2) 
placebo iTBS, accelerated iTBS with 3) 8-min or 4) 15-min inter-protocol intervals. 
Following each procedure, MEPs were elicited for 90 minutes. MEP amplitudes were 
grouped in time bins and analyzed with analyses of variance. In line with several 
previous reports, we did not find increased MEP amplitudes relative to placebo iTBS 
after standard iTBS. Importantly, accelerated iTBS did not amplify/stabilize 
neuroplastic effects, since neither the accelerated 8 nor 15-minute interval protocols 
had significant effects on MEPs. Standard iTBS did not yield reliable, consistent results, 
and short-interval accelerated iTBS did not appear to resolve the issue. We propose 
that longer intervals (45-60 minutes) may improve the effectiveness of accelerated 
iTBS protocols.  
Keywords: Transcranial Magnetic Stimulation, Accelerated iTBS, Cortical Excitability, 





Transcranial magnetic stimulation (TMS) is a form of neuromodulation that uses 
electromagnetic pulses to non-invasively alter cortical excitability. When multiple 
pulses are applied in repetitive protocols (rTMS), lasting changes in neural firing can 
be induced (6). For example, classic rTMS protocols such as high frequency (10-20 Hz) 
stimulation have been shown to increase cortical excitability (7).  However, repetitive 
protocols are notoriously unreliable; with large inter and intra subject variability 
hindering the reproducibility of these neuroplasticity effects (8, 9).  
Many studies have aimed to optimize rTMS protocols, focussing on shortening 
protocol length, increasing plasticity effect size, and decreasing variability. For 
example, the theta burst stimulation (TBS) protocols are a widely used set of protocols 
which require only minutes of application duration. They reportedly induce increased 
plasticity effects which are less variable and longer lasting compared to classic rTMS 
protocols (10). Intermittent TBS (iTBS) is a three-minute protocol which has been 
shown to increase cortical excitability for up to 20 minutes post stimulation (10). 
However, several studies have reported difficulty in replicating these established iTBS 
effects (1-3). This is important, as iTBS is increasingly used in both research and clinical 
environments. If its effects on excitability, possibly extended to clinical treatment 
efficacy, are not very reliable, then research on protocol optimization must continue. 
An additional benefit of iTBS compared to classical high frequency rTMS is its short 
duration, making it a more time and cost-effective alternative (11). Recently, clinicians 
using the FDA-approved rTMS protocol for depression therapy (12) have begun to 
take advantage of this short duration, by administering multiple iTBS sessions per day 
to treat their patients more cost- and time-effectively (5, 13, 14). The hope is that 
neuroplastic effects arise quicker, through condensing a classical week’s worth of 
treatment into a single day. Such ‘accelerated iTBS’ has been successfully applied in 
the treatment of depression (4, 5), with short inter-session intervals (time between 
repeated iTBS administration). 
 Protocol developments in the clinic should go hand in hand with neurophysiological 
investigations of the underlying mechanisms of action. Theoretically, accelerated iTBS 
could not only shorten the treatment process, but also lead to enhanced and more 
stable (reliable) effects on cortical excitability. Initial iTBS sessions could prime, 
normalize, or amplify the neuroplastic effects of subsequent sessions (15). Yet, such 
effects may strongly depend on the time between sessions (16, 17).  
In this study, we investigated the effects of standard iTBS (single-iTBS session) and 
accelerated iTBS (five repeated iTBS sessions) on motor cortical excitability, assessed 
with motor-evoked potentials (MEPs) in healthy volunteers. We included two short 




and variability of MEPs. In this fully within-subject design, effects of standard and 
accelerated iTBS could be compared to placebo (sham) iTBS. We aimed to identify 
whether accelerated iTBS had stronger, more consistent aftereffects when compared 
to standard iTBS, if 8 minutes versus 15 minutes between iTBS sessions had different 
results, and if these effects were longer lasting. MEPs were measured for up to 90 
minutes following each procedure. We were also interested in individual patterns of 
responsiveness to accelerated iTBS, compared to standard iTBS. We investigated 
whether cortical excitability response (increase or decrease in excitability) to 
accelerated iTBS could be predicted by response to standard iTBS, and if accelerated 
iTBS resulted in fewer opposite (clinically averse) responses as compared to standard 
iTBS. These analyses were therapeutically motivated; if patient response to 
accelerated iTBS can be predicted by response to a short standard iTBS protocol, this 
could benefit individualization of treatment options. Opposite response to iTBS, i.e. a 
decrease instead of an increase of excitability, could be harmful to patients, and 
therefore if accelerated iTBS has fewer opposite responders this would also be 
clinically relevant.  
Methods 
Participants 
20 healthy, right-handed participants (7 male), with a mean age of 23.7 years (SD 3) 
were included in this study. All participants were screened for potential 
contraindications as in the established guidelines (18), and gave written informed 
consent before participating in the study. The experimental procedure was in 
accordance with the Declaration of Helsinki and approved by the local ethics 
committee at Maastricht University.    
Experiment procedure 
On the day of each experimental session, a pre-experimental check for safety was 
conducted, and caffeine intake and hours of sleep the night prior were recorded. 
None of these amounts of caffeine or hours of sleep were reported as being more or 
less than normal, or correlated with MEP amplitude.  
Our within-subject design included 4 experimental conditions: accelerated iTBS with 
8-minute breaks between sessions, accelerated iTBS with 15-minute breaks between 
sessions, single session iTBS, or placebo iTBS (Figure 1). The first 3 conditions were 
randomized across experiment days. The placebo condition was added after the first 
11 participants had completed 3 experiment days, making placebo the condition of 
the 4th day. To placebo-counterbalance, placebo was the 1st experiment day for the 
second 9 participants.  If possible, experiment days were planned 1 week apart, at the 
same time of day, and after 13:00 to reduce any potential variability caused by 
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circadian rhythms (19). On average, sessions 1, 2 and 3 (and 4 for the second 9 
participants) were 9.13 days apart (SD 4.09). The average time between experiment 
days 3 and 4 for the first 11 participants was 93.72 days apart (SD 58.85).  
TMS and EMG 
Participants were seated in a comfortable chair with their left hand resting on a table. 
Disposable adhesive surface electrodes (Plaquette, Technomed Europe, Beek, and The 
Netherlands) were placed on the left index finger, belly of FDI muscle, and the wrist 
bone. EMG was recorded using a PowerLab 4/34 with a bio Amp system 
(ADInstruments, Oxford, UK), and LabChart Pro software (ADInstruments, Version 8) 
was used to monitor online muscle activity and for offline MEP analysis. Electrodes 
were adjusted to reach an online resting signal of below 0.02 mV peak to peak.  
TMS was applied through a MagPro X100 stimulator (MagVenture, A/S, Farum, 
Denmark) and an MC-B70 figure-of-eight coil. The coil was hand held at a 45° angle to 
the midline, and biphasic pulses were given with the current flow in an anterior to 
posterior direction. Motor hotspot location was marked with Localite Neuronavigation 
system (Localite GmbH, Schloss Birlinghoven, Germany), to ensure that the same spot 
was targeted throughout the entire experimental session. Resting motor threshold 
(RMT) was determined as the maximum stimulator output (MSO) intensity where 5 
out of 10 pulses gave peak-to-peak amplitude of below 0.05 mV. Active motor 
threshold (AMT) was the MSO where 5 out of 10 pulses elicited a response of below 
0.20 mV while the participant activated their left hand.  The RMT and AMT were re-
assessed during each experimental day.  
Single pulses were given in blocks of 30, at 120% of RMT. Pulses were delivered at 
intervals between 5 and 7 seconds. ITBS sessions were at 80% AMT. Each iTBS session 
consisted of the Huang et al. (2005) published protocol of 50Hz triplets repeated at 5 
Hz, for 2000ms trains and 8000ms inter-train interval for 600 pulses (10). For the 
placebo sessions, the coil was held perpendicular to the skull. The single iTBS 
condition consisted of 4 placebo and 1 real iTBS, with 15-minute intervals between 
sessions. The placebo condition was with 8-minute intervals between the 5 placebo 
sessions. We took 3 baseline measurements, each 5 minutes apart. Following the 
stimulation protocol, lasting between 51.8-75.8 minutes, was an immediate MEP 
measurement block, and then one every 10 minutes for 90 minutes.   
To establish a constant brain state between participants throughout the breaks, a 
relaxing movie clip was played on the computer screen approximately 35 cm in front 
of the participant. Movie clips were counterbalanced against the conditions, which 





Figure 1. Experimental procedure. Each iTBS session consisted of the Huang et al. (2005) 
published iTBS protocol of 5Hz triplets repeated at 50Hz; repeated for 2 seconds, with 8 
seconds in between. These were given with 8 or 15 minutes between. For real stimulation the 
coil was held tangential to the skull, and perpendicular to the skull for placebo. 
Preprocessing/data analysis of the MEP’s 
EMG data recorded in LabChart consisted of epochs beginning 50ms before the TMS 
pulse and ending 100ms after the TMS pulse. Peak-to-peak MEP amplitudes were 
calculated by LabChart software. To account for any muscle tension before the MEP, 
single MEPs where the EMG recording before the TMS pulse was above 0.1 mV were 
removed. Matlab (R2016a, Mathworks Inc.) was used for further analysis. In first 
outlier analysis, MEP’s that were 2.5 standard deviations above the mean per 
participant, per condition were removed. At the group level, MEP time point values 
for individual participants that had a Z score of 3 standard deviations above the mean 
for that condition were removed. Statistical analysis was completed in IBM SPSS 24 
(SPSS for Windows version 24.0. Armonk, NY: IBM Corp) and JASP (JASP Team 2018 
version 0.9).  
Statistical analysis 
For each participant, an average of the 3 baseline MEP blocks was taken. Each of the 
10 post-TMS blocks was then normalized to this baseline average: expressed in 
percentage baseline. In the group level analysis, mean normalized MEPs over factors 
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TIME and CONDITION were tested in a repeated-measures analysis of variance (RM-
ANOVA). For further analysis, specific time bin grand averages were calculated. In case 
of violation of the sphericity assumption (Mauchly’s test), we report Greenhouse-
Geisser corrected statistics.  
For the placebo-subtracted analysis, the normalized values of placebo were 
subtracted from each of the normalized MEP time block values. MEP time bins were 
collapsed into 30-minute blocks, and analyzed in a 3x3 RM-ANOVA with factors TIME 
and CONDITION. The placebo-subtracted responses were characterized into 
responders or non-responders, for each stimulation condition. For both groups, a 3x2 
RM-ANOVA was run with TIME and CONDITION (the 2 conditions not underlying the 
response classification). 
Results 
Baseline measures and stimulation intensities 
All participants completed the 4 experimental sessions, and none reported any 
negative side effects. There were no differences in MEP Baseline (F(3, 74)=0.911, 
p=0.440), RMT (F(3, 76))=0.532, p=0.662), or AMT (F(3, 76))=0.050, p=0.985) across 
conditions.  
Group level analysis 
To evaluate the changes in cortical excitability over time, a RM ANOVA of CONDITION 
(1. Accelerated iTBS with 8 minute breaks, 2. Accelerated iTBS with 15 minute breaks, 
3. iTBS, and 4. Placebo) vs. TIME (0, 10, 20, 30, 40, 50, 60, 70, 80, and 90 minutes) was 
conducted. There was no main effect of CONDITION (F (3, 19) =0.769, p=0.516), TIME 
(F (9, 19) =1.695, p=0.093), and no interaction (F (27, 19) =0.988, p=0.483). Results, 






Figure 2. Baseline-normalized MEP amplitude changes over time. Three baseline measurements 
were taken (Base 1-3) before stimulation, then measurements every 10 minutes from 0-90 
minutes following stimulation. Presented error bars are standard error of the mean. 
Placebo subtracted 
After subtraction of placebo, we found no significant main effect of CONDITION 
(accelerated iTBS with 8 minute breaks, accelerated iTBS with 15 minute breaks, iTBS; 
F(1.509, 19)=1.830, p=0.185) or TIME (0-30, 30-60, 60-90 minutes; F(1.833, 19)=0.056, 
p=0.934), and no interaction (F(2.954, 19)=1.829, p=0.153). Results, including baseline 





Figure 3. Baseline-normalized, placebo subtracted MEP amplitude changes over time. Three 
baseline measurements were averaged, and 30-minute time bins were calculated for the post-
rTMS measurements. Presented error bars are standard error of the mean.  
Total Response 0-60 minutes after stimulation 
Overall, we found no significant effect of accelerated iTBS or iTBS motor cortex 
stimulation on MEP amplitude, both when baseline-normalized and when subtracted 
from placebo. In post-hoc analysis, we aimed to better understand the pattern of 
responses; why they were so variable, and if we could predict responsiveness to one 
stimulation protocol based on responsiveness to another stimulation protocol. In our 
iTBS protocol, 40% of participants responded with a decrease in MEP amplitude, i.e. 
the ‘opposite’ response. We hypothesized that certain protocols, for example; 
accelerated iTBS with 8-minute breaks, produced fewer opposite responders.  
Based on the literature, we should expect the greatest potential modulation of MEP 
amplitudes in the 0-60-minute time window (10). To investigate our responses in this 
time interval, we took a grand average of percentage baseline MEP amplitude from 0-
60 minutes post stimulation. Per condition, this allowed classification into facilitated 
response (greater than 110% of the baseline MEP amplitude), inhibited response (less 
than 90%), or ‘Unchanged’ (between 90% and 110%). Results are shown in Figure 4. 
For none of the iTBS conditions was the distribution of responses altered relative to 
placebo (Stuart Maxwell test for marginal homogeneity, p’s>0.05).  
Opposite Responders 
 If we consider only the inhibited responders compared to the other responders 




accelerated iTBS with 8 minute breaks; χ2 (1, N=20) =0.208, p=0.289; Accelerated iTBS 
with 15 minute breaks; χ2 (1, N=20) =0.469, p=0.344; nor iTBS χ2 (1, N=20) =0.035, 
p=1.000 show a significantly different number of opposite responders than placebo. 
 
Figure 4. Response distribution of participants following stimulation protocol. Responses from 
0-60 minutes following stimulation were averaged. Greater than 110% baseline MEP amplitude 
was counted as a facilitated response, less than 90% was counted as an inhibited response, and 
between 90% and 110% was counted as an unchanged response.  
Responders vs. Non-Responders 
Above, we performed RM-ANOVAs to assess the effects of stimulation condition and 
time on normalized MEP amplitudes, finding no effects. Here, we wanted to evaluate 
whether these analyses yield different outcomes if performed separately for 
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responders and non-responders. Since partitioning the participant sample into 3 
response categories (facilitated, unchanged, inhibited) results in small group sizes, for 
these analyses we split participants into 2 groups; responders or non-responders. To 
do this, we first took a grand average of percentage baseline MEP amplitude from 0-
60 minutes post stimulation, and then subtracted the grand average of the placebo 
stimulation. A response of greater than 0 was classified as a responder, smaller than 0 
as a non-responder. A RM-ANOVA was run with TIME (0-30mins, 30-60 mins, and 60-
90 mins) and CONDITION (the 2 conditions that the underlying response classifications 
were not based on). Graphs are shown in Figure 5.  
Single iTBS: 11 participants classified as iTBS responders. In this subsample, there was 
no effect of CONDITION (F(1, 10)=0.901, p=0.365), TIME (F(1.778, 10)=0.457, p=0.618), 
and no interaction (F(1.097, 10)=0.308, p=0.610). Therefore, those who respond to 
iTBS are likely to respond to accelerated iTBS with 8- and 15-minute breaks as well. 9 
participants classified as iTBS non-responders. There was no effect of CONDITION F(1, 
8)=4.609, p=0.064, TIME F(1.446, 8)=0.432, p=0.597, and no interaction F(1.323, 
8)=1.931, p=0.195. Those who do not respond to iTBS are unlikely to respond to 
accelerated iTBS with 8- or 15-minute breaks. 
Accelerated iTBS (15-minute breaks): 12 participants classified as responders to 
accelerated iTBS with 15-minute breaks. In this subsample there was no effect of 
CONDITION F(1, 11)=0.248, p=0.628 and no interaction F(1.848, 11)=0.581, p=0.555. 
There was, however, a significant effect of TIME F(1.884, 11)=4.711, p=0.022. 
Bonferroni-corrected post-hoc comparisons revealed only a significant effect between 
30-60 minutes and 60-90 minutes (t (11) =-3.107, p=0.030). The responders to 
accelerated iTBS with 15-minute breaks are also likely to respond to accelerated iTBS 
with 8-minute breaks, and to iTBS, with the strongest response at 30-60 minutes post 
stimulation. 8 participants classified as non-responders. There was no effect of TIME 
F(1.590, 7)=0.880, p=0.436, and no interaction F(1.647, 11) =2.638, p=0.120. There 
was, however, an effect of CONDITION; F(1, 7) =9.216, p=0. 019. This suggests that for 
those who do not respond to accelerated iTBS with 15-minute breaks, accelerated 
iTBS with 8-minute breaks may be a good alternative, not producing an opposite 
response. This is important as opposite responses are detrimental during clinical 
treatment. 
Accelerated iTBS (8-minute breaks) There were 14 participants who classified as 
responders to accelerated iTBS with 8-minute breaks. In this subsample there was no 
effect of CONDITION F(1, 13)=0.113, p=0.743, TIME F(1.471, 13)=0.863, p=0.406, and 
no interaction F(1.473, 13)=1.073, p=0.342. Thus, participants who respond to 
accelerated iTBS with 8-minute breaks are likely to respond to all stimulation 
conditions. The other 6 participants classified as non-responders. There was no effect 




interaction effect F(1.841, 5)=0.318, p=0.719. Those who do not respond to 
accelerated iTBS with 8-minute breaks are likely to not respond to the other 3 
conditions.  
 
Figure 5. Responders and non-responders for each different stimulation protocol. Grand 
average of percentage baseline MEP amplitudes from 0-60 minutes following stimulation was 
calculated. Placebo grand average from the same time window was then subtracted. 
Responders showed a response greater than 0. Non-responders showed a response less than 0. 
A.) Responders to iTBS. B.) Non-responders to iTBS. C.) Responders to Accelerated iTBS with 15-
minute breaks. D.) Non-responders to accelerated iTBS with 15-minute breaks. E.) Responders 
to Accelerated iTBS with 8minute breaks. F.) Non-responders to Accelerated iTBS with 8-minute 
breaks. Presented error bars are standard error of the mean. 
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Variability as a covariate 
To account for participants’ individual variability, we calculated total individual 
variance by taking the variance of the 90 baseline MEP’s, across all sessions. When 
this between-subject variability was added as a covariate, we found a significant 
interaction between TIME and CONDITION (F(4.069, 1)=2.808, p=0.031). However, 
there was also a significant interaction between TIME and CONDITION and the 
covariate (total variance) (F(4.069, 1)=4.248, p=0.001). Therefore, we centred the 
covariate around either 1 standard deviation below (0.010) or 1 standard deviation 
above (0.574) the mean total variance. When centring the covariate on the high 
variance value, we see a significant effect of TIME and CONDITION at 30-60 minutes 
(F(3,16)=3.914, p=0.028), with pairwise comparisons indicating a significant difference 
(Sidak-adjusted for multiple comparisons) at 30-60 minutes post stimulation between 
accelerated iTBS with 8 min breaks and iTBS (p=0.027). This suggests that if the 
participant has high baseline MEP variance, accelerated iTBS with 8-minute breaks is 
significantly better than iTBS at increasing MEP amplitude at 30-60 minutes post 
stimulation, however further research is needed to confirm this finding.  
Discussion 
In 2005, Huang and colleagues presented the theta burst stimulation (TBS) protocols, 
a set of novel patterned rTMS protocols which were able to alter cortical excitability 
for 60 minutes following stimulation (10). Since then, an increasing number of studies 
have used these protocols, not only in motor cortex but also in other brain areas, and 
as a treatment for various movement, psychiatric and neurological disorders (For 
review, see: (20)). However, TBS protocols have also shown large inter-subject 
variability and reproducing the initially published effects has proven difficult (1, 2, 9, 
21, 22). 
Recently, optimization of the TBS protocols has included administering multiple TBS 
sessions in a single day (23). Therapeutically, accelerated iTBS protocols condense five 
iTBS sessions into one day (5, 24). Accelerated iTBS protocols have been successful in 
depression treatment, where recent studies have found the treatment to be safe and 
tolerated (4, 5), with the additional benefit of condensing a treatment schedule which 
would normally consist of daily sessions for four to six weeks, into a few days (13).  
We decided to investigate the potential additive plasticity effects of these accelerated 
iTBS protocols over the motor cortex in healthy volunteers. We were also interested if 
the time interval between iTBS protocols had an effect on cortical excitability changes.  
Specifically, we were interested in if we could find stronger and less variable iTBS 




In this protocol testing study, we found there to be no effect of iTBS on MEP 
amplitude over time. Interestingly, we saw an increase in MEP amplitude across all 
protocols, including placebo. There was, however, no difference between a single 
iTBS, accelerated iTBS with 8-minute breaks, accelerated iTBS with 15-minute breaks, 
and placebo.  
Homeostatic Plasticity 
We hypothesized that accelerated iTBS exerts its effects through different plasticity 
mechanisms than a single session of iTBS, which would be represented through MEP 
amplitude. This is because there is evidence that neural networks have the ability to 
monitor previous activity, and to modify subsequent firing rate (25). This activity-
dependent plasticity, is critical for the encoding of new information, and the tuning of 
low activity connections. However, to avoid destabilization, other mechanisms must 
exist to maintain a homeostatic range of neural activity (26). These theories are 
relevant to brain stimulation research, where neural activity can be non-invasively 
altered, and resulting neural activity can be measured (for review see (15, 27, 28)). For 
example, taking homeostatic plasticity into account, we could hypothesize that one 
iTBS session would raise the threshold of neuron firing, so that the next session; if 
given in an appropriate time following the previous session, would result in decreased 
MEP amplitude.  
This has been shown in several studies, for example priming with an identical TBS 
session (iTBS-iTBS) or (cTBS-cTBS) caused a reversal of expected effect directionality 
(28). Similarly, sessions that last twice as long compared to standard TBS showed a 
reversal of effects (16). A recent study repeated iTBS sessions at either 5 or 15-minute 
intervals, and found a reversal of effects (a decrease in MEP amplitude) when iTBS 
sessions were administered 5 minutes apart, and an enhancement (increase in MEP 
amplitude) when two iTBS sessions were administered with 15 minutes between (3). 
Similar to our results, they reported no significant effect of a single iTBS session, with 
only 33% of participants showing a facilitated response, 27% no change, and 40% an 
inhibited response. As a comparison, in our study we found 35% showed a facilitated 
response, 25% no change, and 40% an inhibited response. On the group level, only 
53% of their participants showed a facilitation of MEP amplitude following their 
repeated iTBS sessions with 15 minutes in between (3). This is similar to our findings, 
where 45% showed a facilitation of MEP amplitude following accelerated iTBS with 
15-minute breaks. 
Inter-Session Interval 
We found no differences in MEP modulation by single vs accelerated iTBS, which is 
seemingly in contrast to reports of clinical efficacy of accelerated iTBS (4, 5, 14). One 
explanation for this discrepancy might be that our measurements were constrained to 
a single day, whereas clinical effects often emerge after two weeks or more (13, 14). 
150 
 
Additionally, in the clinic patients received 20 iTBS sessions over four days (5, 14), 
while in our study healthy participants received only five iTBS sessions.  Yet, if iTBS or 
accelerated iTBS do indeed have clinical effects, they must be through plastic 
mechanisms affecting cortical excitability, which should be measurable in motor 
cortex. One potential reason why we see no such effects of accelerated iTBS might lie 
in the short intervals between repeated iTBS protocols. Animal studies in rat 
hippocampal slices have shown that a delay of about one hour between iTBS sessions 
was necessary for additive LTP effects to occur (29). Specifically, the longer inter-
protocol intervals were required for recruitment of synapses that were not affected 
by the first iTBS stimulation. The first iTBS session is thought to induce LTP in low-
threshold synapses, and to lower the threshold for higher-threshold synapses. Shorter 
breaks of 10-30 minutes are not long enough for the high threshold synapses to be 
lowered (29).  There is evidence that 40-50 minutes is required for the initiation and 
protein synthesis of the synaptic machinery necessary for refractory LTP effects in 
synapses with different plasticity thresholds (29, 30).  
Recently, increasing the inter-protocol interval to 50 minutes has been successful in 
the treatment of severe depression (31). This could explain our results have not found 
an effect on MEP amplitude of repeating iTBS sessions with short (up to 15 minute) 
time between sessions.  
MEP variability 
Finally, substantial inter-subject variability has been reported among studies relying 
on MEP’s to assess cortical excitability (1, 2, 9, 21, 22). We also found large inter-
subject variability between our participants (Figure 6). In addition to this, intra-subject 
variability can be seen between different experiment days, as found by a recent study 
in our group comparing iTBS effects in the same subjects over their first and second 





Figure 6. Variability of MEP responses. Individual baseline-corrected MEP grand averages from 
0-60 minutes post stimulation are plotted, and 2-sided t-tests against 0 were performed for 




In this accelerated iTBS protocol testing study, we found no effect of iTBS on MEP 
amplitude on the group level. We found that a single iTBS session did not increase 
MEP amplitude, which has been shown previously (1, 2, 9, 21, 22). We also found no 
evidence for accelerated (5 times) iTBS with short breaks between iTBS sessions to be 
a more effective alternative, with no difference between 8 or 15-minute breaks. Our 
results could be explained by evidence from animal research, where at least 45-
minute breaks are required for additive efficacy of iTBS sessions (29, 30). Accelerated 
iTBS with longer intervals between sessions may also be effective as a depression 
treatment (31). As further, exploratory analysis, we computed post-hoc analysis of 
response patterns. We were able to characterize an ‘opposite responder’, i.e. a 
response in the other direction than expected. This is important in clinical 
applications, where an opposite response is detrimental to recovery. Future studies 
should consider the high variability and patterns of response to brain stimulation 
protocols. Established protocols such as iTBS cannot be assumed to increase cortical 
excitability at the individual or even group level, which has implications for studies 
using brain stimulation on other cortical areas for their involvement in cognitive tasks. 
Moreover, we found no evidence of potential additive plasticity effects through 
accelerated iTBS protocols, in which several sessions are repeated within one day with 
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The overall aim of this thesis was to investigate the underlying neuroplastic 
mechanisms induced by transcranial magnetic stimulation (TMS) in humans, through 
an interdisciplinary series of studies using a variety of techniques. The experimental 
chapters of this thesis describe six different studies, beginning with three in an in vitro 
human neuronal cell culture model, and moving to three in human participants. In 
human neurons, the aim was to investigate the plasticity-related mechanisms induced 
by both excitatory and an inhibitory repetitive TMS (rTMS) protocols, specifically 
through measuring neural activity (calcium imaging), gene expression, and 
morphological and structural changes. We found evidence for immediate changes to 
cell activity following stimulation, but few changes in gene expression and 
morphology. In humans, the aim was to use indirect measures of assessing plasticity 
after the same excitatory protocol used in the first three chapters. We found in 
healthy participants that repeating multiple stimulation sessions in a single day did 
not promote additive plasticity effects. We also did not find evidence that TMS could 
be used to assess plasticity in participants with altered neuroplasticity (insulin 
resistance). Finally, we show using concurrent EEG-TMS and fMRI that excitatory 
stimulation to left dorsolateral prefrontal cortex (LDLPFC) was able to promote 
activation in several important cortical and subcortical structures. Overall, from 
stimulation of living human cell cultures to human participants rTMS has been used in 
this thesis to induce and investigate neuroplastic changes with a range of microscopic 
to macroscopic outcome measures.  
Summary of findings 
This thesis begins with molecular studies in vitro, and moves towards TMS stimulation 
of human participants. For the molecular, in vitro studies, the human SH-SY5Y cell line 
was introduced. SH-SY5Y cells are derived from a human neuroblastoma, and they can 
be differentiated in vitro to a mature, neuronal-like state (1-3). They can be used as a 
model of human neuronal plasticity, as they express many plasticity-related genes as 
well as morphological and functional characteristics of mature neurons (3-5).  
SH-SY5Y cells are grown in a cell culture medium that is commonly supplemented with 
3-10% fetal bovine serum (FBS, serum). To differentiate SH-SY5Y cells to a mature 
state, retinoic acid (RA) is often added to the cell culture medium, and the 
concentration of supplemented serum is reduced, for example from 10% to 3% (1, 6, 
7). Once fully differentiated, the remaining supplemented serum is commonly 
removed from the culture medium before experimentation. This is to synchronize the 
cells to the same phase of the growth cycle (8) as well as to remove all growth factors 
and proteins which may have confounding effects on the experimental intervention 
(9, 10). However, the acute effects of such a complete serum removal from 
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differentiated SH-SY5Y cells had not previously been examined, in particular the 
effects on plasticity gene expression and structural outcome measures.  
In Chapter 2, the effects of serum removal on gene expression and morphological 
markers of plasticity were assessed. We found that serum removal from differentiated 
SH-SY5Y cells does cause acute changes in plasticity markers, in particular in the gene 
expression and morphological outcome measures, which we were interested in 
investigating after iTBS and cTBS. Therefore, in all subsequent chapters we did not 
deprive differentiated SH-SY5Y cells of serum before stimulation. This chapter also 
provides important information for future studies using differentiated SH-SY5Y cells as 
a model for plasticity effects on gene expression and morphology. We show that the 
removal of serum causes acute changes in the expression of genes related to plasticity 
and in neuron morphology, which may mask any plasticity effects of the particular 
intervention. It is therefore important to consider the impact of serum removal before 
experimentation, and perhaps refrain from or thoroughly verify that such acute 
removal would not affect specific target genes/markers of interest before applying the 
intervention.  
Chapter 3 describes the first in-vitro study using the theta burst stimulation (TBS) 
protocols on human neuron-like cells in culture. We were first interested in whether 
stimulation with intermittent TBS (iTBS), a three-minute protocol assumed to have 
excitatory effects, and continuous TBS (cTBS), a 40-second protocol assumed to have 
inhibitory effects (11) have opposite effects on immediate neuronal excitability. To do 
this, we used differentiated SH-SY5Y cells to investigate functional changes in 
neuronal activity, as measured through live calcium imaging. Cells were incubated 
with a fluorescence calcium indicator (Fluo-4AM, Thermo Fisher) which binds calcium 
at concentrations in the 100nM-1mM range (12). Resting calcium levels in neurons are 
between 50-100nM (13), therefore there is almost no fluorescence signal detected at 
baseline. Cells were then stimulated with iTBS, cTBS, or sham stimulation. 
Immediately after stimulation, there was a slight increase in fluoresce levels, however, 
when a depolarization was chemically induced with 1M KCl, a large increase in 
fluorescence levels was recorded. Importantly, cells that had been stimulated with the 
excitatory protocol (iTBS) showed a stronger increase in fluorescence compared to 
sham stimulated cells. Cells stimulated with the inhibitory protocol (cTBS) showed a 
lower fluorescence response to chemical depolarization compared to sham stimulated 
cells. These results provide support for the expected opposite effects of iTBS/cTBS on 
neuronal excitability, namely that iTBS can increase and cTBS can decrease neural 
responsiveness to subsequent depolarization. Further research in more complex 
human neuron models is needed, however these results provide preliminary support 
for the generally assumed effects of these two commonly used protocols, as well as 
provides a potential outcome measure for assessing the responsiveness of neurons to 




To investigate the longer-lasting effects of iTBS and cTBS, we chose to measure 
changes in gene expression and neuron morphology. This is done in Chapter 4, using 
the same human neuronal model (differentiated SH-SY5Y cells) as in Chapter 3. Gene 
expression changes specifically related to plasticity were measured, as well as 
morphological changes in the organization of proteins βIII-Tubulin and MAP2, which 
have also been related to plasticity (14-17). We found that stimulation did not lead to 
dramatic morphological or gene expression changes in any of the plasticity markers 
measured. There was however a slight increase in two genes we measured, NTRK2 
and MAPK9, 24 hours after stimulation. iTBS has been shown to increase excitability, 
as shown in studies in human motor cortex (11), as well as in SHSY5Y cells in Chapter 3 
of this thesis. Therefore, an increase in the expression of these genes may indicate 
plasticity processes induced by iTBS.  
Thus, in Chapters 2-4 the human neuronal cell model (differentiated SH-SY5Y cells) 
was introduced and established, and the effects of rTMS stimulation on immediate 
neuronal activity, gene expression, and morphology in this model were described. 
Evidence for increased neuronal excitability was shown, as well as some support for 
iTBS-induced plasticity effects on gene expression.  
There are benefits to using a human in vitro neuronal model to measure the plasticity-
inducing mechanisms of rTMS, which are further discussed below. However, it is 
important to complement human in vitro studies with in vivo ones. There are many 
large differences between the human brain and human neurons grown in a dish, and 
to fully understand and optimize rTMS for use in research and clinically, its effects 
need to be examined across all levels. Chapter 5 offers an example of how cellular and 
animal studies can be used to inform and design rTMS protocols for use in the clinic.  
This chapter reviews the concept of metaplasticity, and the importance of 
fundamental research to inform the necessary timing between subsequent rTMS 
sessions to maximize stimulation effects. This review is also important in the 
interpretation of the results of Chapter 6, where iTBS sessions are repeated five times 
in a single day in order to maximize excitatory effects of stimulation. 
In the first chapter involving healthy human participants (Chapter 6), we were 
interested in investigating the effects of ‘accelerated iTBS’, a protocol consisting of 
repeated iTBS sessions in a single day, which has shown efficacy in the treatment of 
depression (18, 19). Despite its success in the clinic, the efficacy of accelerated iTBS 
over motor cortex using motor evoked potentials (MEPS) as an outcome measure, had 
yet to be shown. In this chapter, the effects of accelerated iTBS on corticospinal 
excitability (using MEPs) for up to 90 minutes following the stimulation were assessed. 
Effects on MEP amplitude were compared to that after a single iTBS session, and to 
sham. In a fully within-subject design, we found that there was no effect of 
accelerated iTBS on motor cortex excitability compared to sham. As discussed in 
232 
 
Chapter 5, evidence from animal studies showed that longer breaks (60 minutes) may 
be required to maximize excitability effects in repeated stimulation protocols. This 
could explain why, in Chapter 6, we were unable to measure stronger excitability 
effects, as the breaks between stimulation sessions were maximally 15 minutes and 
thus may have been not long enough to promote measurable neuroplastic effects.  
However, in Chapter 6, the effects of iTBS on neuroplasticity were assessed only 
through motor evoked potentials (MEPs), which can be influenced by many sources of 
variability (biological, experimental, etc. (20)). Therefore, in Chapter 7, MEPs were 
combined with TMS-evoked potentials (TEPs) to assess excitability after iTBS. 
Additionally, this chapter investigated iTBS-induced neuroplasticity in type II diabetes 
(T2DM) patients, known to have altered neuroplasticity mechanisms. T2DM patients 
(and high-BMI matched control participants) were classified using blood samples as 
having insulin resistance (IR) or as being matched controls. The aim of this study was 
to investigate whether the degree of insulin resistance correlated with TMS-based 
measures of excitability (MEPs, TEPs). We found no difference in TMS-based 
neuroplastic responses between the IR and matched control groups, and no 
correlation between IR and TMS-based measures of excitability. However, we did not 
find evidence for iTBS-inducing neuroplastic mechanisms in our control group, 
indicating that future studies using a more effective plasticity inducing protocol, such 
as accelerated iTBS, are needed to draw any conclusions from this clinical population.  
In Chapters 6 and 7, iTBS protocols were applied to either a healthy or clinical 
population, and TMS-based measures of assessing neuroplasticity (MEP/TEP’s) were 
used. In both these studies, we found no effect of iTBS stimulation on promoting 
neuroplasticity when stimulating the motor cortex. This adds to recent reports from 
other groups showing difficulties in replicating the assumed excitatory effects of iTBS 
(21-23).  
In the clinic, iTBS has been shown to be an effective option for the treatment of 
depression (24), where stimulation is delivered to frontal cortical areas such as the 
DLPFC (24-26), as opposed to the motor cortex. Therefore, it would be beneficial to 
assess neuroplastic effects of iTBS directly in the DLPFC rather than the motor cortex. 
The study described in Chapter 8 uses a multimodal approach combining TMS, EEG 
and fMRI, pioneered several years ago at Maastricht University (27, 28), to examine 
the neuroplastic effects of iTBS in the DLPFC. This chapter presents preliminary results 
of a within-subject design on eight healthy participants. Offline iTBS stimulation (or 
sham) was delivered to the left DLPFC, followed by concurrent single TMS-pulses in 
the 3T MRI, while simultaneously recording the EEG signal. The project is ongoing, but 
preliminary results suggest that TMS pulses to the DLPFC are able to activate deeper 




that alpha power can modulate the signal elicited by high intensity TMS pulses at 
subcortical structures.  
Throughout the six experimental chapters in this thesis, the neuroplasticity 
mechanisms induced by TMS have been investigated using several different 
techniques and experimental setups. The effects of commonly used rTMS protocols 
iTBS and cTBS have been assessed in a human neuronal cell culture model (neural 
activity, gene expression, morphology), a healthy human population (MEPs), a clinical 
human population (TEPs, MEPs), and finally in a multimodal approach combining TMS-
EEG and fMRI. Our human neuronal cell model was used to establish strong functional 
effects of iTBS and cTBS, as recorded using live calcium imaging (Chapter 3), while 
effects on plasticity-related gene expression and neuron morphology showed fewer 
clear differences between iTBS and cTBS over several later time points (Chapter 4). In 
two of the chapters describing human studies (Chapters 6 and 7), we were unable to 
replicate the established effects of iTBS on MEP amplitude. This difficulty replicating 
the expected iTBS effects has been reported by several other studies (21, 22, 29). 
Limitations of the findings in vitro and of the indirect human neuroplasticity outcome 
measures in vivo are described in the section below.   
A human neuron-like model for assessing TMS effects 
SH-SY5Y human neuroblastoma cells were chosen as a human neuronal model for the 
studies described in Chapters 2-4 of this thesis, as they are relatively easy to culture, 
can be fully differentiated to a mature neuronal-like state (1, 2, 7), and express 
mature neural markers and functional synapses which have been well documented in 
the literature (3, 30-33). This makes them a good model for exploratory, pilot studies 
such as those described in this thesis.  
Why move to human in vitro neural models? 
Animal models have been critical in advancing our understanding of the underlying 
mechanisms of TMS (for reviews; see (34-36)). Animal models have provided evidence 
for the hypothesized opposing neuroplastic effects of iTBS and cTBS (37-39), and 
showed that TMS is capable of inducing an immediate release of intracellular calcium 
following stimulation (40, 41). However, there are several key aspects which limit the 
use of animal models when modelling the complexity of the human brain (42). Several 
animal studies have been carried out in cat (43) and non-human primates (44-46), 
though most studies have used rodents or cell cultures derived from rodents in TMS 
studies (37-41, 47-52). Despite the obvious difference in size and organizational 
complexity between the human and rat brain, human neurons also show different 
gene regulation and expression patterns (42, 53), and different baseline neuronal 
excitability (54-56). Thus, as TMS is thought to work through altering neuronal 
excitability (57), it is important to use human neurons to verify findings from animal 
models. Before the experiments described in this thesis, only two studies had used a 
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differentiated SH-SY5Y cells to investigate the effects of rTMS (33, 58), and none had 
investigated the effects of iTBS/cTBS in a human neuron or neuron-like model.  
Chapters 3 and 4 are the first to describe the effects of iTBS/cTBS on calcium activity, 
gene expression, and morphological markers of plasticity in a human neuron-like 
model. In contrast to animal studies (38, 39, 59), in Chapter 4 we did not show strong, 
opposite effects of iTBS/cTBS on plasticity markers. However, this may be due to the 
different stimulation parameters used, and the lack of cortical organization and 
inhibitory interneurons in our human neuronal setup. We stimulated at 100% 
maximum stimulator output, in order to ensure that TMS was able to induce activity 
in our cells. This is verified by our findings from Chapter 3, which convincingly show 
that iTBS and cTBS are able to immediately induce changes in response to chemical 
depolarization using calcium imaging. However, animal studies often repeat iTBS/cTBS 
protocols several (up to five) times (38, 39, 59), while we stimulated our cells with a 
single iTBS/cTBS protocol. Therefore, the many more stimulation pulses could explain 
our lack of strong findings in SH-SY5Y cells on the gene expression and morphological 
levels. 
Additionally, our findings in Chapter 4 describing the gene expression and morphology 
effects after stimulation can also be explained by several limitations of our SH-SY5Y 
human neuron-like cell model. First, they are derived from human neuroblastoma 
cells; and while differentiation protocols aim to establish mature, neuron-like 
phenotypes in the majority of cells (1, 7), there is still dish-to-dish variation between 
cultures (6). For instance, there are different ratios of mature, neuron-like cells and 
undifferentiated, epithelial-like cells, which likely respond differently to TMS.  
Second, SH-SY5Y cells develop a catecholaminergic-like phenotype, with the potential 
to synthesize dopamine and noradrenaline (30). They do not represent the mix of 
excitatory (glutamatergic) and inhibitory (GABAergic) neurons thought to be most 
involved in rTMS response (34), or the complex spatial organization of cortical 
columns within the human brain. Animal studies often investigate TMS effects over 
the whole cortex, or in slice cultures, which contain various neural cell types. Animal 
studies have found TMS effects to be specific to the cortical region (59), and largely 
working through inhibitory interneurons (37, 39, 48, 60-62) both of which are not 
represented in our SH-SY5Y setup.  
In humans, many biological and experimental factors contribute to the high degree of 
variability associated with indirect assessment of TMS-induced neuroplasticity using 
MEPs (20, 21, 36). By performing experiments in a human neuron-like model, we 
show the value of systematically assessing the neuroplastic effects induced by 
iTBS/cTBS from the most basic level up. In Chapter 3 we show that iTBS can increase 
the excitability of neurons as expected. Future studies can build on this finding, in 




cerebral organoids, to human cortex), to better understand which layers contribute to 
variability of TMS responsiveness. Through in vitro human studies, these factors can 
be measured and controlled, and can contribute to a better understanding of how 
TMS is able to induce neuroplasticity in human neurons.  
Future Directions of human in vitro modelling 
Future studies using the SH-SY5Y cells could be informative by applying different TBS 
protocols (such as accelerated protocols, or repeating sessions up to five times as in 
some rodent studies (38, 39, 59)), different gene expression or morphological 
assessment techniques, or following up on protein/phosphorylation changes in these 
cells. However, based on the limitations of SH-SY5Y cells as a model for human 
neurons following TMS, it would also be beneficial to consider more complex, 
advanced human neuronal setups. The studies described in this thesis were important 
in piloting the setup in SH-SY5Y cells, and serve as a basis for future studies in more 
complex human in vitro neural models to better understand TMS neuroplasticity 
effects.  
For example, it is now possible to take fibroblasts from a skin biopsy and transform 
them through treatment with a series of reprogramming factors to become induced 
pluripotent stem cells (iPSCs) capable of differentiating to any cell fate, including 
neurons (63). Since this ground-breaking discovery in 2006, protocols for direct 
differentiation from fibroblast to neural progenitor cells have become available (64-
66). After differentiation to functional neural progenitors, neurons can then be further 
differentiated into specific neural phenotypes (glutamatergic, GABAergic, 
dopaminergic, serotonergic, motor neurons, etc.) (67).  iPSCs can also organize into a 
3D structure, or cerebral organoid, which can be used to model the complexity of 
neurodevelopment of the human brain (68, 69).  
The development of these advanced, in vitro human neural model systems has 
allowed for progress in disease modelling, but also in personalized medicine. For 
example, TMS is widely used as a clinical treatment for a range of psychiatric and 
neuropsychological disorders (70). It is most widely used as a treatment for 
depression (25, 26, 71), however many patients are nonresponsive to treatment, with 
about a third of patients completing stimulation treatment in remission (72). iPSC-
derived neurons offer the possibility to pre-screen patient-derived neurons for 
responsiveness to particular stimulation protocols, before undergoing TMS treatment. 
In this way, the parameters of stimulation protocols could first be optimized in vitro, 
which would likely improve the remission rate in the clinic. Building on the results 
presented in Chapter 3, one relatively quick way to assess whether neurons respond 
to specific TMS protocols could be to test their responsiveness to rTMS protocols with 
calcium imaging. This method could potentially verify whether patient-specific 
neurons respond to a particular stimulation protocol within a relatively limited time 
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window. This method would furthermore benefit from validation in iPSC-derived 
neural setups, while forming a proof-of-principle study of how in vitro human neural 
models and interdisciplinary research can be extremely valuable for the future of TMS 
applications.  
Indirectly assessing neuroplasticity in humans 
In the first half of the thesis, techniques such as calcium imaging, qPCR and 
immunocytochemistry were used to directly measure the molecular neuroplasticity 
changes induced by iTBS and cTBS in SH-SY5Y cells. In the second half, such a direct 
assessment of molecular changes following stimulation was not possible. The studies 
done in humans relied on indirect measures to assess neuroplasticity, such as 
corticospinal (MEP) or cortical (TEP) excitability assessment measures, as well as 
neuroimaging (fMRI). In Chapters 6 and 7, we report difficulty in replicating the 
established, excitatory effects of iTBS. In Chapter 6 and 7, we found no difference 
between MEP amplitude induced by sham, iTBS or accelerated iTBS. Essentially, we 
were unable to validate the assumption that iTBS increases cortical excitability in 
humans, as measured by corticospinal assessment (MEP amplitude).  
This difficulty in replicating an iTBS-induced increase in corticospinal excitability as 
assessed through MEP amplitude has also been reported by several other groups (21, 
23, 29). Our null findings do not necessarily indicate that iTBS does not work as 
previously hypothesized, but highlight the limitations of using MEP amplitude as an 
indirect assessment outcome measure following stimulation.  
For example, the use of MEPs can be confounded by substantial variability related to 
both experimental and biological factors (20). Several uncontrollable neurobiological 
dynamics such as cortical network activity, developmental factors and 
neurotransmitter availability are thought to influence the variability of responses (36). 
Substantial intra-subject variability has also been reported, for example with subjects 
showing highly variable responses to iTBS stimulation on different experimentation 
days (22). To control for as many factors as we could, in Chapters 6 and 8 we planned 
all experiments (if possible) at the same time of day, 1 week apart, and told 
participants to maintain a normal routine and drink the same amount of caffeine as 
normal. While we aimed to control for as many confounding factors as possible, MEPs 
remained a variable outcome measure in these two studies.  
Additionally, brain-state has been suggested as a factor contributing to variability of 
individual responses to rTMS protocols (73). For example, in a setup such as that in 
Chapter 6, where iTBS sessions were repeated multiple times within a single day, the 
effects of brain state can strongly influence results. Even the effect of the metal 
visualization of activity can prime the motor cortex and affect MEP amplitude (74-76). 




between participants during the breaks between iTBS sessions. We did this by playing 
the same video clips to all participants, to hopefully maintain a relatively controlled 
group brain state.  
An alternative to MEPs as an assessment of corticospinal excitability is to use 
simultaneous TMS-EEG, and to record TMS-EEG evoked potentials (TEPs). TEPs are 
recorded in the ongoing EEG signal, where positive (P) and negative (N) fluctuations at 
predictable latencies milliseconds after the TMS pulse (N15, P30) can indicate neural 
excitability (77-79). TEPs are not yet commonly used to assess neuroplasticity, 
however they have been shown to be highly reproducible (80, 81), in contrast to MEPs 
(22). In Chapter 7, we found no effect of iTBS on any TEP component measured (N15, 
P30, N15-P30). As this study was carried out in an elderly population of participants 
with high BMI or clinical T2DM diagnosis, it is difficult to draw conclusions on the use 
of TEPs to assess neuroplasticity, as iTBS may have been unable to induce the 
hypothesized neuroplastic effects in this clinical population. Since we also found no 
effect of iTBS on MEP amplitude, it is feasible that a single iTBS protocol is not 
sufficient to induce neuroplastic changes in this participant group. However, the 
accelerated protocols, such as those used in Chapter 6 may be a promising 
alternative. The mini-review in Chapter 5 also hypothesizes that accelerated protocols 
with longer breaks between stimulation sessions may be more effective at promoting 
stronger neuroplasticity effects in the clinic.  
In this thesis, both Chapters 6 and 7 describe a lack of iTBS effects on indirect 
outcome measures; MEPs and TEPs. Additionally, in Chapter 4, gene expression and 
morphological markers of plasticity show little to no modulation by iTBS at the cellular 
level. Therefore, three chapters in this thesis do not provide support for the assumed 
excitatory-effects of iTBS. Importantly, we do show evidence for an immediate 
modulation of neural calcium activity induced by iTBS at the cellular level (Chapter 3). 
Cells that were stimulated with iTBS showed a stronger fluorescence response to 
chemical depolarization thank sham and cTBS stimulated cells. This fundamental 
finding in a simple, monolayer human neural setup is important to contrast with the 
null in vivo and in vitro findings described in Chapters 4, 6 and 7.   
Homeostatic Plasticity 
The underlying neuroplastic effects of rTMS are thought to work through synaptic 
plasticity, as well as by altering molecular mechanisms, which maintain a dynamic 
threshold for subsequent plasticity (82-85). Therefore, if the first stimulation primes 
the neuron for a particular direction of plasticity (for example LTP), homeostatic 
plasticity would act against this to promote plasticity in the opposite direction (LTD, in 
this example) following the subsequent stimulation. A full review on metaplasticity 
and its relation to brain stimulation studies can be found in Chapter 5.  
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Accelerated iTBS (Chapter 6) is also important to interpret in light of the mini review 
of metaplasticity in Chapter 5. With accelerated iTBS in particular, homeostatic 
metaplasticity mechanisms may act against intended stimulation effects. Accelerated 
protocols have also been shown to be effective when given with 50 minutes between 
stimulation (86), which aligns with animal research describing that 40-60 minutes 
between stimulation sessions is required to ensure additive LTP effects (87, 88). 
Accelerated iTBS protocols offer a promising alternative as an optimized treatment 
protocol, but it is important to consider homeostatic plasticity effects from in vitro 
studies, to best determine optimal spacing between stimulations. 
Interdisciplinary Research 
The research in this thesis aims to provide some insight into the neuroplasticity 
mechanisms induced by iTBS and cTBS. More generally, the interdisciplinary aspect 
(studies in both in vitro and in vivo, and using a range of techniques) of this research 
can highlight the value of these combined approaches. For example, as described in 
the mini review in Chapter 5, fundamental research on in vitro models is critical for 
determining the optimal parameters for clinical or research stimulation protocols in 
humans. Additionally, starting from a simple, unorganized neuronal model such as SH-
SY5Y cells and building up to more complex in vitro models containing relevant 
functional organization can provide valuable information on processes influencing the 
large variability of rTMS responses in humans. Combining both fundamental, cellular 
studies where such stimulation protocols can be directly tested for effectiveness, and 
clinical studies where these protocols can be tested in patients are important. In the 
future, this presents the possibility for personalized medicine, by deriving patient or 
person-specific neural cells (iPSC-derived) and testing the effects of various 
stimulation protocols, before stimulation of the patient/person in the clinic or lab. 
This could greatly benefit the effectiveness of brain stimulation protocols.  
However, there have been some additional challenges in the dissemination of some of 
the studies described in this thesis, which may be partially related to their 
interdisciplinary nature. For example, we have received many critiques of our studies, 
such as not fitting the scope of the journal, and not having a strong, realistic human 
neuronal model. While there are certainly limitations to the use of SH-SY5Y cells 
(discussed in detail in the discussion of Chapters 2,3 and 4 as well as above), the novel 
and interdisciplinary aspect of the studies was often overlooked. Therefore, in 
addition to the high-risk nature and variety of techniques in these studies, this 
difficulty with dissemination is an additional barrier that we have encountered in this 
interdisciplinary research.   
Different perspectives, skill sets, and communication methods are critical to start 
unravelling the complexities of the human brain. For the studies included in this thesis 




such as TMS, we can move towards optimizing them, personalizing treatment options, 
and predicting the most successful outcome measures.  The exploratory studies 
presented in this thesis provide a basis from which future research can build on, to 
hopefully better understand, develop and optimize rTMS protocols for 
patient/research use.  
Concluding remarks 
The main aim of this thesis was to investigate the neuroplasticity mechanisms induced 
by TMS (iTBS/cTBS) in humans. Starting from the neuronal level and working up to 
studies in human participants, the experiments described in this thesis begin to 
unravel the neuroplastic mechanisms induced by TMS, and pave the way for future 
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“If all you have is a hammer, everything looks like a nail.” 
-Abraham Maslow, “The Psychology of Science”, 1966 
This thesis describes a series of experiments which advance our understanding of a 
widely used neuroscientific and therapeutic tool, Transcranial Magnetic Stimulation 
(TMS). In addition to the scientific and societal impact of the results described, this 
thesis is an example of approaching a research question from different perspectives 
and combining different disciplines, expertise, and research techniques to approach 
scientific bottlenecks. It is the first funded project in a newly established collaboration 
between the Faculties of Psychology and Neuroscience (FPN) and Health Medicine 
and Life Sciences (FHML) called the “Centre for Integrative Neuroscience (CIN)”. This 
initiative has allowed for the bridging of research, expertise, techniques and 
communication between two different neuroscience disciplines at Maastricht 
University.   
The research and main findings described in this thesis are important for advancing 
our understanding of how TMS exerts its effects. TMS is a form of non-invasive brain 
stimulation, which is widely used in neuroscience research around the world. It uses 
electromagnetic pulses to briefly and painlessly send electricity into the brain (1). For 
example, when a pulse is given over the motor cortex, it can directly activate the 
neurons beneath, carrying an electrical signal along a specific neural circuit to a finger 
muscle, and causing a visible finger twitch (2). When many of these pulses are 
repeated in a specific pattern (as repetitive, rTMS), longer-lasting stimulation effects 
can be induced, including increased or decreased activity of a particular brain region 
(3). In other words, giving a short round of rTMS over a particular brain region can 
deactivate or increase activity in that specific brain region for a short time after the 
stimulation is over. This is very useful in understanding what role a particular brain 
region plays in certain processes.  
Perhaps the most important use of rTMS is in the clinic, where it is a treatment option 
for several psychiatric and neurological disorders. It is most commonly used as a 
treatment for depression (4-6), but obsessive-compulsive disorder (OCD), pain and 
stroke are some other examples of disorders being treated with rTMS (7). Despite the 
widespread use of rTMS both in research and therapeutically, the underlying 
mechanisms are relatively unknown. Understanding the very basic, molecular 
machinery which underly rTMS effects would allow us to design stimulation patterns 
to be the most safe and effective for research and clinical treatment. With advances in 
neuroscientific methods, it may even be possible personalize treatment protocols, but 
only with a strong background of research identifying reliable molecular targets of 
rTMS effects.  
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This thesis takes a unique, inter- and cross disciplinary approach to understanding the 
underlying molecular mechanisms of TMS. It is interdisciplinary for combining studies 
on a molecular level using human neurons grown in the lab (Chapters 2-4), with rTMS 
studies in human participants (Chapters 6-8). Several important findings are reported 
in these chapters, and they contribute to a better understanding of how rTMS is able 
to create lasting effects in humans. We show in Chapter 3 that human neurons 
stimulated with different rTMS protocols respond in the expected way. Neurons 
stimulated with an rTMS protocol thought to increase the activity of a particular brain 
region were more strongly activated than neurons stimulated with an rTMS protocol 
thought to decrease it. Similarly, in Chapter 4 we show evidence for increased 
expression of a few important genes after stimulation with the excitatory protocol, 
but more research is needed on the specific molecular pathways activated by the 
different stimulation protocols. In humans, we show that it can be difficult to replicate 
the expected effects of stimulation due to many sources of variability, which again 
supports that future research in human cellular models such as in Chapters 3 and 4 is 
important. We hypothesize that combining multiple stimulation sessions could 
enhance stimulation effects, and in the final chapter (Chapter 8) provide preliminary 
evidence that stimulation at one area of the brain could lead to activation of different, 
remote brain areas. Overall, the findings of this thesis both in human neuronal cell 
culture and in human participants add to our understanding of the underlying 
mechanisms of TMS, and offer suggestions for future research in this area.  
One of the larger, societal impacts of these findings lies in the therapeutic potential of 
TMS. We are currently in the middle of a serious global pandemic, where many are 
forced to self-isolate, work from home and are burdened with financial and health 
worries. This understandably has a large impact on the mental health of millions 
worldwide, with likely consequences such as an increase in the global burden of 
depressive disorders for years to come (8).  
Depression is one of the most severe mental health disorders, ranked by the WHO as 
the single largest contributor to global disability (9), and with several large studies 
consistently placing it within the highest for disease burden and disability adjusted life 
years (DALYS) (10-12). Depression therefore has a huge impact on the quality of lives 
of millions of people worldwide, having substantial social and economic 
consequences. In addition to severely reducing the quality of lives of people suffering 
from depression, the economic costs of depression are huge. Global estimates of costs 
due to lost productivity are in the billions (US dollars) (13), not to mention the burden 
on the healthcare system. This indicates the critical need for an effective and quick 
treatment option. The findings of this thesis highlight the potential of a short-duration 
rTMS protocol: intermittent Theta Burst Stimulation (iTBS), which requires only 3 
minutes to apply, and has also been shown to be effective as a treatment for 




used to treat many people per day. This thesis provides support for iTBS as a 
treatment protocol, in particular when repeated several times in a single day (as 
accelerated iTBS). A review on this idea is also included as a chapter in this thesis.  
There are several steps required for the findings described in this thesis to have a 
clinical impact, not only in the treatment of depression but also in the treatment of 
other mental and neurological disorders. First, more research needs to be done on the 
efficacy of accelerated iTBS with longer intervals (50-60 minutes). For instance, 
research with healthy participants in a similar setup as described in Chapter 6, but as 
proposed in Chapter 5, with three iTBS sessions separated by 50-60 minutes. If this is 
proven effective in healthy participants, large clinical trials could test whether it is also 
as effective as a treatment. Some potential disorders where this could be effective 
could be in cognitive decline and dementia, where patients could do cognitive 
enhancement tasks (memory games, reading or drawing tasks) during the long breaks 
between iTBS sessions. Similarly, as a treatment for depression, Cognitive Behavioral 
Therapy (CBT) could be done in the breaks between iTBS sessions, as this combination 
has proven to improve treatment efficacy (15).   
At the molecular level, further research following up on the findings of this thesis 
using TMS and human neuronal cells is needed. Identifying specific, molecular 
mechanisms of rTMS effects could help us to understand why some people respond 
well to rTMS treatment, but others do not. This thesis provides evidence for calcium 
imaging being a potential indicator of iTBS efficacy (Chapter 3), but further research 
would be needed to confirm this. Studies could use patient-derived neurons to 
indicate whether a particular patient would be responsive to a particular stimulation 
protocol. For example, if a particular cellular response (such as calcium imaging) can 
indicate responsiveness to a certain rTMS protocol, then patients could have their 
neurons tested for responsiveness before undergoing rTMS treatment. Much more 
research is needed for this to be a realistic option in the future; however, this thesis 
provides a step in this direction towards identifying molecular targets to indicate rTMS 
efficacy, and to use these targets as predictors for patient responsiveness to 
treatment.        
Future studies can use more advanced human neuron models to investigate different 
molecular targets, and can work with other TMS users from different disciplines to 
better understand the limitations and main research questions in their research areas. 
Combining input from experts in computational modelling, engineers and physicists 
who can work to develop optimal TMS coil designs, and researchers/clinicians who 
use TMS on human participants or can establish a neuronal cell model are all 
important in advancing our understanding of how TMS works. In conclusion, this 
thesis provides an example of the benefits of interdisciplinary research, and describes 
several important findings which have a larger societal and clinical impact. Notably in 
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the treatment of depression, but also for other applications, where support for 
accelerated treatment protocols as well as molecular targets for assessing stimulation 
responsiveness are reported. Future interdisciplinary research into these ideas will 
lead us to gain deeper insights into the underlying mechanisms of rTMS, and optimize 
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